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The primary therapeutic use of norphi.c.e is to alleviate pain. 
Recent evidence suggests that opiates can exert their analgesic effect 
in three ways. First, opiates can inhibit prL~ary afferent transmis-
sion in the dorsal horn of the spinal cord. Cells in lamina I and V of 
the spinal cord which receive noxious input are inhibited by morphine: 
whether they are firing spontaneously, or induced to fire by noxious 
stimuli applied to their receptive field (Kitahata, Kosaka, Taub, 
Bonikos and Hoffert, 1974; Takagi, Doi a.c.d JL~aike, 1976; Duggan, Hall 
and Headley, 1977b). The response of cells in the spinal cord to non-
noxious stimuli (jet of air, light touch) are not inhibited by morphine 
(Calvillo, HenrJ and Neuman, 1974). Further support for a direct 
spinal action of opiates includes the finding by Yaksh and Rudy (1976) 
that morphine injected into the spinal subarachoid space of a rat (with 
its spinal cord transeeted) produces antinociception. The response was 
rapid, making unlikely the possibility that diffusion of the opiate to 
supraspinal structures was involved. Second, opiates can inhibit so-
matosensory affe:::-ent t!·ansmission at the supraspinal level. Morphine 
applied directly to the periaqueductal grey (PAG) hypothalamus, nucleus 
reticularis gigantocellularis and medial thalamus results in analgesia 
(Herz, Albus, .Metys, Schubert and Teschemact~er, 1970; Pert and Yaksh, 
1974; Takagi et al., 1976; Pert, 1978). One important observation con-
cerning brain regions that appear to mediate opiate analgesia is that 
they receive input from the anterolateral pathway of the spinal cord: 
l 
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a pathway which presumably carries pain information. Injection of ~or-
phine into certain other areas of the brain such as the cerebral cortex, 
tectum and midbrain reticular formation was ineffective in producing 
analgesia (Pert, 1978). However, interpretations of these findings are 
difficult in view of the possibility that morphine could have diffused 
into the ventricular system. Third, opiates can activate the descend-
ing inhibitory pathways. Descending pathways from the raphe magnus, 
periaQueductal grey and possibly the locus coeruleus inhibit the firing 
of dorsal horn cells and their responses to noxious input (Oliveras, 
Besson, Guilbaus and Liebeskind, 1974; Fields, Basbat,m, Clanton and 
Anderson, 1977; Basbaum and Fields, 1978) . SubseQuent studi.es have 
shown that syste_mically administered mor:phine increases the spontaneous 
activity of cells in the raphe magnus and PAG (Anderson, Basbaum and 
Fields, 1977; Urea and Liebeskind, 1979). Satoh and coworkers (1971) 
presented additional support for the importance of descending supra-
spinal control by demonstrating that bradykinin induced increases in 
activity of dorsal horn cells \vere inhibited by morphine (2 mg/kg) in 
intact rabbits, but not in spinal rabbits. 
With chronic exposure to morphine, tolerance to many of the 
acute effects develop and the sudden discontinuation of the drug leads 
to profound physiological and behavioral changes. 'l':fo methods have 
been used to establish the brain region~ important in the development 
of opiate dependence. One method involves the lesioning of discrete 
brain regions. Chemical or electrolytic lesions attenuate or abolish 
certain signs of opiate withdrawal. The following areas have been 
lesioned in the rat and shown to be involved: ventromedial nucleus of 
3 
the hypothalamus (Kerr and Pozuelo, 1971), medial forebrain bundle 
(Glick and Charap, 1973), noradrenergic bundles which innervate the 
thalamus or hypothalamus (Lewis, Costa and Jacobowitz, 1976), medial 
thalamic nuclei (Teitelbaum, Catravas and McFarland, 1974) and caudate 
nucleus (Borison, 1971). In addition, it ha,s been demonstrated in 
human addicts that prefrontal lobotomy reduces the craYing for opiates 
(Mason and Hamby, 1948). It is difficult to assess any c~US13.1 relation--
ship from such studies: the lesions may.owe their effects to nonspecif-
ic sequelae of the operation or to loss of integrated cerebral activity 
and circuitry which are essential to the expression of the opiate with-
drawal syndrome. The second method involves the microinjection of nar-
cotic antagonists into discrete orain sites. ?ne injection of naloxone 
into a n~~ber of brain regions precipitates abstinence in addicted rats. 
The brain sites in which these withdrawal signs could oe elicited a-
ppeared to be localized in the nucleus anterior ventralis, anterior 
media~is and parafascicularis of the ~halamus (Wei, Loh and Way, 1973). 
More recently, Wei and coworkers (1975) reported that injection of na-
loxone into the medial hypothalamus and periaqueductal grey matter e-
licited an intense withdrawal reaction in morphine dependent rabbits, 
and concluded that the medullary and pontine regions of tfJ.e brainstem 
were important areas for the development of opiate dependence. Al-
though there appeared to be site specificity with the microinjection 
studies, it is difficult to reach de~ite conclusions due to incomplete 
information about the spread of the injected antagonist. Both the le-
sion and microinjection studies suggest a numbe~ of different brain 
sites as foci fo~ addictive mechanisms; however, both studies suffer 
4 
from the inherent assum~tion (which need not necessarily be correct) 
that those areas which can elicit or su~press signs of withdr~val are 
those areas intimately involved in the development of dependence. In 
other words, it is not possible to decide whether the site of action 
was made at the primary site of withdrawal or along a complex neuronal 
circuit. 
The basic mechanisms underlying the acute analgesic effect of 
ouiates and opiate tolerance and addiction remain obscure in spite of 
numerous efforts by investigators usiP~ a variety of biochemical, be-
havioral and pharmacological techniques. It has been established that 
opiates act directly on neurons and the result of such an interaction 
are changes in the mer:tbrane properties of the neuron. It was my in-
tention to elucidate the underlying mechanism of acute and chronic o-
piate action in single myenteric neurons using an electrophysiological 
approach. 
Electrophysiologica~ studies of neural tissue may be carried 
out in vivo or in vitro. There are advantages and disadvantages to 
each approach. Studies in vivo are performed under physiological con-
ditions in which the anatomica~ and functional connections are left in-
tact. Further advantage includes the ability to record while the an-
L~al is moving and behaving normally. Yet, there are lL~itations to 
the i~ vivo approach. The method of drug administration is usually by 
local application onto the tissue under investigation (iontophoresis, 
microinjection) or by systemic injections into blood vessels. In either 
case the concentration of the drug and the exact site of drug action 
is unLnown. Advantages of the in vitro technique include the following. 
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One, the concentration of the drug at the site of its action is known. 
Two, the ionic composition of the perfusate can be altered when the 
ionic mechanism of action is to be studied. Three, it can generally 
be distinguished whether the observed effects are taking place directly 
on the neuron lli~der study. Limitations of the tec~Dique include main-
taining viability and stability for long periods of time and extrapo-
lation of the data to the whole animal is difficult because anatomical 
connections have been severed and the physiological mileu altered. 
The isolated myenteric plexus-longitudinal muscle of the guinea-
pig ileum is a site in the peripheral nervous system which is sensitive 
to the opiates. It is a network of neurons adherent to the longitud-
inal muscle layer of the gut wall. The myenteric plexus affords one 
the opportunity to measure electrophysiologically the activity of 
single mammalian neurons which are morphine sensitive. The tissue pro-
vides a convenient model to study the responses which directly follow 
the interaction of a narcotic agonist with the opiate receptor. The 
acute actions of opiates in this preparation are to inhibit the nerve 
mediated contraction of the longitudinal muscle by reducing the output 
of acetylcholine from cholinergic nerves and to inhibit the spontaneous 
' 
firing of neurons which can be recorded with extracellular electrodes 
(Paton, 1957; Schaumann, 1957; Sato, Takayanagi and Takagi, 1973; 1974; 
Dingledine, Goldstein and Kendig, 1974; Dingledine and Goldstein, 1975; 
1976; North and Williams, 1977). That the action of opiates on the 
myenteric plexus is mediated by opiate receptors identical to those 
subserving analgesia in the central nervous system (CNS) is substanti-
ated by the following evidence. First, the myenteric plexus possesses 
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opiate binding sites (Pert and Snyder, 1973). Second, the potency of 
an antagonist to inhibit naloxone binding in brain homogenates corre-
lates well with its dissociation constant for binding in the myenteric 
plexus (Creese and Snyder, 1975). Third, the opiate action is stereo-
specific and occurs at low concentrations. Fourth, the action of o-
piates is reversed with a concentration of naloxone several fold lower 
than that of the agonist (Kosterlitz et al., 1968; North and Williams, 
1977). Fifth, the relative potencies of a series of narcotic agonists 
in depressing the electrically induced contractions of the myenteric 
plexus-longitudinal muscle preparation are comparable to their analgesic 
potency in man (Kosterlitz and Waterfield, 1975; Creese and Snyder, 
1975). Sixth, narcotics in,.'-libit the spontaneous firing of myenteric 
neurons (Sato et al., 1973; Dingledine and Goldstein, 1975) which is 
similar to the action of opiates on central neurons (see review by North, 
1979a). Seventh, the antagonist potency of na~cotics determined in 
morphine-dependent monkeys correlates well with their antagonist potency 
determined on the guinea-pig ileum (Kosterlitz, Waterfield and Berthoud, 
1971~) • 
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1.1. OPIATE TOLERANCE k~ DEP&~ENCE 
When morphine is acutely administered to man a number of pharma-
cological effects are seen. Among the most salient acute effects are 
sedation, analgesia, euphoria, constipation, respiratory depression and 
cardiovascular depression. With repeated (chronic) exposure to morphine, 
tolerance to most of the acute effects develop. 1~at is, to attain a 
desired effect the dose of the narcotic must be progressively increased. 
Chronic administration of morphine leads to profound physiological and 
behavioral changes which readily become evident upon the sudden discon-
tinuation of the drug. The characteristic withdrawal syndrome >vhich 
ensues has many of its clinical manifestations in directions onposite 
....,,..., ' 
to thos.e seen when opiates are given acutel:r (Ja,ffe, 1968}. A more 
violent yet shorter lasting withdrawal syndrome is induced when nalox-
one or nalorphine is administered to chronically opiate treated individ-
uals (Jaffe, 1968). 
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1.1.1. Definitions 
Legal involvement in dealing with narcotic addiction along with 
common street terminology has led to much confusion over the exact def-
inition of the narcotic related terms. Efforts have oeen made oy the 
World Health Organization (WHO) to develop a consistent terminolo~J 
with an exact definition. The following terms are commonly referred 
to in this manuscript and their WHO definition is presented (IsoelJ. 
and Cr~usciel, 1970). 
Drug Dependence: A state, psychic and sometimes also physical, re-
sulting from the interaction between a living organism and a drug, 
characterized by behavioral and other responses that always include 
a compulsion to take the drug on a continuous or periodic basis in 
order to experience its psychic effects, and somet:i.m.es to ayoid the 
discomfort of its absence. Tolerance may or may not oe present. 
A person may be dependent on more than one drug. 
Psychic Dependence: A compulsion that requires periodic or contin-
uous adr.:tinistration of a drug to produce pleasure or avoid discom-
fort. This compulsion is the most pow·erful factor in chronic in-
toxification with psychotropic drugs, and with certain types of 
drugs may be the only factor involved in the perpetuation of abuse 
even in the case of most intensive craving. Psychic dependence, 
therefore, is the universal characteristic of drug dependence. 
Operationally, it is recognized oy the fact that the dependent con-
tinues to take the drug in spite of conscious admission that it is 
causing harm to his health and to his social and familial adjust-
ment, and that he takes great risks to obtain and maintain his sup-
ply of the drug. 
Physical dependence: A pathological state brought about by repeated 
administration of a drug and that leads to the appearance of a 
characteristic and specific group of symptoms, termed an abstinence 
syndrome, when the administration of the drug is discontinued or 
in the case of certain drugs -- significantly reduced. In order to 
prevent the appearance of an abstinence syndrome the continuous 
taking of the drug is required. Physical dependence is a powerful 
factor in reinforcing psychic dependence upon continuing drug use or 
in relapse to drug use after wi thdra;ral. 
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Tolerance: The state in which repetition of the same dose of a CL"Y>Ug 
has progressively less effect, or in which the dose needs to be in-
creased to obtain the 5ame degree of pharmacological effect as was 
caused by the original dose. 
Cross-tolerance: The state in which tolerance to one drug has the 
effect of causing tolerance to another drug of the same or a dif-
ferent chemical type. 
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1.1.2. Opiate Receptor Studies 
The concept of receptors was originally introduced by Paul 
E'nrlich who stated that "substances can only be anchored at any partic-
ular part of the organism if they fit into the molecules of the recip-
ient complex like a piece of mosaic finds its place in a pattern" 
(Ehrlich, 1960). However, several criteria must be fulfilled before a 
binding site can be classified as an opiate receptor. 'I'he drug must 
have a high affinity for the binding site, there must be a difference 
in the affinity with which stereoisomers bind, the number of binding 
sites must be limited, and interaction of an agonist w·ith the binding 
site must elicit a hiological response. 
The interaction of opiates with high affinity membrane binding 
sites ·(re~eptors) results in a series of neuronal events leading to 
changes in pain perception, motor behavior, mood and autonomic ·.:respons.es. 
Opiate receptors have been localized to discrete brain areas; some prob-,. 
ably subserve pain perception but others are not associated 1vith pain. 
'Two techni~ues have been used to study opiate specific binding 
sites (receptors) in nervous tissue. The radioreceptor assay is an ill 
vitro technique which discrimi::J.ates between opiate enantiomers (Pert 
and Synder, 1973). Radioreceptor studies have revealed that the fol-
lowing brain regions are rich in opiate stereospecific binding sites: 
caudate, putamen, amygdala, periaqueductal grey, thalamus, hypothalamus 
and substantia gelatinosa (Kuhar, Pert and Synder, 1973; Lamotte, Pert 
ll 
and Snyder, 1976). Autoradiography is the second technique available 
with which to study opiate specific bi:c.ding sites. After parenteral 
injection, 3H-diprenorphine is localized primarily in the caudate, puta-
men, locus coeruleus, amygdala, zona compacta of the substantia nigra, 
nucleus tractus solitarius, nucleus ambiguous and the substantia 
gelatinosa (Pert, Kuhar and Snyder, 1975; Atweh, Murrin and Kuhar, 1978). 
There is a good correlation betvreen the regional distribution of the 
specific binding sites indicated by the two techniques. Both techniques 
reveal negligible density of specific binding sites in the cerebellum and 
white matter. There are disadvantages and difficulties with each tech-
nique. The radioreceptor technique does not localize receptors in their 
physiological or functional setting and stereospecific binding has been 
shown to occur at clearly non-functional sites, such as glass filters 
(Snyder, Pasternak and Pert, 1975) and cerebroside sulfate (in vitro) 
(Loh, Cho, Wu and Way, 1974). There are also limitations with the 
autoradiographic technique. These include diffusion of the high affinity 
ligand away from the specific binding site to other areas ;.;hich there-
fore sets limits to the resolution of the technique. Furthermore, the 
technique fails to differentiate between multiple high affinity binding 
sites. Also one is restricted to using high affinity compounds T..rhich are 
not readily metabolized by the body. 
Subcellular distribution studies reveal high densities of stereo-
specific binding sites in the mitochondrial and microsomal brain fractions. 
These fractions are rich in synaptosomes and membrane fragments, respect-
ively and the inference is that opiate receptors may be located on nerve 
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terminals (Pert, Snowman and Snyder, 1974). Evidence that opiate recep-
tors are located primarily on nerve terminals and associated 1vith pri-
mary afferent fibers comes mainly from studies of deafferentation. De-
afferentation of the vagus or enucleation of the eye resulted in a mar-
ked reduction of autoradiographically identifi.ed opiate receptors in 
the respective primary sensory nuclei (Atweh et al., 1978). In addition, 
Lamotte (1976) demonstrated an approximately 50% loss of opiate specific 
binding sites in the dorsal horn of monkey spinal cord following tran-
section of the ~orsal roots. 
A study of several narcotic agonists has revealed that several 
distinct clinical syndromes accompany their administration. Martin 
(1976) has postulated that these differences, most notably in subjective 
effects and tJ~es of physical dependence, are a consequence of the drug 
interacting with different types of the opiate receptor. He suggested 
that there are three types of opiate receptor located in nervous tis-
sue and designated them~' K, and cr. Prototypic agonists for these re-
ceptors are morphine (~), N-allylnormetazocine (a) and ethylketocy-
clazocine (K). More recently, Lord and colleagues (1977) have identi-
fied a fourth form of the receptor fihich has been designated 8. These 
investigators found that ·in the guinea-pig ilema, the enkephalins are as 
readily antagonized by naloxone as is normorphine; however, in the mouse 
vas deferens they are not. About 10 times more naloxone was required to 
reverse the inhibition produced by enkephalins than was required to re-
verse the inhibition caused by normorphine. Such a difference in the pA2 
values for enkephalin in the guinea-pig ileum and mouse vas deferens 
strongly suggests that the receptor populations in the two in vitro models 
13 
are heterogeneous and not identical. In addition, these investigators 
demonstrated that the inhibition of 3H-leu-enkephalin and 3H-naloxone 
binding in brain homogenates of guinea-pig was not equal for opiates 
and opiate peptides. That is, both met and leu-e~~ephalin displaced 
3H-leu-enkephalin binding whereas morphine was a much better inhibitor 
of 3H-naloxone binding than of 3R-le11-e~~ephalin bindir~. Again, such 
findings strongly suggest the existence of a heterogeneous population 
of opiate receptors. 
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1.1. 3. Pharme,cology of Opiates 
For the most part, ne.rcotic analgesics have been classified as 
belonging to one of two groups. The classification is based on their 
acute pharmacological effects as well as their dependence producing 
liability. Agonists are classified as being either morphine-like or 
nalorphine-like (Martin et al. , 1976). 
Mor£hine-like agonists_ 
The acute effects include analgesia, sedation, alteration in 
mood, mental clouding, euphoria, miosis, cardiorespiratory depression, 
nausea and constipation. T:"le analgesic effect is relatively selective, 
in that ~ensory modalitie$ other tP~n pain are left intact (touch, propio-
ception, vibration). The patient may still recognize painful stimuli but 
he is not bothered or concerned over it. Morphine is more effective in 
relieving dull chronic pain rather than sharp intermittent pain. 
Studies performed on absorption, distribution and metabolism 
indicate that morphine and its surrogates are not readily absorbed from 
the gastro-intestinal tract. It is readily accessible to the target 
site if given parenterally and is distributed in pa.renc~vmous. tissue. 
The major metabolic pathway in h1.1.ffians is conjugation 1-rith glucuronic 
acid in the liver, N-demethylation and 1..rrinary excretion of free mor-
phine subserving minor roles (Jaffe and Martin, 1975). Morphine does 
not accumulate in tissue, and 24 hours after the last dose, tissue 
concentrations are quite low. An analgesic dose ~f morphine (10 mg) 
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given subcutaneously acts within minutes and its effect typically lasts 
4 to 5 hours (Jaffe and Martin, 1975). 
Tolerance to and physical dependence on morphine occur with re-
peated use. Studies on the suppression of withdrawal in subjects physic-
ally dependent on morphine reveal that morphine at a dose which is 10-
20% of a stabilization dose will markedly suppress abstinence in patients 
who are near maximally dependent on morphine (Martin, 1971). Methadone 
(Dole and Nyswander, 1965), propiram, profadol (Jasinski, Martin and 
Hoeldtke, 1971) and d-propoxyphene (Fraser and Isbell, 1960) will sub-
stitute for, and show cross-tolerance with, morphine in the morphine-
dependent subject. Cyclazocine (Martin, Fraser, Gorodetzky and Rosen-
berg, 1965) and pentazocine (Jasinski, Martin and Hoeldtke, 1970) will 
not suppress abstinence symptoms in subjects dependent on morphine; nor 
will ketocyclazocine and ethylketocyclazocine suppress signs of abstin-
ence in the morphine dependent dog (Gilbert and 'Martin, 1976). 
The severity of the characteristic syndrome which occurs when an 
individual abruptly discontinues chronic use of narcotic analgesics is 
determined by several factors such as, specific opiate administered, 
daily dose, duration of use, and health and personality of the individual. 
\Vhen morphine is abruptly withdraw~.,the ensuing abstinence syndrome is 
characterized by an early and protracted phase. The early phase begins 
manifesting symptoms at the time of the next scheduled dose and lasts 4-
10 days. Early signs of opiate withdraw-al are nervousness, weakness, 
muscle aches, lacrimation, abdominal cramps, anorexia, nausea, craving 
for sweets, aversion to tobacco, rhinorrhea, yawning, perspiration and 
restless sleep. As the syndrome approaches its peak (2-3 days in the 
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case of morphine and heroin), irritability, insomnia, anorexia) yawning, 
sneezing, weakness, depression, rlse in blood pressure, pulse rate, 
respiratory rate and body temperature, intestinal spasm and diarrhea in-
crease. Administration of opiate at any point during the withdrawal 
completely suppresses the syndrome. The early phase of abstinence in a 
moderately dependent individual usually subsides in 7-10 days. However, 
a much more prolonged return to preaddiction levels has been noted for 
some of the signs, especially blood pressure, pulse rate, body tempera-
ture and pupillary diameter. Between the sixth and ninth week of ab-
stinence, p0~siological changes begin to emerge as a result of the dis-
continuation of morphine. This later phase, known as protracted ab-
stinence, persists for more than 30 weeks. During this phase, blood 
pressure, pulse rate, body temperature, pupillary diameter and the sen-
sitivity of the respiratory center to C02 are below normal levels. 
The level of tolerance and cross tolerance which develops de-
pends upon the type of narcotic administered and its dose. There have 
been no thorough studies of the disappearance of tolerance following 
cessation of drug treatment. Most studies indicate that tolerance is 
attenuated a few days after cessation of drug administration when com-
pared with tpe degree of tolerance at the time of cessation. Goldstein 
and Sheehan (1969) showed that the return to normal sensitivity to the 
stimulatory effect of levorphanol in mice was complete in 48 hours after 
withdrawal. In clinical studies narcotic addicts undergoing withdrawal 
reported a rapid recove~J (within a few days) of the euphoric and de-
pressant effects of narcotis (Light, 1931). However, tolerance to cer-
tain effects such as nausea and emesis, persists for months after termi-
nation of chronic morphine ac~inistra~ion (rraser and Isbell, 1952). 
Cochin and Kornetsky (1964) have reported that residual tolerance to 
the analgesic effects of morphine can be demonstrated in rats up to 
15 months after a. single injection of a. large dose of morphine. 
Buprenorphine is a. strong analgesic which is some 25-40 times 
more potent than morphine in rodents. It has a rapid onset and dur-
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ation of action (Cowan, Lewis and Macfarlane, 1977). In man buprenor-
phine is capable of producing morphine-like subjective, behavioral and 
analgesic effects and is 25-50 times more potent than morphine (Jasinski, 
Pevnick and Griffith, 1978). Buprenorphine has been also shown to possess 
narcotic antagonist properties (Cowan et al., 1977). In man abrupt 
withdrawal of chronically administered buprenorphine results in a. mild 
abstinence syndrome with the first signs appearing 2-3 days followir~ 
withdrawal. The abstinence syndrome reaches its peak intensity at 14 or 
15 days after withdrawal, at which time the subjects display a drug crav-
ing behavior (Jasinski et a.l., 1978). .tUthough buprenorphine is sj_'llilar 
to morphine in certain respects (Martinet al., 1976), there are also 
marked differences between these drugs. First, in the buprenorphine 
dependent subject administration of naloxone failed to precipitate an 
abstinence syndrome; and second, abrupt vithdraval of buprenorphir'1e 
resulted in only a very weak withdrawal syndrome (Jasinski et al., 1978). 
In chronic spinal dogs buprenorphine induced a state of physical depend-
ence and also partially suppressed morphine withdrawal. Over 20 times 
more naloxone was required to precipitate abstinence in the buprenor-
phine dependent dog than would have been necessary in dogs dependent 
upon an equivalent amount of morphine (Martin et al., 1976). In rats, 
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mice and monkeys chronic administration of buprenorphine failed to pro-
duce overt signs of physical d;:;pendence (Cowan et al., 1971). Wo satis-
factory explanation is available ~s to why different results were obtained 
with the monkey, rat and mouse a,s opposed to the dog e,nd human. Perhaps, 
the dependence which is observed in the dog and human is minimal or 
clinically insignificant. It is suggested that the long duration of 
action and the lack o:r effect by naloxone in precipitating abstinence 
are e.n indication of the high affinity of the buprenorphine-receptor 
interaction, as bindibg studies indicate an extraordinarily low dis-
sociation rate constabt (Rance and Dickens, 1978). 
Nalo!_'phipe-like agoni:sts 
Cyclazocine is a very potent and long acting nl".rcotic antagonist, 
but when given alone has narcotic analgesic properties. In man cycla-
zocine (0.25 - 2.0 mg) produces a state of analgesia comparable to that 
seen with morphine 20 mg (Lasagna, DeKornfeld and Pearson, 1964). Sub-
jective effects of cyQlazocine closely resemble those seen with nalor-
phine and consist of ~eelings of apatP~, sleepiness, tiredness, irrita-
bility, racing thoughts, delusions, and hallucinations. The majority 
of subjects do not either like or dislike the drug (Fraser and Rosenberg, 
1966). In the chroniQ spinal dog cyclazocine produces nalorphine-like 
effects in single dos~s and physical dependence with chronic administra-
tion (Gilbert and Martin, 1976). 
Chronic administration of cyclazocine to man induces a state 
of physical dependenc~. Such subjects show tolerance to all major 
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pharmacological effects of cyclazocine as well as cross-tolerance to 
nalorphine. Abrupt withdrawal or administration of naloxone results in 
an abstinence syndrome which closely resembles that following nalorphine 
but which is clinically different to the one seen in morphine dependent 
subjects (Jasinski, Martin and Sapira, 1968; Martinet al., 1965). Af-
ter subjects have been stabilized on parenteral doses of cyclazocine 
for several weeks, abrupt withdrawal results in an abstinence syndrome 
which does not manifest itself until the fourth day and which does not 
become maximal until the seventh day (Martin et al., 1965). Signs of 
abstinence consist of mydriasis, increased pulse rate and -body tempera-
ture, decreased body weight, lacrimation and diarrhea. Certain signs 
persist for periods as long as 6 weeks following 1-rithdrawal (Martin, 
Fraser, Gorodetzky and Me Clane, 1965). The syndrome has been charac-
terized as being slow in onset and mild. No compulsion to take the 
drug is apparent upon withdrawal as is common with morphine addiction. 
In short, although an abstinence syndrome ensues upon abrupt vrithdrawal 
of cyclazocine, the withdrawal syndrome does not produce a great desire 
to continue taking the drug and,therefore,liability for abuse of cycla-
zocine seems slight. Nalorphine and ketocyclazocine both suppress signs 
of cyclazocine withdrawal in man and dog (Fraser and Rosenberg, 1966; 
Gilbert and Martin, 1976). 
Ketocyclazocine is a narcotic analgesic of the nalorphine type. 
It has an analgesic activity equivalent to cyclazocine·in the rat ab-
dominal constriction test (Michne, Pierson and Albertson, 1974) .. Chronic 
administration leads to the development of tolerance and physical depen-
dence. Ketocyclazocine does not suppress abstinence symptoms in the 
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morphine dependent rat (Michne et al., 1974)) monkey (Swain and Seevers, 
1974), or dog (Gilbert and Hartin, 1976). Characteristics of keto-
cyclazocine withdrawal closely resemble those of cyclazocine and, there-· 
fore, differ from those of morphine. 
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1.1.4. Mechanisms and Theories of Opiate Tolerance and Dependence 
The question of whether opiate tolerance and dependence exists 
as two separate but closely related phenomena, or as quite inseparable 
phenomena with a common underlying mechanism remains unresolved. Evi-
dence in support of the hypothesis that the two phenomena are inextricably 
linked includes; 1) the finding that physical dependence seems to develop 
in parallel with analgesic tolerance (Way, Loh and Shen, 1969), 2) the 
greater the level of tolerance attained the harsher the withdrawal syn-
drome (Martin, 1971), and 3) all of the narcotics known to man cause both 
phenomena (Hartin, 1971). 
Several theories on the mechanism of tolerance have been pro-
posed, but none appears to have been defined precisely and to have es-
tablished its role in the development of tolerance and dependence. 
Counter-Adaptive Theory of Himmelsbach 
One of the earliest theories of opiate tolerance and dependence 
1-ras proposed by Himmelsbach (1943). In this theory, the effect of opi-
ates on hypothalamic centers is to disturb homeostasis. This leads 
to physiologic adaptations which oppose the acute actions of opiates. 
That is, repeated exposure to the narcotics leads to a neT,; equiliori um 
in which the narcotic drug is an essential component. wnen the narcotic 
is withdrawn, it disrupts this new state of equilibrium; therefore, the 
physiologic adaptations are no longer balanced by the opiate, and a c-rith-
drawal syndrome is observed in which the clinical manifestations are 
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usually in directions opposite to those following the acute administra-
tion of opiates. 
Altered Disposition 
A second theory of the mechanism of tolerance and dependence 
was based on the differences i:o. biologic disposition between tolerant 
and non-tolerant subjects (Light, 1931; Axelrod, 1956; Hug, 1972). How-
ever, thorough investigations have revealed no differences in the ex-
cretion of either free or bound morphine in tolerant and non-tolerant 
dogs (Cochin, Haggart, Woods and Seevers, 1954) or in the distribution 
and fate of morphine in tolerant dogs, rats (Woods, 1954) or monkeys 
(Mellett and Woods, 1956). 
It is generally accepted that differences in absorption, distri-
bution, metabolism and excretion of narcotic analgesics cannot possibly 
account for the differences in pharmacological responses observed be-
tween tolerant and non-tolerant subjects. 
Role of the Opiate Receptor 
Several studies have demonstrated that naloxone,given before or 
concurrently with morphine,to rats or mice, blocked the development of 
tolerance to and dependence on morphine (Mushlin, Griffel and Cochin, 
1975; Yano et al., 1979). Such findings lead inv2stigators to conclude 
that the opiate receptor was somehow necessary for the induction of toler-
ance and dependence. Studies cvere made to determine whether changes in 
receptor number or affinity parallelled the development of tolerance and 
dependence. 
Pert and coworkers (1973) were the first to demonstrate an in-
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crease in stereospecific binding Jf 3H-dihydromorphine in mice implanted 
with morphine pellets. Similarly, Frederickson et al. (1974) reported an 
increase in the number of opiate binding sites in rats rendered tolerant 
and dependent on morphine. Conversely, several investigators have re-
ported a decrease in the number of opiate specific binding sites with the 
development of opiate tolerance and dependence. Davis and coworkers 
(1975) found that with chronic morphine therapy a decrease in receptor 
affinity to morphine occurred in brainstem slices; however, these same 
investigators found no difference in binding properties when binding was 
measured in brainstem homogenates. In contrast to the aforementioned 
studies, the majority of investigations suggest no change in either the 
affinity or number of opiate receptors. Klee and Streaty (1974) were 
the first to show no change in the stereospecific binding for either 3H-
dihydromorphine or 3H-naloxone in brains from naive and opiate tolerant 
rats. Similar findings were reported by Bonnet (1976). The reasons for 
these disparities in results remain unknown; they may be related to dif-
ferences in experimental technique, approach and methods used by the vari-
ous investigators. 
It is difficult to assess the significance of such experiments 
because the binding properties which are recorded are those of a tissue 
which is undergoing withdrawal from opiate rather than a tissue which 
continues to be tolerant and dependent on opiate. This is because the 
opiate ~ust be withdrawn from the tissue for the binding studies to be 
perfor~ed. This procedure of washing the tissue (in vitro) induces a state 
of opiate withdrawal and ~erhaps an altered (conformational) state of 
the receptor. Thus, such findings may not be a reliable index of opiate 
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receptor properties during the phenomena of tolerance and dependence. 
In general, it is fairly well accepted that changes in the opiate recep-
tor, if in fact they do occur, can..'1ot adequately account for the changes 
observed during opiate tolerance and dependence. Therefore, it appears 
likely that this phenomenon is somehow dependent upon events which fol-
lm.r receptor occupation. 
Immune Mechanisms 
A number of observations have suggested that irr®unoreactions may 
be involved in opiate tolerance and dependence (Cochin, 1970). In rab-
bits, chronic morphine administration resulted in an increased capacity 
of serum proteins to bind morphine by as much as 100 fold (Herndon, 
Baeder and Ringle, 1974) and there is evidence that serum proteins of 
heroin addicts have a greater affinity for heroin than serum proteins 
from drug naive individuals (Ryan, Parker and Williams, 1972). Immuni-
zation of mice with a morphine immunogen (3-carboxy.m.ethyllnorphine-BSA) 
resulted in the formation of an antibody to morphine. In these mice, 
the analgesia produced by a single dose of morphine was significantly 
less than the analgesia produced by morphine in the adjuYant treated an-
imals (Berkowitz and Spector, 1972). This finding suggests that toler-
ance to the analgesic effect of morphine was accelerated by the for-
mation of antibody. A problem with this theory is that it does not ade-
quately explain cross-tolerance among structurally unrelated narcotics. 
For instance, antibodies to morphine do not readily cross react with 
methadone (Wainer, Wung, Connors and Rothbert, l979),yet methadone is 




Administration of a phosphodiesterq.se inhibitor induces a syn-
drome in rats which is indistinguishable from the synd:come seen upon 
cessation of chronic morphine therapy (Francis, Roy and Collier, 1975). 
This behavioral pattern elicited by the pt.osphodiesterCJ.se inhibitor is 
known as the qug,si-morphine abstinence syndrome ( QJvLA.S). A fair corre-
lation has been found between the abUity of various agents to inhibit 
phos:phodiesterase and the intensity of the withdrawal syndrome (Francis, 
Cuthbert, Saeed, Butt a;:J.d Collier, 1978). The q':.lasi-:rr;.orphine abstinence 
syndrome is potentiated by n"1rcotic antagonists and s-uppressed by na.r-
cotic agonists (Collier, Francis, Henderson and Scl1neider, 1974). In 
addition, phosphodiesterase inhibitors or cyclic-M1P alone will intensi-
fy the naloxone precipitated withdrawal syndrome in morphine dependent 
rats (Francis, Roy and Collier, 1975; Collier and Francis, 1975). Con-
sistent '..ri th the premise that the cyclic nucleotides play a prominent 
role in opiate tole:cance and dependence is the finding by Ho and col-
leagues (1973b) that administration of cyclic-AMP to mice enhanced the 
development of opiate tolerance and dependence. On the other hand, 
chronic administration of t.9-tetrahydrocannabinol (Kaymakcalan, Hak-
kiayhan and Cankattulany, 1977) or a single microinjection of hist&~ine 
in the hippocampus of the rat (Glick and Crane, 1978) and probably other 
procedures can induce an opiate-like abstinence syndrome. These com-
pounds are neither opiate-like nor do they illi~ibit phosphodiesterase. 
Studies of neuroblastoma-glioma hybrid cells (~TG108-15) have 
demonstrated that after an initial decrease in cyclic-:\MP levels by 
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opiates there is a compensatory increase to control levels. That is, 
cyclic-AMP levels return to normal values while the opiate is present 
(acquisition of tolerance). The hybrid cells g.lsp acquire a dependence 
on opiates, in the sense abrupt ivithdrawa.l of the opiate or addition of 
naloxone to the tissue results in an increase in cyclic-AMP levels well 
in excess of the original level (Sharma, Kl.ee and Nirenberg, 1975), 
Tolerance and dependence in NG108-15 cells are also elicited by opioid 
peptides such as methionine-enkephalin (Klee, 1978). 
The experiment~ described have led to the concept of dual regu~ 
lation of adenylate cyclase as a biochemical model for the acute and 
chronic actions of opiates. The inference from these studies is that 
the compensatory increase in cyclic-AMP levels is responsible for symp-
toms associated with opiate withdrawal (see section 1.3). 
Inhibitors of Tolerance and Dependence 
The early findings that calcium ion antagonized the analgesic 
effect of opiates (Kakunaga, Kaneto and Hano, 1966) prompted further 
studies on the role of calcium in opiate tolerance and dependence. 
Kaneto (1971) reported that mice given repeated intracisternal injections 
of morphine plus calcium were less tolerant to the analgesic effect of' 
morphine than were the group receiving morphine alone. Calcium was also 
found to inhibit certain aspects of the naloxone precipitated withdrawal 
in morphine dependent mice (Harris, Bhargava, Loh and Way, 1974). The 
mechanism by which calcium inhibits the development of tolerance and the 
s~~ptoms of withdrawal is not known. Kowever, it may be linked to its 
involYeJ..rlent with neurotransmitter release and a possible interaction 
between calcium and morphine with respect to release because opiates in-
27 
hibit transmitter release at various sites in the nervous system 
(Paton, 1957; Sanfacon and Lambreque, 1977; Henderson and Hughes, 
1976). 
Protein synthesis inhibitors have been shown to attenuate mor-
phine tolerance and dependence. Tolerance to the analgesic effect of 
morphine was reduced or prevented by several drug treatments which in-
hibited protein synthesis. That the effect of these agents are not due 
to lethargy or debilitation of the animal or alteration in metabolic 
disposition was shown by Cox and Osman (1970) and Feinberg and Cochin 
(1977). The inhibitors studies were cycloheximide, 5-fluorouracil, 6-
mercaptopurine, actinomycin D and puromycin. The study by Cox and Os-
man (1970) was designed to reduce the complications due to systemic tox-
icity of the various agents. Infusion of small doses of protein syn-
thesis inhibitors intracerebroventricularly or intravenously inhibited 
the development of acute tolerance to morphine produced during a 3 to 7 
hour continuous infusion. The results support the hypothesis that pro-
tein synthesis is an integral function in the development of tolerance 
to narcotics in vivo. 
Neurohypophyseal peptides, as ,,,.ell as certain of their deri va-
tives, have oeen recently shown to alter the development of opiate toler-
ance and :ienendence in rodents (\'l'al ter e": al., 1973; 1979). ='he mechan-
ism of action by which these peptides exert their effect remains ooscure. 
Enkenhalins and R-endornhin 
The involvement of enkephalins or S-endorphin in the mechanis~ 
underlying ouiate tolerance and dependence is not clearly understood. 
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It is knO'Nn that cross-tolerance between morphine and enkephalins occurs 
in the guinea-pig ileum and mouse vas deferens (Waterfield, Hughes and 
Kosterlitz, 1976) and ~ith respect to their analge3ic effect in the rat 
(Pert, 1976). Kosterlitz and Hughes (1975) have suggested. that the 
development of tolerance to morphine may be associated with a decrease 
in the levels and synthesis of enkephalin. It was further suggested 
that a deficiency of an endorphinergic system could explain the pro-
tracted phase of the abstinence syndrome (Goldstein, 1976) and the 
high rate of recidivism after abstinence in heroin addicts (Przevlocki, 
Holt, Duka, Leber, Gramsch, Haarman and Herz, 1979). Hovever, no change 
in either ~endorphin or er~ephalin levels were detected in rat brains 
from rats subjected to acute or chronic morphine treatment over a maxi-
mum period of 10 days (Childers et al. , 1977; Fratta et al. , 1977; Wesche 
et al., 1977), although a decrease in the S-endorphin levels was observed 
(in rat brain) when morphine therapy was ~~tended for periods of 30 days 
(Przev1ocki et al., 1979). Therefore, a relatively 1on,s exposure to mor-
phine appears to be necessa..7 to decrease S-·endorphin or enkephalin levels 
in rat brain, and to effect the development of opiate dependence and 
characteristics of withdraval. 
1.2. SINGLE NEURON STUDIES 
1.2.1. Acute Effects of Opiates 
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Early electrophysiological studies on the action of opiates 
were limited to those brain areas associated with pain and its trans-
mission. The discovery and localization of opiate receptors in dis-
crete brain regions (Pert and Snyder, 1973) redirected the studies of 
single neurons toward areas enriched with these receptors. Three cri-
teria must be fulfilled before an opiate effect may be considered re-
ceptor mediated. First, the effect should be observed at a concentra-
tion of opiate which is pharmacologically relevant. Second, the effect 
should be stereospecific; that is, mimicked only by the (-) isomer of 
enantiomeric opiates. ~nird, naloxone should antagonize the effect. 
The use of naloxone reversibility as the sole criteria for opiate speci-
ficity should be viewed with caution since naloxone has been shown to re-
verse the inhibitory effect of y-aminobutyric acid (GABA) on the firing 
rate of neurons located within the olfactory tubercle (Dingledine, Iver-
son and Breuker, 1978), the fatigue of peristalsis induced by adenine 
nucleotides,haloperidol and ~Jlocaine in the guinea-pig ileum (Van Nue-
ten, Jansen and Fontaine, 1976a; 1976b) and the antinociception pro-
duced by phenoxybenzamine in mice (SpieP~er and Paalzow, 1979). However, 
it remains to be determined whether these effects are mediated through 
the release of enkephalin. 
There is generally a good correlation between the density of 
opiate binding sites and the number of cells which are responsive to 
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opiates and opioid peptides (Nicoll, Siggins, Ling, Bloom and Guillemin, 
1977). Opiates administered either systemically or by iontophoresis in-
hibit the spontaneous firing of neurons in the rat sensorimotor cor-
tex (Satoh, Zieglg~nsberger, Fries and Herz, 1974), hypothalam11s (Eidel-
berg and Bond, 1972), medial thalrurrus (Linse~an, 1978), parafascicular 
nucleus (McClu.."lg and Dafny, 1978), locus coerulem: (Korf, Bunney and 
Aghajanian, 1974; Bird and Kuhar, 1977), and caudate nucleus (Dafny et 
al., 1979). 
A number of studies have shown that the excitatory response of 
single neurons to the stimulation of their peripheral receptive fields 
are inhibited by opiates. In the rat, morphine inhibits the neuronal 
activity evoked by noxious stimulation in the mesencephalic reticular 
formation (Haigler, 1976), lamina V cells of the spinal cord (Calvillo 
et al., 1974; Duggan et al., l977b), thalamus (Hill and Pepper, 1978) 
and locus coeruleus (Korf et al., 1974). One area which has been ex-
tensively studied with respect to selective depression of nociceptive 
activity by narcotic analgesics is the dorsal horn of the spinal cord of 
cats (Kitahata et al., 1974; Duggan et al., 1977b). Iontophoretic ap-
plication of morphine into the substania gelatinosa or systemic aruQini-
stration (1-2 m.g/kg i. v-.) produced a selective depression of dorsal horn 
cell responses to noxious stimulation, but did not affect responses to 
non-noxious stimuli. These effects were reversed by low concentrations 
of naloxone (O.l m.g/kg i.v.) (Duggan et al., 1976; l977b). 
Whereas opiates usually inhibit neuronal activity, there are at 
least two areas in the CNS where the predominant effect of opiates and 
opioid peptides is neuronal excitation. These are the Renshaw cells 
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of cats (Davies, 1976; Davies and Dray, 1978) and the hippocampal pyra-
midal cells of rats (Nicoll et al., 1977). However, ~ve may not deal here 
with a direct increase in neuronal activity, as Zieglgansberger and 
colleagues (1978) have provided evidence that the opiate induced exci-
tation of hippocampal py-ramidal cells is due to inhibition of neighboring 
tonically active inhibitory neurons. It is possible that the excitation 
of Renshaw cells may have a similar explanation. 
The p~ese~t review of the electrophysiological study of opiates 
in vivo is incomplete. The reader is referred to reviews by Bradly (1978) 
and North (1979a) for a complete and detaiJ.ed description of the action 
of opiates in vi-vo. 
In Vitro Studies 
Sa to and colleagues (1973) were the f:!.:rst to demonstrate an 
effect of morphine on myenteric neurons in vitro. In this study, mor-
phine (approximately 8.5 ~w1) inhibited the spontaneous activity of sin-
gle myenteric neurons. These same investigators later demonstrated that 
morphine (approximately 3 ~M) inhibited neurons whether they were firing 
spontaneously or induced to fire by 5-hydroxytryptam.ine (5-HT) or caer-
ulein (Sato, Takayanagi and Takagi, 1974). The concentrations of mor-
phine used in these studies were quite high, considerably greater than 
the concentration necessa~J to inhibit the electrically induced contrac-
tion of the longitudinal muscle myenteric plexus preparation of the 
guinea-pig ileum (ID50 85 ru1) (Goldstein and Schulz, 1973). Subsequent 
studies by Dingledine and Goldstein (1975; 1976) have demonstrated that 
the inhibitory effect of morphine on myenteric neurons could be repro-
duced using a concentration of morphine comparable to those used in the 
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twitch studies. The inhibition of firi~g was stereospecific, that is it 
was mimicked by levorphanol but not dextrorphan, and was antagonized by 
low concentrations of naloxone (Dingledine, Goldstein and Kendig, 1974; 
Dingledine and Goldstein~ 1975). Their findings confirm and extend 
those by Sato's group. In addition, morphine was shown to be effective 
under conditions of synaptic transmission blockade (Dingledine and Gold-
stein, 1976; North and Williams, 1977). The inference from these studies 
as well as those by Sato in which morphine depressed the excitations 
induced by 5-HT, caerulein and nicotine vras that morphine probably acts 
directly on the myenteric neuron to reduce excitability. Similar results 
were obtained with the endorphins (North and Williams, 1976; Williams 
and North, l979a). The mechanism of action of opiates on single myenteric 
neurons is discussed in detail below. 
Studies of dorsal root ganglia and spinal cords dissociated from 
each other and allowed to make connections in culture have demonstrated 
a possible presynaptic site of opiate action (Crain, Peterson, Crain and 
Simon, 1977; MacDonald and Nelson, 1978). In the study by Crain et al. 
(1977), electrical stimulation of the attached dorsal root ganglion re-
sulted in a complex negative slow vave potential which vras selectively 
depressed by opiates. The effect was seen with low concentrations of 
morphine, etorphine and levorphanol, and was antagonized by naloxone. 
Dextrorphan had no effect. Naloxone alone in many cases selectively 
increased the amplitude and duration of t~e sensory evoked potential 
in the dorsal horn. The inference was tnat these sensory networks develop 
localized opioid inhibitory control syste~s mediated by the endorphins. 
In the other study, intracellular recordings were made from spi-
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nal neurons. Stimulation of the dorsal root ganglion gave rise to an 
excitatory postsynaptic potential (e.p.s.p.) in spinal neurons. The 
e.p.s.p. was depressed by iontophoretically applied etorphine. Since 
etorphine did not have any postsynaptic effect of its own, the authors 
concluded that etorphine exerted its effects by inhibiti~~ the release 
of transmitter from the primary afferent terminals (MacDonald and Nel-
son, 1978). 
There are at least two viewpoints as to the underlying mechanism 
of opiate action in single mammalian neurons. One view holds that mor-
phine acts postsynaptically to block the inward sodium current induced 
by glutamate or possibly other excitatory agents at the subsynaptic mem-
brane. Intracellular recordings of spinal motoneurons in vivo revealed 
no significant changes in the membrane potential or input resistance to 
iontophoretically applied morphine but it was found that morphine reduced 
the rate of rise of the e.p.s.p. and the potential evoked by iontophoretic 
application of glutamate (Zieglg~nsberger and Bayerl, 1976). A second 
view proposes a membrane hyperpolarizing effect of morphine as the under-
lying mechanism of action. A significant proportion of myenteric neurons 
recorded in vitro were hyperpolarized by opiates and opiate peptides 
(North and Tonini, 1977; North, Katayama and Williams, 1979). It has 
been proposed that such a hyperpolarizing effect may explain not only the 
inhibition of neuronal firing but also the inhibition of acetylcholine 
release evoked by field stimulation. Furthermore, it appears likely 
that the site of opiate action in the myenteric plexus is non-somatic; 
that is, morphine acts by hyperpolarizing the nerve processes. Morphine 
showed no consistent effects on the amplitude of the excitatory post-
synaptic potential (North, 1979b). 
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1.2.2. Chronic Effects of Opiates 
T~en rats were chronically exposed to morphine by means of sub-
cutaneous pellet implantation or by multiple subcutaneous (or intraperi-
toneal) injections, no change in the pattern or frequency of the spon-
taneous neural firing was reported for the opiate treated animals as 
compared with drug naive animals (Satoh, Zieglgansberger and Herz, 1976). 
Furthermore, tolerance to the usual depressant effect of morphine on spon-
taneous activity or activity evoked by acetylcholine or glutamate was dem-
onstrated on neurons in the rat sensorimotor cortex (Satoh et al., 1974), 
hypothalamus (Eidelberg and Bond, 1972), parafascicular nucleus (McClung 
and Dafny, 1978) and locus coeruleus (Aghajanian, 1978) (Table 1.). Simi-
larly, tolerance to the inhibitory effect of morphine on single neuron 
activity has been demonstrated in the medial thalamus, periaqueductal grey, 
caudate nucleus, hippocampus and nucleus accumbens of rabbits (Peters and 
Klem, 1977). 
Naloxone >:o7as '.vi thout effect on the firing rate of neurons in 
drug nai7e animals, whereas it induced a marked excitation of neurons in 
opiate dependent animals (Table l.). In opiate dependent rats, those 
brain si~es in which naloxone increased neuronal activity included the 
sensorimo~or cortex (Satoh et al., 1975), hypothalamus (Eidelberg and 
Bond, 1972), medial thalamus (Frederickson, Norris and Hewes, 1975) and 
the locus coeruleus (Agha,j ani an, 1973). This increase in neuronal acti v-
ity induced oy naloxone has been referred to by some investigators as a 
::J.anifestation of opiate dependence. Similar results have been renorted 
35 
Table l. The action of morphine and naloxone on the firing rate 
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for peripheral mammalian neurons studied in vitro. Extracellular re-
cordings from myenteric neurons from guinea-pigs pretreated with mor-
phine demonstrated tolerance to the usual inhibitory effect of morphine. 
A naloxone-induced excitation was also observed (North and Zieglg~ns­
berger, 1978). 
Changes in neuronal sensitivity occur concommitantly with the 
development of tolerance. The sensitivity to excitations by glutamate 
of striatal neurons (of drug naive rats) increased during and after a 
prolonged microelectrophoretic application of met-enkephalin: at the 
same time, the inhibitory effect of met-enkephalin progressively dimin-
ished. This tachyphylaxis to the inhibitory effect of met-enkephalin 
occurring concurrently with an increased sensitivity to glutamate may 
or may not be related to the tolerance described (Fry, Zieglgansberger 
and Herz, 1978). The mechanism underlying the changes in neuronal sensi-
tivity has not been thoroughly investigated; however, one hypothesis 
suggests a membrane depolarization as the basis for the effect (Johnson, 
Westfall, Howard and Fleming, 1978). In support of this view, is the 
membrane depolarization recorded when naloxone is administered to tissue 
(myenteric neurons) which has been pretreated (20 h) with a morphine 
solution (Johnson and North, 1980). It is believed that tissue exposed 
in this manner is tolerant to and dependent on morphine (Hammond et al., 
1976). 
1.3. THE INTERACTION OF CYCLIC~AMP IU~ RELATED AGENTS WITH OPIATES 
1.3.1. Antinociception 
Recent studies on the biochemical basis of opiate analgesia 
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have implicated the cyclic nucleotide system(s). It has been demonstra-
ted that cyclic adenosine-3' ,5'-monophosphate (cyclic-AMP), dibut~~yl cy-
clic adenosine-3' ,5'-monophosphate (dbcyclic-AMP), or theophylline ad-
ministered intracerebrally or intravenously antagonizes the antinoci-
ception produced by morphine in mice (Ho, Loh and Way, 1973a). Similarly, 
prostaglandin E1 (PGE1 ) administered intraventricularly reversed the 
antinociception produced by morphine in the rat (Feri, Santagostino, 
Braga and Galatulas, 1974). This effect of PGE1, which is to reverse 
the antinociception produced by morphine, may be due to its ability to 
elevate cyclic-AMP levels (Collier and Roy, 1974; Welman and Schawabe, 
1973). Nevertheless, the mechanism whereby these compounds reverse the 
analgesic effect of morphine has not been completely elucidated. It may 
be that they are indeed exerting their effect by directly altering intra-
cellular levels of cyclic nucleotides, or perhaps by affecting neuro-
transmitter release (Nathanson, 1977; Schulz and Cartwright, 1976) or 
mobilizing ca++ stores (Ramwell and Shaw, 1970; Hayashi, Mori, Yamada 
and Kunimoto, 1978). The acute actions of opiates have been shown to be 
related to each of these factors. 
1.3.2. Studies on Brain Homogenates and Neuroblastoma-Glioma 
Hybrid Cells 
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Studies by Collier and Roy (1974) provided the earliest biochem-
ical evidence linking the opiates to a.denylate cyclase activity. These 
workers found that the conversion of 3H-ATP to 3H-cyclic-AMP was stim-
ulated approximately two fold by prostaglandin E1 . Morphine inhibited 
this stimulation but was without effect on the basal production of cy-
clic-AMP. The inhibitory effect was dose related, mimicked by heroin 
but not dextrorphan, and reversed by naloxone. Similar findings in 
homogenates of monkey amygdala (Wilkening, Mishra and Makman, 1976), 
and in brain slice preparations (Minneman and Iverson, 1977) have con-
firmed the results by Collier and Roy (1974), although a number of other 
laboratories have been unsuccessful in their attempts to do so (Katz and 
Catravas, 1977; Van Inwegen, Strada and Robison, 1975). Several expla-
nations· have been offered to account for these discrepancies, such as 
regional heterogeneity of cell types in brain homogenates, lability of 
brain enzymes under experimental conditions, inability to control fac-
tors which are known to affect adenylate cyclase activity such as ions 
and neurotransmitters, and the possible variable effects of morphine on 
cyclic-AMP levels in different brain regions (Bonnet, 1975). 
Studies on neuroblastoma-glioma hybrid cell (NGlOB-15) have re-
vealed an inhibitory action of morphine on basal and PGE1 stimulated 
cyclic-AMP levels. The parent cell lines, neuroblqstoma Nl8TG-2 and 
glioma C6BU-l, are not significantly affected by opiates and this agrees 
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with the finding by several investigators that they posses few if any 
opiate binding sites (Klee, Sharma and Nirenberg, 1975). The hybrid 
cells on the other hand, possess opiate receptors (Klee, Sharma and 
Nirenberg, 1975; Chang, Cooper, Hazum and Cuatrecasas, 1979). Mor-
phine inhibits basal, PGE1 , and adenosine stimulated cyclic-AMP form-
ation in these cells. These effects are stereospecific and naloxone re-
versible (Sharma, Klee and Nirenberg, 1975). In the continued presence 
of morphine (several hours), the initial inhibition of adenylate cyclase 
in these hybrid cells is followed by an increase in enzyme activity. 
After a 12 hour exposure to morphine, adenylate cyclase activity has 
returned to normal and the cells could be said to be tolerant. With-
drawal of the morphine or addition of naloxone leads to a rapid increase 
in cyclic-AMP formation which exceeds the original level (Sharma, Klee 
and Nirenberg, 1975); this has been interpreted as a sign of dependence. 
Thus, tolerance to and dependence on morphine have been induced in neuro-
blastoma-glioma hybrid cells in vitro. The effects were only partially 
blocked by the protein synthesis inhibitor cycloheximide, implying per-
haps, only a limited role for protein synthesis in the underlying mech-
anism (Sharma, Klee and Nirenberg, 1977). 
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1.3.3. Myenteric Plexus 
Adenosine and the adenine nucleotides such as adenosine tri-
phosphate (ATP), cyclic adenosine 3'-5'-monophosphate and dibutyryl cy-
clic adenosine 3'-5'-monophosphate depress the nerve mediated contrac-
tions of the longitudinal muscle of the guinea-pig ileum by inhibiting 
the release of acetylcholine (Takagi and Takayangi, 1972; Sawynok and 
Jhamandas, 1976; Hayashi, Mori, Yamada and Kunitomo, 1978). Several 
xantine derivatives including theophylline have been reported to antag-
onize this inhibitoryeffect (Hayashi et al., 1978; Sawynok and Jhaman-
das, 1976). In addition, theophylline has been reported to reverse the 
inhibition of the contractile response by morphine but not by tetrodo-
toxin, adrenalin and strychnine (Hayashi et al., 1978; Hammond, Schneid-
er and Collier, 1976). The mechanism whereby theophylline reverses the 
inhibitory effects of both morphine and adenosine is not clearly under-
stood. It appears unlikely that a common mechanism mediates the reversal 
of the effects by both drugs for the following reasons. First, there 
is evidence that the adenine nucleotides mediate their depressant effect 
by activation of an extracellular adenosine receptor and that theophylline 
is a competitive antagonist at this receptor (Hayashi et al., 1978). Two, 
the low concentration of theophylline necessarJ to antagonize the adeno-
3ine response does not itself alter the size of the nerve mediated con-
traction, whereas the higher concentration of theophylline necessarJ to 
reverse the morphine depression, itself, increases the nerve-mediated 
2ontraction. 
It may be that an alteration in the intracellular calcium dis-
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position is involved in the underlying mechanism of action since the 
antagonism of morphine is seen only with those phosphodiesterase inhibi-
tors which mobilize calcium stores. For example, the phosphodiesterase 
inhibitors theophylline and xanthine antagonize morphine's inhibitory 
action on the twitch response of the guinea-pig ileum, whereas Ro 20-
1724, a non-xanthine phosphodiesterase inhibitor, does not. Theophylline 
and xanthines mobilize calcium stores whereas Ro 20174 does not (Hayashi 
et al., 1978; Gintzler and Mussachio, 1975). Therefore, it seems likely 
that it is the mobilization of the neuronal calcium stores and not phospho-
diesterase inhibition which is the mechanism by which theophylline reverses 
opiate inhibition. 
l. 4. THE MYENTERIC PLEXUS 
l. 4 .l. Anatomy 
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The "enteric nervous system" consists of two major ganglionated 
plexuses of considerable complexity (Gabella, 1976). One plexus is situ-
ated between the longitudinal and circurar muscle layers and is known as 
the myenteric or Auerbach's plexus. The second plexus is located in 
the submucosa and is the submucous or Meissner's plexus. They extend 
uninterrupted from the lower part of the esophagus to the anus and send 
nerve fibers to the musculature, blood vessels and mucosa. Single gan-
glia within the plexus contain between a few to several hundred neurons. 
The number of neurons depends upon the species studied as well as the 
segment of the alimentary canal under investigation (Gabella, 1976). 
Glial cells are numerous and in the guinea-pig outnumber neurons by a 
ratio of 3:1 (Gabella, 1972). The entire surface of the ganglia is en-
capsulated by a very thin sheet of collagen (Taxi, 1965). 
In the myenteric plexus of the guinea-pig ileum, the ganglia 
are arranged in a regularly spaced manner with many interconnecting 
strands located between them. The number of neurons 1vithin each ganglia 
varies between 20 to 200. The neurons range in size from 15 to 45 ~m 
in length. With respect to histological organization, the presence of 
a dense neuropil, absence of an extracellular space, compactness of 
structure, arrangement of blood vessels and connective tissue make the 
cells of the myenteric plexus more like CNS tissue than autonomic gan-
glia (Gabella, 1972). 
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Studies of myenteric neurons by light microscopists have demon-
strated the presence of three types of neurons. This cl8ssification was 
based primarily on morphology (see Schofield, 1968). However, classi-
fication of myenteric neurons on the basis of ultrastructural character-
istics has revealed the presence of nine distinct types of ganglion cells 
(Cook and Burnstock, 1976). The classification is based on neuronal 
size, distribution of organelles and their location and relationship to 
satellite cells. Similarly, eight different types of axon profiles were 
identified according to vesicular size, shape and content (Cook and Burn-
stock, 1976). Still other studies have utilized intracellular staining 
techniques to identify and describe myenteric neurons (Nishi and North, 
1973a). These studies have demonstrated that most neurons are multi-
polar and have from one to seven processes. The processes usually arise 
from the poles of the oval soma and are varicose; however, some are 
smooth. 
The enteric nervous system of vertebrates contains a multiplicity 
of neurotransmitters. Cholinergic innervation of the gastrointestinal 
tract of the cat, guinea-pig and monkey has been studied using the histo-
chemical method for acetylcholinesterase or choline acetylase (Jacobo-
witz, 1965; Feldberg and Lin, 1950). From these and other studies 
(Koelle, Koelle and Friedenwald, 1950) it was established that the in-
tramural plexuses consist of cholinergic neurons whose postganglionic 
fibers innervate the intestinal musculature. Adrenergic cell bodies do 
not exist in the myenteric plexus of the guinea-pig ileum but there is 
an adrenergic innervation from the prevertebral ganglia (Gabella, 1976). 
Norberg (1964) and Jacobowitz (1965) using fluorescence microscopy 
demonstrated the presence of nQ~erous adrenergic nerve fibers terminating 
in the myenteric plexus. Denervation of the sympathetic nerves led to a 
marked reduction of noradrenaline fluorescense in the gut (Furness, 1969). 
The presence of 5-HT in nerve terminals and its uptake and synthesis in 
cultured myenteric neurons suggests that 5-HT may function as a neuro-
transmitter in the gut (Dreyfus, Sherman and Gershon, 1977; Dreyfus, 
Bornstein and Gershon, 1977). However, these results await further con-
firmation. Finally, immunohistochemical studies have demonstrated the 
localization of enkephalin (Elde, Hokfelt, Johansson and Terenius, 1976), 
substance P (Nilsson, Larsson, Hakansson, Brodin, Pernow and Sundler, 
1975), vasoactive intestinal polypeptide (VIP) (Larsson et al., 1976) and 
somatostatin (Costa, Patel, Furness and Arimura, 1977) in nerve fibers 
and/or cell bodies in the myenteric plexus of the guinea-pig. 
Electrophysiological studies have demonstrated a clear functional 
role for acetylcholine in the myenteric plexus (see below) (Nishi and 
North, 1973a). The action of noradrenaline in the myenteric plexus is to 
inhibit the presynaptic release of neurotransmitter (Nishi-and North, 
1973b; Hirst and McKirdy, 1974); and the fULDctional role of substance P 
(Katayama and North, 1978) or 5-HT (Wood and Mayer, 1978) may deal with 
slow excitatory synaptic transmission. Extracellular recordings of my-
enteric neurons in vitro have demonstrated excitatory effects of sub-
stance P (Williams and North, l978a) and VIP (Williams and North, l979b), 
and inhibitory effects of enkephalin (North and Williams, 1976) and 
somatostatin (Williams and North, 1978b). These are discussed in greater 
detail in sections 1.4.2. and 1.4.3. 
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1.4.2. Electrophysiology 
Extracellular Recordings. The first to report on extracellular recorded 
action potentials from single myenteric neurons in vitro was Yokayama in 
1966. Subsequent studies by Wood (1970) and Ohkawa (1972) further demon-
strated three types of myenteric neurons. This classification was based 
on the pattern and frequency of spike discharge. These studies were per-
formed on myenteric neurons from cat jejunum and employed similar experi-
mental methods. The three types of neurons described by these investi-
gators were 1) single spike 2) burst and 3) mechanosensitive. Single 
spike type cells continuously fired action potentials at low frequencies 
(0.1 - 1 Hz) and with no consistent pattern of discharge. Burst type 
cells fired action potentials at very high frequencies (2 - 34 Hz) but 
only intermittently (intervals between bursts of 0.5- 40 sec). Mechano-
sensitive cells responded to mechanical distortion with an increased rate 
of discharge; for example, pressure applied to the ganglion by the re-
cording electrode served to activate these neurons. Several subclasses 
for each of the types have been reported by Wood (1970). 
On the other hand, electrophysiological studies by Dingledine 
(1974; 1975) and Sato (1973) demonstrated only two types of myenteric 
neurons in the guinea-pig. They classified the cells as being of the 
single spike or burst type. The majority of neurons recorded were of 
the single spike type whereas Wood (1970) and Ohkawa (1972) found that 
the majority of cells were of the burst type. The difference in the 
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number of cell types and the type most frequently recorded can be ex-
plained as due to a difference in the experimental techniques used by 
the two groups. For instance, the studies by Wood (1970) and Ohkawa 
(1972) utilized metal electrodes for recording while those of Dingle-
dine and Sato utilized glass suction electrodes. It is possible that 
a particular type of electrode may preferentially select a distinct 
neuronal type. 
Typically, action potentials of myenteric neurons were biphasic, 
ranging in amplitude from 50 to 300 ~V and in duration from 2 - 4 ms. 
The spikes were abolished by tetrodotoxin and local anesthetics (Wood, 
1970; Sato et al., 1973; Dingledine et al., 1974; North and Williams, 
1977). Mechanosensitive and burst type neurons were relatively insen-
sitive to most drugs, whereas single spike units were sensitive to a 
variety of agents. Single spike neurons were excited by 5-HT, acetyl-
choline, nicotine, pentagastrin, caerulin (Sato et al., 1973), substance 
P (Williams and North, 1978a), neurotensin (Williams, Katayama and North, 
1979), and VIP (Williams and North, 1979b). The firing of these neurons 
was inhibited by morphine, noradrenaline (Sato et al., 1973), somato-
statin (Williams and North, 1978b) and enkephalin (North and Williams, 
1976; Williams and North, 1979a). 
Intracellular Recordings 
Studies using intracellular recording techniques have revealed 
two types of myenteric neurons. This classification was based on the 
electrical and membrane properties of the neurons (Nishi and North, 
1973a; Sirst, Holman and Spence, 1974). One type (Type lor S cell) 
receives a synaptic input (cholinergic), has a relatively ~igh input 
resistance, and a low membrane potential. The second type (Type II or 
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or AH cell) does not receive a fast synaptic input, has a higher resting 
potential and lower input resistance, and is less excitable than the S 
cell. An excitatory post synaptic potential is observed in the Type 1 
cell as a result of electrical stimulation of the preparation (Nishi 
and North, 1973a; Hirst, Holman and Spence, 1974) or by distension of 
the ileum by an intraluminal balloon (Hirst, Holman and Spence, 1974). 
The e.p.s.p. is abolished by 5-HT and noradrenaline; these substances 
do not affect depolarizations of a time course similar to that of the 
e.p.s.p. produced by iontophoresis of acetylcholine. This finding sug-
gests a presynaptic site of drug action for 5-HT and noradrenaline 
(Nishi and North, 1973b; Henderson and North, 1975). The second type 
of neuron is characterized by a prolonged hyperpolarizing afterpoten-
tial. The afterhyperpolarization persists for 10 - 20 seconds, requires 
calcium ions and is produced by an increase in potassium conductance 
(North, 1973; Nishi and North, 1973a). 
The main difference between the results obtained with intra-
cellular and extracellular recording techniques in the guinea-pig myen-
teric plexus was the lack of spontaneous activity recorded with the 
intracellular electrodes. Wood as early as 1975 explained this apparent 
discrepancy as a differential selectivity of each method for a particular 
type of neuron and/or for specific parts of the same neuron. Another 
explanation was proposed by North and \Hlliams in 1977. 'They suggested 
that large extracellular electrodes mec~anically deforms the cell mem-
brane causing the membrane potential to reach threshold and discharge 
action potentials. 
1.4.3. Actions of Opiates on the Guinea-Pig Myenteric Plexus 
Electrical stimulation of the isolated guinea-pig ileum, or its 
myenteric plexus longitudinal muscle preparation, induces the release 
of acetylcholine from intramural nerves and this results in a contrac-
tion of the longitudinal muscle (Paton, 1957). Narcotic analgesics in-
hibit this nerve mediated contraction by inhibiting the release of 
acetylcholine (Paton, 1957; Schauman, 1957). This action is stereo-
specific, concentration dependent, and reversed by naloxone in a com-
petitive manner (Kosterlitz and Watt, 1968; Kosterlitz and Waterfield, 
1975b). A number of narcotic analgesics have been shown to depress the 
electrically induced contraction; these include morphine, normorphine, 
buprenorphine, levorphanol, ketocyclazocine and cyclazocine (discussed 
below). The myenteric plexus of the rabbit (Greenberg, Kosterlitz and 
Waterfield, 1970) and cat (ErNin, Nonchoji and Wood, 1978) are not 
opiate sensitive. 
The concentration of a drug which inhibits the nerve mediated 
contraction of the guinea-pig ileum by 50% is known as the rc 50 . The 
rc 50 for morphine, normorphine, levorphanol, ketocyclazocine, cyclazo-
cine and buprenorphine in this preparation was 68, 73, 9.2, 2, 3.6 and 
4 nM respectively (Kosterli tz et al., 1972; Kosterli tz et al. , 1974; 
Schulz and Herz, 1976b). 2ecovery from the depressant effect of high 
concentrations of normorphine was complete within 90 seconds of washout 
and a constant depression was observed with repeated exposures at 5 min-
ute interYals (Kosterli tz, =:..ord and r,ratt, 1972). The half-time of re-
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covery from the inhibition produced by morphine, ketocyclazocine and 
levorphanol in the guinea-pig ileum was 32, 130 and 268 s respectively 
(Kosterlitz, Leslie and Waterfield, 1975; Schulz ~~d Herz, 1976b). The 
half-time of recovery from the inhibition produced by buprenorphine was 
so very long that it could not be determined with accuracy (Schulz and 
Herz, 1976b). In general, the more lipophilic the compound the longer 
its half-time of onset of action and half-time of recovery in the guinea-
pig ileum (Kosterlitz, Leslie and Waterfield, 1975). It appears that 
important differences between the actions of normorphine and morphine in 
the guinea-pig ileum is the rapid recovery of the twitch after inhibition 
by normorphine and the reduced tendency of normorphine to develop tachy-
phylaxis (Kosterlitz, Lord and Watt, 1972). 
Naloxone antagonized the inhibitory effect produced by morphine 
and the other agonists. However, naloxone was much less effective in 
antagonizing the inhibition of the twitch produced by cyclazocine, 
ketocyclazocine and buprenorphine than the illi~ibitions produced by 
normorphine and morphine (Kosterlitz et al., 1972; Kosterlitz and Watt, 
1968; Hutchinson et al., 1975; Schulz and Herz, 1976b). 
The action of opiates on the firing rate and membrane properties 
of single myenteric neurons has been described in section 1.2.1. 
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1.4.4. Opiate Receptor Studies 
Opiate receptors of myenteric neurons appear identical to those 
receptors subserving analgesia in the cer-tral nervous system. This 
statement is supported by the following evidence. First, the myenteric 
plexus possesses high affinity opiate binding sites (Gyang and Koster-
litz, 1966; Pert and Snyder, 1973). Second, the potency of an antagonist 
to inhibit naloxone binding in brain homogenates (Pert and Snyder, 1973) 
correlates well with its dissociation constant determined pharmacologically 
in the myenteric plexus (Kosterlitz and Watt, 1968; Kosterlitz, Lord and 
\iatt, 1972). Third, the relative potencies of a series of opiates in de-
pressing the electrically induced contractions of the guinea-pig myenteric 
plexus longitudinal muscle preparation is comparable to the analgesic po-
tency in man (Kosterlitz and Waterfield, l975a; Creese and Snyder, 1975). 
Fourth, the depressant ,effect of narcotic agonists on the firing rate of 
myenteric neurons is similar to the action of opiates on central neurons 
(North, l979a). Fifth, the inhibitory action of opiates in the myenteric 
/ 
plexus is stereospecific and occurs at low concentrations (Kosterlitz and 
Waterfield, 1975b; North and Williams, 1977; Dingledine and Goldstein, 
1975). Sixth, the action of opiates is reversed with a concentration of 
naloxone several fold lower than that of the narcotic agonist (Kosterlitz 
et al., 1972; North and Williams, 1977). Seventh, the antagonist potency 
of narcotic analgesic drugs determined in morphine-dependent monkeys cor-
related well with the antagonist potency determined on the guinea-pig 
ileum (Kosterlitz, Waterfield and Berthoud, 1974). Finally, tolerance 
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and cross tolerance to the action of narcotic analgesics and the endogenous 
opioid peptides develops in the guinea-pig ileum (Goldstein and Schulz, 1973; 
Waterfield, Hughes and Kosterlitz, 1976), as it does in the central neryous 
system {Pert, 1976). 
' 
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1.4.5. Opiate Tolerance and Dependence 
The first demonstration of tachyphylaxis to opiates in the 
guinea-pig ileum was made by Paton in 1957. In his experiments he de-
scribed that the action of morphine to inhibit the electrically induced 
contraction of the longitudinal muscle was diminished with repeated large 
concentrations or with lesser concentrations repeated at shorter intervals 
(less than 15 minutes). This finding was later confirmed by Kosterlitz 
and Waterfield in 1975 using very high concentrations of morphine (66 -
300 ~M). They showed that this effect of opiates was related to their 
anticholinesterase action and was not an opiate receptor mediated event. 
A second demonstration of tachyphylaxis to morphine in the guinea-pig 
ileum was made by Shoham and Weinstock in 1974. In their experiments a 
lower concentration of morphine (50 - 100 nM) was used, and the morphine 
was allowed to remain in contact with the tissue for 90 minutes. During 
this time, the inhibitory response to morphine slowly diminished, al-
though the output of ACh remained constant. The authors concluded that 
the tachyphylaxis observed was due to a supersensitivity of the muscle 
to ACh much like the denervation supersensitivity observed at other 
neuromyal junctions (Thesleff, 1960; Fleming, 1976). 
Studies on the opiate binding sites during the development of 
opiate tolerance and dependence revealed no detectable changes in either 
affinity or number of sites. That is, direct measurement of 3H-etorphine 
binding indicated no difference in receptor nw~ber or affinity in myen-
teric plexus strius from morphi~e dependent guinea-pigs (Cox and Padhya, 
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1977). However, it is difficult to interpret the results obtained from 
this type of experiment (see section 1.1.4.}. 
Two techniques of exposure haye been used to induce opiate tol~ 
erance and dependence in the guinea-pig ileum. The first technique, in 
~exposure to opiates, was achieved by implanting morphine pellets 
subcutaneously in guinea-pigs (Schulz and Goldstein, 1973). The second 
technique, in vitro exposure, was made by incubating segments of guinea-
pig ileum with a physiological solution containing morphine for periods 
of 18 - 22 h (Ha.nunond et al. , 1976). 
In Vivo Exposure 
Ileum removed from opiate pretreated animals which is then main-
tained in an opiate containing Krebs solution (normorphine 200 nM) shows 
a reduced sensitivity to subsequent applications of morphine. That is, 
tolerance to the inhibitory effect of morphine on the nerve mediated 
contraction had developed (Schulz and Herz, 1976a). Cross-tolerance to 
the inhibitory action of pentazocine, ketocyclazocine (Schulz and Herz, 
1976b), and enkephalin (Waterfield et al., 1976) also developed. Ex-
posure to naloxone resulted in a contracture of the longitudinal muscle 
(Schulz and Herz, 1976a). The contracture was greater when a larger 
dose of naloxone was used and was the result of a relatively synchronous 
release of ACh from the myenteric neurons which innervate the longitud-
inal muscle (Frederickson, Hewes and Aiken, 1976). This contracture has 
been taken by some investigators to be a manifestation of opiate depen-
dence. A good correlation has been found between the ability of a series 
of opiates to maintain a state in which naloxone can induce a contracture 
and their drug dependence liability (Schulz and Herz, 1976b). For exam-
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ple, buprenorphine produces a very low level of physical dependence in 
man (Jasinski et al., 1978) and does not substitute for morphine in 
maintaining a state giving a naloxone contracture. Likewise, ketocyclaz-
ocine and pentazocine only poorly maintain a state in which naloxone pro-
duces a contracture (Schulz and Herz, 1976b). 
Changes in neuronal sensitivity accompany the development of 
opiate tolerance and dependence. These experiment3 were performed with 
the isolated tissue placed in a Krebs solution free·of opiate or with the 
tissue placed in a solution containing morphine. In the first instance, 
it was found that the tissues were supersensitive to agents which excite 
neurons or release ACh, such as 5-HT, potassium chloride, nicotine and 
PGE1 (Johnson et al., 1978; Schulz and Herz, 1976a) but subsensitive to 
agents which inhibit the release of acetylcholine, such as adrenaline, 
dopamine, noradrenaline and clonidine (Schulz, Cartwright and Goldstein, 
1974; Ward and Takemori, 1976; Hughes, Kosterlitz, Robison and Water-
field, 1978). Similar, but less dramatic results have been found with 
tissue maintained in a morphine containing Krebs solution (Schulz and 
Herz, 1976a). The mechanism whereby the supersensitivity and -subsensitiv-
ity to a number of agents was achieved has not been elucidated. It appears 
that these changes are relatively non-specific and that the continued 
(chronic) presence of the opiate may lead to a slight depolarization of 
the cell membrane. This explanation would account for the apparent in-
crease in sensitivity to excitatory agents and a decrease in sensitivity 
to inhibitory agents. Compatible with such an explanation was the find~ 
ing by Cox (1978a) that the tension produced by a given electrical stim-
ulus was greater in ileal tissue removed from morphine pretreated guinea-
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pigs than in drug naive guinea-pigs. 
Extracellular recordings have been made from myenteric neurons 
removed from morphine pretreated guinea-pigs. The ileum was excised and 
placed in a physiological solution either with or without morphine. In 
the latter condition neurons fired at a higher frequency than neurons 
from drug naive guinea-pigs, and they were also 10 times more sensitive 
to the excitatory effects of 5-HT (Takayanagi, Sato and Takagi, 1974). 
Recordings from neurons which were maintained in a morphine containing 
Krebs solution yeilded somewhat different results. No obvious change in 
the pattern of spontaneous activity was noted but the frequency of the 
spontaneous activity was less than those of neurons from drug naive an-
imals (North and Zieglg~nsberger, 1978). Myenteric neurons treated in 
this manner responded to the application ot naloxone by greatly increas-
! 
ing their spontaneous rate of discharge. The frequency which was often 
attained was rarely seen in control situations (North and Zieglg~nsber-
ger, 1978). 
In Vitro Exposure 
Hammond et al. (1976) found that incubation of ileal segments with 
morphine (0.35- 17.5 ~M) for approximately 20 hours, induced a state of 
tolerance and dependence. Tolerance was measured as a reduced ability of 
morphine to inhibit the contractile response and the degree of tolerance 
was dependent upon the concentration of morphine in the incubation media. 
Tolerance was induced by levorphanol but not dextrorphan; control in-
cubations were without effect on the sensitiyity of the tissue to opiates. 
Tissue incubated with morphine responded to naloxone with a contracture. 
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These long term effects of opiates were observed whether incubations 
were made at 4°C or 37°C, and were similar to those seen in tissues re-
.' 
moved from opiate dependent animals (Hammond et al., :1976; Schulz and 
Herz, 1976a). 
Several agents have been shown to modify this development of 
opiate tolerance and dependence. Concomitant incubation of ileal seg-
ments with morphine and cycloheximide (1.9 ~M) attenuated the degree-of 
tolerance to moprhine. Similar findings were obtained when segments of 
ileum were incubated with morphine and PGE2 , or morphine and dbcyclic-
AMP (Hammond et al., 1976). Agents which were found to enhance the 
development of opiate tolerance included caffeine and 8-bromocyclic-3', 
5'-guanosine monophosphate sodium (Hammond et al., 1976). If the action 
of caffeine is mediated through an adenylate cyclase-cyclic-AMP mech-
anism then we would expect dbcyclic-AMP to have an action similar to that 
of caffeine~ because caffeine inhibits the enzyme phosphodiesterase which 
would result in an increase in the intracellular levels of cyclic-AMP. 
A further inconsistency includes the results obtained from whole animal 
studies where it was demonstrated that cyclic-AMP and related agents 
enhanced the development of opiate tolerance (Ho et a1.,· 1973b). 
Similarily, the involvement of protein synthesis in the develop-
ment of opiate tolerance and dependence is somewhat ambiguous. Hammond 
(1976) reports that cycloheximide (1.9 ~M), a protein synthesis inhibi-
tor, reduces tolerance formation in the guinea-pig ileum, yet states 
that an equieffective level of tolerance was induced at 4°C and 37oc. 
It is doubtful whether any protein synthesis is being carried out at 
4°C (Gutfreund, 1966) and furthermore, other investigators have re-
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ported that concentration of cycloheximide necessary to inhibit protein 
synthesis in this preparation to be 100 ~M (McKnight, Sosa, Hughes and 
Kosterlitz, 1978). 
Time Courses of the Recovery of Opiate Sensitivity After Chronic Ex-
posure 
A biphasic recove~J from opiate tolerance has been demonstrated 
in subjects made physically dependent on opiates (see section 1.1.3). 
A similar biphasic pattern of recovery has been demonstrated in the 
guinea-pig ileum (Cox, 1978b). Cox has reported that ileum removed 
from morphine-dependent guinea-pigs and maintained in an opiate con-
taining Krebs solution were highly tolerant to the inhibitory actions 
of morphine. However, when the opiate was washed from the tissue, tol-
erance rapidly declined (within 2 hours) until a stable state had been 
attained. A.second protracted phase of tolerance then ensued which 
persisted 10 hours or more (Cox, 197&; Johnson, personal communication). 
Cox referred to the tolerance associated with the first (rapid) and 
second (protracted) phases of recovery as type 1 and type 2 respect-
ively. Type l tolerance has been likened to a state of receptor de-
sensitization and it is in this state that naloxone proyokes a with-
drawal reaction (a contracture). Within 1 hour of switching to a so-
lution free of normorphine it was found that naloxone had lost its pro-
pensity to induce a contracture. Narcotic antagonists do not provoke 
a withdrawal reaction during type 2 tolerance unless an opiate agonist 
is previously readministered (Schulz and Herz, l976a). 
The isolated vas deferens from morphine pretreated mice is an 
example of a tissue which rapidly returns to normal sensitivity when 
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it is washed with a solution lacking opiate. However, if the yasa are 
maintained in an opiate containing solution after their removal from the 
animal, and then tested to a higher dose of normorphine, a 4 fold toler-
ance is exhibited. In other words, this is an example of a tissue which 
develops only type 1 tolerance (Cox, 1978b). 
6o 
1.5. SPECIFIC AIMS 
The first aim of the present study was to investigate the under-
lying mechanism of acute opiate action in the guinea pig myenteric plex-
us. Extracellular recording techniques were used to determine the in-
volvement of the cyclic nucleotides in the depression of neuronal activ-
ity by morphine. This part of the study included elevating intracell-
ular cyclic-AMP levels and subsequently testing the preparation for 
opiate sensitivity. 
The second aim of this study was to examine the phenomena of 
opiate tolerance and dependence at the single neuron level. This part 
of the study included: (a) an electrophysiological investigation of 
the effects of long term exposure of myenteric neurons to opiates in 
vitro or in vivo in order to determine whether tolerance and depen-
dence could be demonstrated; (b) an examination of the effects of drugs 
which c~n modify the development of any tolerance and dependence ob-
serve~ and (c) an investigation of the time course of events 
recovery from any opiate tolerance and dependence observed. 
2. METHODS 
2.1. THE TISSUE 
Male guinea-pigs (250 - 500 g) were stunned and bled from the 
neck. A section of ileum 10 - 15 em in length, excluding the portion 
·10 em oral to the ilea-caecal junction, was rapidly removed and placed 
in Krebs solution. The ltiminal content was then gently flushed out. A 
2 - 3 em piece of ileum was cut and gently slipped onto a glass rod 
(diameter 4- 6 mm). The diameter of the rod was slightly greater than 
that of the relaxed ileum. Under the dissecting microscope (lOX) the 
longitudinal muscle with the attached myenteric plexus was carefully 
stripped away from the circular muscle by gently stroking it with damp 
cotton wool. The myenteric plexus-longitudinal muscle preparation was 
gripped by forceps and gently pulled from the remainder of the ileum 
and placed in a shallow tissue bath. 
The method of dissection was originally described by Ambache 
(1954) , and modified later for electr~phy::tiological x-eco,:rdin~s- by- Nis.hi 




The longitudinal ntuscle was pinned with slight stretch and 
with ple~~s uppermost. Ganglia were visualized under a dissecting micro-
scope (10- 60X) and viewed by transmitted light. Electrophysiological 
recordings from ganglia which contained large swollen cells or those 
which were concealed by a thick sheet of circular muscle often proved 
unsuccessful. An area surrounding several suitable ganglia (free of 
circular muscle and with no swollen cells) was immobilized with several 
pins (tungsten wire 25 ~min diameter and 1- 2 mm in length). There-
maining tissue was cut and discarded. 
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2. 3. PERFUSION AND DRUG APPLICATION 
Krebs solution of the following composition (roM): NaCl 117, 
KCl 4.7, CaC12 2.5, MgCl2 1.2, NaHC03 25, Glucose 11.5, gassed with 95% 
o2 - 5% C02, was continuously pumped over the tissue at a rate of 1 - 3 
ml/min. The Krebs solution was warmed in a heating jacket such that 
the final bath temperature was maintained at 35 - 37°C. Drugs were 
applied to the tissue by changing the perfusing solution to one which 
differed only in its content of the drug, 
Drugs were prepared fresh daily from stock solutions (1 mM in 
distilled water) except cyclic-AMP and dbcyclic-AMP which were prepared 
daily from the solid. Stock solutions of ketocyclazocine and cyclazo-
cine were acidified to pH 5.0 and all stock solutions were kept frozen 
when not in use. Prostaglandin E2 was dissolved in ethyl alcohol be-
fore addition of the Krebs solution. There was a "dead time" of about 
45 - 90 seconds between the time the tap was turned and the arrival of 
the drug at the bath. In the figures presented in this manuscript, the 
times indicated are those at which the tap was turned. 
The drugs use~ were: normorphine hydrochloride (Dr. E.L. May), 
normorphine sulphamate (Dr. E.L. May), normorphine base (Dr. E.L. May), 
(-)-naloxone hydrochloride (Endo Laboratories), hexamethonium bromide 
(Sigma), morphine sulphate (Mallinckrodt), dextrorphan tartrate (Roche), 
levorphanol tartrate (Roche), cycloheximide (Sigma), ketocyclazocine 
(Dr. R. Schuster), cyclazocine (Dr. R. Schuster), buprenorphine (Reck-
itt and Colman), PGE2 (Dr. S. Ehrenpreis), lidocaine (ICN- K&K Labs), 
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theophylline (1,3-dimethylxanthine) (Sigma), 3-isobutyl-1-methylxanthine 
(Aldrich), adenosine 3' ,5'-cyclic monophosphoric acid (Sigma), N6, 02-
dibutyryl adenosine 3' ,5'-cyclic monophosphoric acid (sodium salt) 
(Sigma), hyoscine { (-) scopolamine HCl} (Sigma)", · (+)-naloxone hydro-
chloride (Dr. A. Jacobson), (+) and(-) 5,9-diethyl-2-(3-furyl methyl)-
2'-hydroxy-6,7 benzomorphan hydrochloride (Mr 2266/7) (Boehringer Ingel-
heim). Morphine antibody was a gift from Dr. B. Wainer. 
None of the drugs used significantly altered the pH of the Krebs 
solution. Concentrations of drugs refer to the final bath concentrations 
of the compounds listed above. 
2. 4. THE TISSUE BATH 
The tissue bath was similar to the one described by Nishi and 
North (1973a). A rectangular hole (20 x 40 mm) was cut from the center 
of a piece of plexiglass (50 x 80 x 1 mm). A coverslip (23 x 50 mm) 
was then glued over the hole and the trough filled with a thin layer 
(1 mm) of silicone rubber (Sylgard,#l84; Dow Corning Corp.). 
This clear resin can be transilluminated and is soft enough to 
allow penetration by fine tungsten pins (for fixing the tissue). A rim 
of bathtub caulk (5 mm) along the edge of the trough was used to pre-
vent overflowing of solutions and to secure the perfusing tubes and the 
indifferent electrode. 
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2.5. ELECTROPHYSIOLOGICAL RECORDINGS 
A glass suction electrode of tip diameter 40 - 90 ~M was used 
to record extracellular action potentials. The recording electrode 
was prepared by breaking longer electrodes with a smaller tip diameter. 
The electrodes were then examined microscopically and those with smooth, 
flat tips of appropriate size were used. The use of electrodes with a 
tip diameter greater than 90 ~m often resulted in simultaneous recording 
from more than one neuron, whereas attempts to record with electrodes 
with tip sizes less than 30 ~m were usually unsuccessful. The indif-
ferent electrode was similar but had a tip diameter of 90 - 150 ~n; ±t 
was placed near the site of recording. The recording electrode had a 
resistance of 300 - 1000 !ill. It was attached by a piece of rubber 
tubing to a syringe (5 ml) and suction was applied by withdrawing the 
plunger. The electrode was gently lowered onto the surface of the gan-
glia. The suction was sufficient to cause the ganglion to adhere to 
the electrode tip when the electrode was raised 10 - 20 ~m. A third 
electrode (chlorided silverwire) was placed at a distant site and served 
to ground the bath. 
The recording and indifferent electrodes were filled with Krebs 
solution,; chle>rided silver wires led to an AC..,..ce>upled prea.mJPlifier 
(Tetronix 122, coupling time constant of 2 ms). The signal was ampli-
fied and displayed on an oscilloscope (Tetronix 502A). 
Spike activity was gated by amplitude (Mentor Spike Analyzer) 
and the output was used to determine the number of spikes in a given 
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time period. This was done either directly from a chart recorder or 
from a rate analyzer (Fredrick-Haer). Histograms of firing rate were 
plotted (with respect to time) either by hand from the chart recorder 
or automatically from the output of the rate analyzer. 
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2.6. 24 HOUR INCUBATIONS - IN VITRO 
Pieces of ileum several centimeters in length from newly killed 
guinea pigs were incubated for approximately 24 hours in either normal 
Krebs or Krebs solution containing an opiate. Conditions of the in-
cubation were such that the Krebs solution was changed every 4- 6 hours, 
gassed with 95% 02- 5% C02 to maintain a pH of 7.4, and the temperature 
was kept at approximately 21- 24°C. In the first of two situations, 
the ileum was incubated in a normal Krebs solution. Individual myenteric 
neurons from the incubated preparation were observed with regard to their 
pattern and frequency of firing, and the acute action of agonists and 
antagonists on their firing rate. These results were compared with the 
data obtained from non-incubated preparations. In the second situation 
ileum was incubated in a Krebs solution which differed only in its con-
tent of a narcotic. This Krebs solution was also perfused over the tis-
sue throughout the period of extracellular recording to maintain a con-
stant narcotic environment. Individual myenteric neurons from this in-
cubated preparation were observed with regard to their pattern and fre-
quency of firing, and the effect of agonists and antagonists on their 
firing rate. 
In cases where the ileum was concomitantly incubated with a nar-
cotic and another agent, control incubations were also performed with 
the other agent alone. A summary list of all incubation solutions used 
is in Table 3. 
Tolerance was tested in two ways. First, the concentration 
of the narcotic in the incubation solution was sufficient to inhibit 
completely the spontaneous actiyity of non-incubated cells or of cells 
incubated in normal Krebs solution. Therefore) any neuronal activity 
recorded after 24 hour exposure to an opiate should reflect tolerance. 
Second, the ability of eyen higher concentrations of narcotics to in-
hibit neuronal firing of cells incubated for 24 hours was tested. The 
effective concentrations of the narcotics were compared with concentra-
tions which were effective in control incubated tissues. 
Signs of dependence were sought in two ways. The firing rate 
of the myenteric neuron was recorded whilst changing the perfusing 
solution either to a solution which did not contain morphine, or to a 
solution which contained both morphine and a narcotic antagonist. 
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2 • 7. MORPHINE PELLET L\fPLANTED OR INJECTED ANLV1ALS - IN VrTO 
Guinea pigs were injected subcutaneously (cervical area) '1-Ti th 
morphine sulphate 3 times daily for two days. The following regimen of 
fixed doses and times was employed: 10 mg/kg, 4 p.m.; 20 mg/kg, mid-
night; 40 mg/kg, 8 a.m.; 80 mg/kg, 4 p.m.; 100 mg/kg, mi~~ight; 100 mg/ 
kg, 8 a.m. Two hours after the last dose the animal was stunned and 
exsanguinated. 
Guinea pigs were also ·subcutaneously implanted with 4 morphine 
base pellets (2 x 75 mg pellets on each flank). The animals were then 
sacrificed on the third day after implantation. The ileum from both 
groups of animals was removed as previously described and placed in a 
Krebs solution which contained morphine (200 - 500 Th\1). This concen-
tration was chosen because it approximates that in plasma on the third 
day after pellet implantation (Schulz and Goldstein, 1973). 
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2.8. PLASMA LEVELS OF MORPHINE 
Trunk blood was collected from guinea-pigs at the time of death 




The following terms are commonly referred to in this text. 
inhibition - is defined as a reduction in the spontaneous firing 
rate of a neuron to a rate which is less than 75% 
of the control rate. 
excitation - is defined as an increase in the firing of a neuron 
to a rate which is at least double the control rate. 
slight excitation - an excitation during which the firing rate rises 
to less than 3 times the original rate. 
marked excitation - an excitation during which the firing rate rises 
to more than 3 times the original rate. 
slight inhibition - an inhibition during which the firing rate falls 
to not less than 75% of the original firing rate. 
marked inhibition - an inhibition during which the firing rate falls 
to a level which is less than 75% of the original 
firing rate. 
majority - a number greater than 1/2 the total number. 
passed off - is an example of a response which does not remain 
rapid 
unit 
constant at its maximal level. 
a drug effect was described as rapid in onset if 
the observed response occurred within 40 s on 
arrival of the drug to the tissue bath. 
- neuron. 
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2.10 ANALYSIS OF DATA 
The percentage change in cell firing (HZ) in response to a drug 
treatment was determj.ned as follows. After a control period o:t at least 
five minutes, the tissue was perfused with drug and the change in the 
rate of discharge recorded. The rate interval analyzer was limited to 
frequencies less than 10 Hz. Therefore it was necessary, for the purpose 
of calculating the actual firing in cases of marked excitation, to ascribe 
a numerical value of 15 Hz to any frequency greater than 10 Hz. The 
justification for selecting this value was provided by visual observation 
of the interspike interval meter. A drug effect was not accepted tmless 
a reversal of the effect occurred upon washout of the drug solution. 
Results were analyzed by calculation of the mean, standard devi-
ation and standard error of the mean, for the percentage change from con-
trol frequencies of firing. The Student's t test was used to compare the 
means of two groups which received different experimental treatments. 
3. RESULTS 
The present results are based on extracellular recordings made 
from 540 neurons in ganglia removed from 162 animals. 
3.1. EXTRACELLULAR RECORDING 
Two types of electrical potentials were recorded from the myen-
teric plexus. They were distinguished from one another on the basis of 
their duration, amplitude, spike waveform (Fig. 1) and sensitivity to 
tetrodotoxin and lidocaine. Electrical activity was considered to be 
of neuronal origin if it lasted 1-3 ms in duration, ranged in amplitude 
from 50 to 400 ~V and was reversibly abolished by tetrodotoxin and 
lidocaine (Sato et al., 1973; Dingledine et al., 1974; 1975; North 
and Williams, 1977). Neuronal action potentials had a biphasic wave-
form with a fast component followed by a slower one of opposite polar-
ity(-/+) (Fig. 2). Neuronal action potentials were recorded when the 
extracellular recording electrode was placed on the surface of a gan-
glion and suction was applied. It was not possible to record spon-
taneous neuronal activity without the use of suction; nor were record-
ings successful with electrodes of tip diameter less than 30 ~m or when 
the electrode tip was placed on interconnecting strands between the 
ganglia or on the muscle itself. Occasionally, when larger tip elec-
trodes (90 ~m) were used, multi-unit recordings were ~ade possible with 
one electrode in a single position. Individual neuronal action ~oten­
ti~ls were distinguished on the basis of their spike waveform and ampli-
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tude (Fig. 2). The precise origin of this spontaneous neuronal activity 
has not been thoroughly investigated; howeve~, it may be attributed to 
a mechanical deformation of the neuronal membrane caused by the suction 
electrode (North and Williams, 1277} . The second type of electrical 
activity recorded originated from -muscle. The spike waveform r,.ras typi-
cally biphasic, greater than 20 ms in duration, the amplitude ranged from 
400 ~V to 2 mV; this activity could be recorded only if the electrode were 
placed on the muscle. These action potentials were resistant to the action 
of lidocaine and tetrodotoxin (Sa to et al., 1973; Dingledine et al., 1974). 
The marked difference in spike duration allowed neuronal action potentials 
to be easily distinguished from muscle action potentials (Fig. 1). 
Two types of neurons were distinguished on the basis of their 
frequency of firing, pattern of discharge, spike waveform and sensitiv-
ity to drugs (Sato et al., 1973; 1974; North and Williams, 1977). The 
most common type encountered fired at a rate. of 3.0 + 0.2 Hz (mean + 
S.E.M., n=79) and the pattern of discharge was quite variable. In most 
cases the firing rate declined throughout the period of extracellular 
recording. Only those units having a stable baseline for at least .15 
minutes were included in this study. The spike amplitu~e ranged from 
50 ~V to 300 ~V and spike duration was 2-3 ms. The spike waveform was 
usually biphasic. The second type of neurons (15% of cells) had a higher 
spike amplitude (150 to 400 ~V) and fired regularly with low frequency 
(0.1- 1Hz). These findings confirm previously published reports (Dingle-
dine et al., 1974; North and Williams, 1977). 
Fig;ure l. Comparison of neuronal ar:.d s:uooth !lluscle action potentials ', 
recorded with an extracellular suction electrode. Figure 
illustrates one sweep of the trace across the oscilloscope, 
The first potential change is a smooth muscle action poten~ 
tial; the later hro arise from tv':l different neurons. In 
this and ~11 subsequent oscilloscope photographs, an up-
ward deflection indicates negativity of the recording elec-
trade. Calibration: Horizontal 20 ms. Vertical 200 1-1V. 





Figure 2. Spike waveforms recorded with a single extracellular elec-
trode in one position. ~~e two distinct waveforrns indicate 
the electrode is sL~ultaneously recording activity from two 
neurona. Calibration: Horizontal 5 ms. Vertical 100 ~V. 
Coupling time constant of the preamplifier was 2 ms. Note 
the typical biphasic waveforms. 
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3.2. THE ACTION OF OPIATES 
3.2.1. Morphine 
so 
Morphine (10 nM - l ~M) inhibited the neuronal firing rate in 
86% of the neurons tested (n = 42; 12 animals). Of ll cells tested with 
morphine (300 nM), one was unaffected and the degree of inhibition of 
the remaining cells was 90% + 3 (mean~ S.E.M.). In a given cell the 
degree of inhibition was related to the concentration applied. The 
inhibition reached its maximum within 30 s of the application of the 
drug, lasted throughout the period of application (2 - 60 min) and was 
relatively slow to washout. After a 3 min exposure to morphine (300 ~~), 
6 - 9 min was usually required for the neuronal firing to return to its 
original rate (Fig. 8a). Tachyphyl~~is was not observed with repeated 
applications of morphine (100 nM - l ~M) for 3 min periods at intervals 
of 12 min. 
3.2.2. Normorphine 
Nonnorphine had an action similar to that of morphine on the 
neuronal firing rate. Normorphine (l nM - 1 ~M) inhibited the neuronal 
firing rate in 85% of the neurons tested (n = lll; 41 animals). The 
inhibition was rapid in onset, usually lasted throughout the period of 
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Figure 3. The inhibition of neuronal firing by morphine and the re-
versal of inhibition by an antibody to morphine. Ordinate: 
spike freQuency (bin width- 10 s). Abscissa: time. Dur-
·ing the·periods indicated by the solid and open bars, the 
solution which perfused the tissue contained morphine (300 
nM) and morphine antibody (morph-Ab), respectively. Mor-
phine produced an inhibition in firing which was immedi-
ately reversed by the concurrent presence of morph-Ab. If 
3.3 times more antibody was added to the bathing solution 
than was necessary to completely bind all the morphine, 
then a more rapid reversal was observed. The morph-Ab 
alone did not cause any effect on the firing rate. The 
action of morphine on this cell was unusual in that the 
period of inhibition of cell firing did long exceed the 
period of application. 
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application (2- 60 min) and was readily reversed on washing (Fig. 4). 
Following exposure (2 min) to normorphine (300 nM), 2-3 min were re-
quired for the neuronal firing to return to its control rate. Tachy-
phylaxis to the inhibitory effect of normorphine on the neuronal firing 
rate was sometimes observed (section 3.5.1.). Those cells which were 
inhibited by morphine were also inhibited by normorphine; the com-
pounds appeared to be approximately equipotent. The inhibition of 
firing caused by normorphine was related to the concentration applied: 
at 30 nM, 2 cells were unaffected and the mean inhibition of 4 other 
cells was 58%; at 100 nM, 4 cells were unaffected and the inhibition 
of 19 other cells was 80% + 4 (mean .i S.E.M.); at 300 nM, 4 cells were 
unaffected and the inhibition of 22 other cells was 82% 1. 3; at l ~M, 
l cell was unaffected and 6 other cells were inhibited by 93% + 2. 
3.2.3. Levorphanol 
Levorphanol (30 ru~ - 4 ~M) inhibited the neuronal firing rate 
in 84% of the neurons tested (n = 18; 5 animals). The inhibition was 
rapid in onset, persisted throughout the period of exposure (2- 45 min), 
and washed out with a time course similar to that of morphine. Neurons 
which were inhibited by morphine were also inhibited by levorphanol 
(Fig. 5). Levorphanol (100 nM) inhibited the spontaneous firing of 
cells by 91% + 2 (n = 7): this was approximately the same degree of 
84 
Figure 4. Concentration dependent inhibition in firing produced by 
normorphine. During the periods indicated by the solid 
bars, the perfusing solution •H"as changed to one vrhich con-
taine~ normorphine (~T.M). The numbers above the bars indi-
cate the concentrations (nM). Ordinate: spike frequency 
(bin widih- 10 s). Abscissa: time. Normorphine caused 
an inhibition in firing which was related to the concentr~ 
tion in the bath. During the prolonged exposure to a rel~ 
tively low concentration of normorphine (50 nM) the 
tory response 'passed off' with time. 
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Figure 5- The effect of morphine, levorphanol, dextrorphan and nalox-
one on a single myenteric neuron. Ordinate: spike fre-
quency (bin width- 10 s). Abscissa: time. The solid bam 
·indicate the periods during which the bathing solution con-
tained either morphine, levorphanol or dextrorphan and the 
hatched bat indicates the period during which naloxone was 
added to the perfusing solution. The numbers above the bam 
indicate the concentration (ni1). Morphine and levorphanol 
caused a marked decrease in the firing rate which was rapid 
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inhibition as that observed with normorphine (1 ~M). 
3. 2. 4. Dextrorphan 
Dextrorphan (100 ru~ - 3 ~M) had no effect on the spontaneous 
firing rate of 9 cells from 3 animals (Fig. 5; Table 2). These ob-
servations confirm those previously reported by Dingledine and Gold-
stein (1975) and North and Williams (1977). 
3.2.5. Cyclazocine 
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Cyclazocine (3 - 300 nM) inhibited the neuronal firing rate of 
53% of the neurons tested (n ~ 19; 6 animals). The inhibition was 
Tapid in onset, persisted throughout the period of application (2 - 8 
min) and washed out slowly. The inhibition produced by a 3 min ex-
posure to cyclazocine (100 ru1) often outlasted the period of exposure 
by about 3 - 6 min. Neurons inhibited by cyclazocine were also inhibited 
by normorphine (n = 6) and met-enkephalin (n = 2). Three cells were 
unaffected by cyclazocine (10 nM). Cyclazocine (30 nM) was without 
effect on 3 cells, excited 1 cell and inhibited 6 cells by 80% ~5. 
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Table 2. The number of neurons in which firing was inhibited by 
various narcotic analgesics. Inhibition indicates that 
the firing rate fell to at least 75% of the control rate. 
Drug Excited 
Normorphine 
(1 nM - 1 )JM) 2 
Morphine 
(10 nM - 1 )JM) 0 
Levorphanol 
(30 nM - 1 IJM) 0 
Dextrorphan 
(30 nl-1 - 1 )JM) 0 
I 
Keto cyclazocine 
(30 nM -l)JM) 1 
Cyclazocine 
(3 - 300 nM) 2 
Buprenorphine 




















A concentration of 100 ru~ cyclazocine was without effect on 7 cells, 
and the inhibition of firing of 8 other cells was 83% + 4. In 2 out 
of 3 cells in which cyclazocine (30 and 100 nM) had no effect on neuronal 
firing, its presence prevented the inhibition of firing caused by nor-
morphine. That is to say, it acted as a narcotic antagonist. 
3.2.6. Ketocyclazocine 
Ketocyclazocine (30 nM - 1 ~) inhibited the neuronal firing 
rate in 80% of the neurons tested (n ~ 10; 4 animals). The inhibition 
was rapid in onset but did not readily reverse upon washing (Fig. 6). 
In a given cell, higher concentrations of ketocyclazocine caused 
greater degrees of irillibition. Neurons inhibited by ketocyclazocine 
were also inhibited by normorphine. Ketocyclazocine (100 nM) had no 
effect of 3 cells, and inhibited the fi~ing of 6 other cells by 81% + 5 
(mean+ S.E.M.). 
3.2.7. Buprenorphine 
The effect of buprenorphine (10 - 100 nM) on the firing rate was 
variable (n ~ 17; 5 animals). Neurons were excited (30%), inhibited 
(23%) or not affected (47%) (Table 2). Ti?O cells initially showed a 
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a biphasic response, excitation followed by inhibition, but with the 
second application of buprenorphine to the same cell only an excitation 
was observed (Fig. 7). The excitations recorded were slight, occurred 
within seconds on entry of the drug to the tissue bath and lasted 
throughout the period of exposure. No particular tendency was noted 
for higher concentrations to cause an inhibition or vice-versa. In 
those cells whose firing was inhibited by buprenorphine, the inhibition 
was slight, slow in onset (3 - 20 min) and never fully recovered to 
control levels upon washout of the drug. Prior exposure of the tissue 
to buprenorphine much reduced the sensitivity of the neurons to the 
inhibition by normorphine (Fig. 7). 
3.2.8. Narcotic Antagonists 
In only one of 9 cells did naloxone (1 ~M) increase the firing 
rate to two times its original value. This confirms previously published 
findings in which naloxone had no effect on 85% of myenteric neurons 
tested (n = 30) (Williams and North, l979a) (see also Fig. 5). Both 
enantiomers of 5,9-diethyl-2-(3-furylmethyl)-2'-hydroxy-6,7-benzomorphan 
excited a similar proportion of cells (n = 8). The excitation with any 
antagonist was always slight (less than three fold increase in rate) and 
rarely lasted throughout the period of application (3- 9 min). The 
lack of stereospecificity of this effects suggests that the excitation 
was not a conseQuence of the occupation of the opiate receptor by the 
antagonist. 
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Figure 6. A comparison of the effects produced by normorphine and 
ketocyclazocine on a single myenteric neuron. Ordinate: 
spike frequency (bin width- 10 s). Abscissa: time. Dur-
lng the periods indicated by the solid and hatched bars, 
the perfusing solution was switched to one which contained 
normorphine and ketocyclazocine respectively. Normocphine 
(300 nlvi) produced a marked irL.'1.ibition in the firing rate 
which rapidly reversed upon washout. ~ne inhibition of 
firing by ketocyclazocine (180 nM) was also rapid in onset, ·I;.· 
























Figure.7. A comparison of the effects produced oy normorphine and 
buprenorphine on a single myenteric neuron. Ordinate: 
spike frequency (bin width- 10 s). Abscissa: time. Dur-
. 
ing the periods indicated by the solid and open bars, the 
perfusing solution •,ras switched to one which contained nor-
morphine and buprenorphine respectively. Normorphine (300 
nM) caused a marked inhibition of the firing rate. The 
first application of buprenorphine produced a biphasic re-
sponse, excitation followed by inhibition; the subsequent 
application caused only a slight excitation. Exposure of 
I, j 
the tissue to buprenorphine prevented the response of the j 
1 
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Naloxone (30 - 300 nM) prevented or reversed the inhibition of 
firing rate by morphine (100 r~- 1 ~M) (18 of 18 cells) (Fig. Sa); 
normorphine (100 nM- l~M) (9 of 9 cells); levorphanol (100- 300 nM) 
(10 of 10 cells) (Fig. 8b); cyclazocine (30 -100 nM) (2 of 3 cells) 
and ketocyclazocine (100 nM) (once in one cell). The inhibition of 
firing by buprenorphine (10 - 100 nM) was not reversed by naloxone 
(100 nM- 1 ~M) (3 of 3 cells). 
The inhibition of firing produced by· morphine was prevented 
or reversed by an antibody to morphine (Fig. 3) (n ~ 4). The antibody 
alone had no effect on the spike firing rate. 
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Figure 8, Inhibitions of firing produced by morphine and levor-
phanol and the reversal of these inhibitions by naloxone. 
Ordinate: spike fre~uency (bin width- 10 s). Abscissa: 
time. The solid bars indicate the periods during which 
the bathing solution contained either morphine or levor-
phanol in the concentrations indicated, and the hatched bars 
indicate the period during which naloxone was added (200 -
300 nM) to the perfusing solution. (a) The inhibition of 
firing produced by morphine (1 ~M) was marked and long 
lasting and did not 'pass off' with a prolonged exposure 
(60 min). The addition of naloxone (200 nM) caused an im-
mediate reversal of the firing rate to control levels. 
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Figure 8b. Levornhanol (100 nM) produced an inhibition in the firing 
rate and this effect was immediately reversed by the addit-
ion of naloxone (300 nM). There was a "rebound" increase 
in the firing rate during the naloxone reversal which was 
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3. 3. THE ACTION OF THE CYCLIC NUCLEOTIDES AND RELATED 
COMPOUNDS ON S:INGLE UNI.T ACTIVITY 
3.3.1. Cyclic-AMP 
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Cyclic-AMP caused an inhibition of neuronal firing in 80% of 
the neurons tested; 20% were not affected (n = 20). The inhibition 
was rapid in onset and decline, lasted throughout the period of appli-
cation (2 - 10 min) and was readily reversed on washout. Increasing 
the concentration of cyclic-AMP (5 11M - 1 mM) caused greater degx·ees 
of inhibition. The inhibition of firing was prevented or reversed by 
the administration of theophylline (50- 4oo llM) (Fig. 9). Theophyl-
line alone produced a weak excitation (1.5 - 3x) in the majority of 
cells tested (n = 17). Naloxone (1 llM) failed to affect the inhibition 
'produced by cyclic-AMP in the three cells tested. 
3.3.2. Dibutyryl Cyclic-AM? 
The effects of dbcyclic AMP were more variable than those of 
cyclic-AMP. Eighteen % of the neurons were excited, 25% of the neurons 
were inhibited and 57% were unaffected (n = 28). No particular tend-
ency was noted for higher concentrations to cause excitation and lower 
concentrations to cause inhibition, or vice-versa. The inhibition of 
firing was rapid in onset and decline, lasted throughout the period of 
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application (2- 10 min), and readily reversed on washout, The inhi-
bitory effect was concentration dependent (Fig. 10) and when inhibition 
occurred the effect could be induced repeatedly by repeated applications 
of the same concentration of dbcyclic-AMP at intervals of 6 minutes. 
The inhibition of neuronal firing was prevented or reversed by theo-
phylline (50- 4oo ~M)(n = 3). 
3.3.3. Prostaglandin E2 
PGE2 (10 - 30 nM) increased the firing rate in 80% of the 
neurons tested (n = 26). It was difficult to perform experiments with 
concentrations greater than 30 nM because muscle contractions occurred 
which sometimes dislodged the recording electrode. The increase in 
firing caused by PGE2 was rapid in onset; however, it often did not per-
sist throughout the period of exposure (5- 15 min). The excitations 
occurred in the presence of hexamethonium (300 ~M) and hyoscine (1 ~M) 
and are,therefore,unlikely to be the consequence of the release of 
acetylcholine. 
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Figure 9. The inhibition of firing rate by cyclic adenosine 3' ,5'-
monophosphate (c-A}P) and the reversal of inhibition by 
theophylline. Ordinate: spike frequency (bin width - 10 
s). Abscissa: time. During the periods indicated by the 
open and solid bars the perfusing solution was changed to 
one which contained c-AMP and theophylline,respectively. 
The mnnbers along side the bars indicate the concentration 
(~M). c-AMP caused an inhibition of firing which was rapid 
in onset and offset, and which persisted throughout the 
period of exposure. Theophylline (50 - 300 ~M) rapidly re-
versed the i~~ibitory action of e-ft~~. The rapidity and 
degree of reversal was dependent upon the concentration of 
theophylline. 
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dibutyryl cyclic adenosine-3' ,5'-monophosphate (dbcyclic-
A~). Ordinate: spike frequency (bin width- 10 s). Ab~ 
scissa: time. During the periods indicated by open and 
solid bars, the perfusing solution contained dbcyclic-AMP 
(concentrations indicated) and normorphine (NM) (300 nM) 
respectively. The firing of this neuron was inhibited in 
a dose dependent manner by dbcyclic-AMP. It was also in-,! 






























IBMX ( 6 - 50 ~M) did not affect the firing rate of 78% of the 
myenteric neurons; 22% of the neurons tested were excited (n = 28). 
In these neurons the excitation was slight (2 - 3 x: the control firing 
rate), rapid in onset and did not persist throughout the period of 
application. 
3. 4. LACK OF EFFECT OF CYCLIC NUCLEOTIDES ON THE INHIBITION 
OF NEURONAL FIRING BY OPIATES 
3.4.1. Cyclic-AMP 
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In those neurons in which morphine inhibited firing, the inhi-
bition was not changed when the perfusion solution contained cyclic 
At~ (5 ~M - 1 mM) for 6 min prior to and during the presence of the 
morphine (n = 12). This lack of effect of cyclic-~W was observed 
both in cells in which cyclic-AMP itself inhibited firing and in those 
in which cyclic-AMP had no effect. When the firing was inhibited by 
morphine, changing to a solution which contained both morphine and 
cyclic-AMP did not reverse the effects of the morphine (n =5). 
3. 4. 2. Dibutyr:yl Cyclic-At"lP 
Results obtained using dbcyclic-AMP were similar to those re-
ported for cyclic AMP (n = 11) (Figs. 11 and 13). 
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Figure 11. Lack of effect of dibutyryl cyclic adenosine 3' ,5 1 -mono-
phosphate (dbcyclic-AMP) on the inhibition of firing caused 
by normorphine in a single m;yenteric neuron. Ordinate: 
spike freq~ency (bin width- 10 s). Abscissa: time. Dur-
ing the periods indicated by the solid and open bars, the 
bathing solution contained dbcyclic-M1P (500 ~M) and nor-
morphine (concentration indicated in nM), respectively. The 
neuronal firing rate was depressed by normorphine before, 
during and after the exposure to dbcyclic-AMP. The sensi-
tivity to normorphine was not reduced during concurrent 
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3.4.3. Prostaglandin E2 
Tissues were exposed to PGE2 (10 - 30 nM) both prior to (6 - 10 
min) and during the application of morphine (300 DP!- 1 pM). A given 
concentration of morphine caused the same degree of inhibition of cell 
firing in the presence and absence of PGE2 (n = 8) (Fig. 12). When 
cell firing was depressed by normorphine, changing to a solution which 
contained both normorphine and ?GE2 did not reverse the inhibition 
(n = 5) (Fig. 13). 
3.4.4. Isobutylmethylxanthine 
Tissues were exposed to I~~ (50 ~M) prior to (6 - 60 min) and 
during the application of morphine. A given concentration of morphine 
produced the same degree of inhibition whether in the presence or ab-
sence of IBMX (n = 12) (Fig. 14a). Likewise, morphine was eq~ieffective 
in inhibiting neuronal firing even after prolonged exposure (24 h) of 
the tissue to IBMX (50 ~M). Also the narcotic antagonist naloxone was 
without effect on neurons exposed to IBMX (Fig. l4b). 
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Figure 12. Interaction between prostaglandin E2 and normorphine on a 
single myenteric new:·on. Ordinate: spike frequency (bin 
width- 10 s). Abscissa: time. During the periods in-
dicated by the solid and open bars, the bathing solution 
contained normorphine (NM) and prostaglandin E2 (PGE2 ) re-
spectively. Neuronal firing was inhibited by normorphine 
(300 nM). PGE2 (30 nM) caused an excitation of the neuron 
but this did not persist throughout the eXJ?osure. Normor-
phine was equally effective in inhibiting neuronal firing 



















Figure 13. Interaction between normorphine, prostaglandin E2 and di-
cut~lcyclic-fu~. Ordinate: spike frequency (bin width_ 
10 s). Abscissa: time. During the periods indicated by 
the solid, open and hatched bars, the perfusing solution 
was changed to one which contained normorphine (NM), prosta-
glandin E2 (PGE2 ), and dibutyrylcyclic adenosine 3' ,5 1-mono-
phosphate (dbcyclic-AMP) respectively. Normorphine (300 
ru1) inhibited the firing of this neuron, and the irillibition 
remained throughout the 30 min period of application. PGE2 
(10 nM) did not excite the cell during the inhibition by 
normorphine although it did excite the neuron when morphine 
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Figure 14. Lack of effect of isooutyLmethylxanth~ne (IBMX) on the in-
hibition of netrronal firing by' ~or~hine. Ordinate: spike 
frequency (oin width- 10 s). Abscissa: time. (a) The 
. neuromd firing rate was depressed oy morphine (1 pH) be-
fore, during and after ex~osure to IBM:X: (50 pM). The sen ... 
sitivity to morphine did not appear altered during the con~ 
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Figure 14o. Prior to this experiment, the isolated ileu~ had oeen incu-
oated in a Kreos solution containing IBMX (50 ~M) for 24 h· , 
the IBMX was present throughout the period of extracellular 
·recording with the exception of the period indicated oy the 
open oar. During the periods indicated oy the crosshatched 
and solid bars, the oathing solution also contain2d nalox-
one (1 ~M) and morphine (300 nM), respectively. Naloxone 
was without effect, and morphine was as effective as usual 
in causing an inhioition of firing. Washing out the IBMX 
did not change the firing rate. 
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3.5. EFFECTS OF PROLONGED EXPOSL~E TO OPIATES 
3.5.1. Prolonged Exposures (~h) whilst Recording from a 
Single Neuron 
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Tachyphylaxis ('acute tolerance') to the inhibitory effect of 
normorphine on neuronal firing was sometimes observed (n = 7). Low 
concentrations (10 - 50 nM) of normorphine applied for long periods 
(8 - 60 min) resulted in an inhibition which was not maintained at its 
maximal level throughout the drug exposure. That is to say, the inhi-
bition of firing 'passed off' during the presence of the normorphine 
(Fig. 4). The other circumstance in which tachyphylaxis was apparent 
was following prolonged exposures (30 - 60 min) to a high concentration 
of normorphine (l ~) (n = 6). Following this exposure, the sensitivity 
of the neuron to previously administered concentrations of normorphine 
was reduced (Fig. 15). 
3.5.2. Prolonged Exposures (~24 h) to Opiates Prior to and 
During the Recording from a Q~ngle Neuron 
3.5.2.1. Normal Krebs Solution (control incubations) 
Extracellular recordings of myenteric neurons were made from 
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Figure 15. Inhibition of firing of a myenteric neuron by normorphine. 
Before the beginning of this recording (time zero), this 
neuron had been incubated in normal Krebs solution for 24 h. 
Grdinate: spike frequency (bin width- 30 s). Abscissa: 
time. During the periods indicated by the solid bars, the 
solution contained normorphine (NM) in the concentrations 
indicated (nM). This neuron was one of the most sensitive 
to the inhibition by morphine which was obserred. Following 
the prolonged exposure (30 min) to a high concentration (1 
~M), the neuron became somewhat less sensitive to the sub-
sequent effect of the lower concentrations. 
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tissue which had been incubated 24 h in a normal Krebs solution (n = 30; 
12 animals). The firing rate was 2.9 ~ 0.4 Hz (mean+ S.E.M.) and this 
value did not differ from those of fresh tissue (3.0 ~ 0.2 Hz). The 
spike waveform and pattern of firing of these neurons did not appear 
to be different from those tissues which were not incubated. Morphine 
or normorphine (1 - 300 nM) inhibited neuronal firing in a dose-dependent 
manner. Normorphine ( 30 nM) inhibited 12 of 14 cells to •t1hich it was 
applied and the degree of inhibition was 56%~ 8; at 100 nM, 2 cells 
were unaffected and the inhibition of 10 other cells was 81% + 6; at 
300 nM, one cell was unaffected and the inhibition of 11 other cells 
was 89% ~ 5. The time course of the inhibition was the same as that 
described above (see sections 3.2.1. and 3.2.2. ). 
Naloxone (100 ru\1 - 1 f.lM) was without effect on 77% of the neur-
ons tested (n = 13); 23% were excited (Table 3). The mean excitation 
by naloxone (200 nM) was 248% (n = 3), and did not persist throughout 
the period of application (3- 9 min). The excitation was mimicked by 
both the (+) and (-) isomers of the benzomorphan antagonist (Mr 2267 
and Mr 2266 respectively) ( n = 3). 
~icroscopic examination of ganglia from tissue which had been 
incubated for 24 h in Krebs solution (pH 7.4; 22- 26°C) revealed no 
gross differences 'tlhen compared •t1i th ganglia from freshly removed tis-
sue. 
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Table 3. The effect of narcotic agonists and antagonists on the firing 
rate of myenteric neurons incubated 24 h in a normal Krebs 
solution or in a Krebs solution containing opiate. .An in-
crease in the firing rate (a~citation) indicates that the 
firing rate at least doubled. An inhibition indicates that 
the firing rate fell to at least 75% of the control rate. 
The proportion of units inhibited by opiates and excited by 
narcotic antagonists changed w~en the tissue was subjected 
to prolonged exposures to morphine, levorphanol, bu.prenor:phine 
and ketocyclazocine. For the concentration of opiate used 
please refer to the text. 
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3.5.2.2. Morphine 
Extracellular recordings from myenteric neurons were made from 
tissue which had been incubated 24 h in a morphine (1 ~M) containing 
Krebs solution (n =55; animals= 18). The tissue was also continuously 
exposed to morphine (1 ~M) throughout the subsequent period of extra-
cellular recording. The firing rate of these neurons was 1.5 ~ 0.2 Hz 
(mean~ S.E.M.) and this rate of discharge was significantly different 
than in those cells which had been incubated without the morphine (2.9 
~ 0.4 Hz) (control incubation) (p < 0.05, t-test, df = 44). The 
firing pattern was generally more erratic with distinct bursts of 
spiking. The spike waveform was not altered. Increasing the morphine 
concentration to 10 or 30 ~M was without effect on the firing rate of 
21 of 27 neurons; 6 cells were inhibited by 73% ~ 6 (mean~ S.E.M.) (Fig. 
16). Levorphanol (l - 10 llM) ( n = 7) and met-enkephalin ( 3 & 10 llM) 
(n = 3) had no inhibitory effect on neuronal firing. That is, tolerance 
and cross-tolerance were apparent. 
iN:hen the solution was changed to one which differed only in its 
lack of morphine, the firing rate increased in 13 of 21 neurons. 'The 
firing rate increased by 464% ~ 65 and this excitation often did not 
persist during the entire period of 9erfusion with a morphine free 
solution (up to 60 min). When the perfusing sol,~tion was changed to 
one which contained both mor9hine (l llM) and naloxone (10 nM - l ~M) a 
marked increase in the firing rate was observed (Fig. 16; Table 3). The 
excitation by naloxone oegan immediately ( '·ri thin 40 s) of the arrival of 
:1aloxone at the tissue. Tb.e naloxone excitation occurred in 30 ouc. e:~' 
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of 38 neurons, its amplitude was dependent on the concentration (10 nM-
1 ~M), and it sometimes outlasted the period of application (Fig. 16). 
Naloxone (100 nM) excited 5 cells by an average of 636% + 191; at 200 
ffi~ the average degree of excitation in 8 cells was 729% ~ 145, and at 
1 ~M the average degree of excitation in 11 cells was 868% ~ 150. The 
firing rate of neurons excited by naloxone often reached frequencies 
which were never observed in control situations (usually more than 10 
Hz). The excitation was mimicked by the benzomorphan antagonist Mr 2266 
(100 nM- 1 ~M) but not its (+) -enantiomer Mr 2267 (100 ru~- 1 ~). 
(+) -naloxone did not affect the firing rate (n = 3). The excitation 
was reproducible in 73% of the cells when short exposures (3 min) to 
naloxone were used. However, 27% of the neurons tested showed progres-
sively declining excitations upon the second and third applications. 
When naloxone was applied for a prolonged period of time (120 min) the 
excitation 'passed off' during the presence of naloxone. 
3.5.2.3. Levorphanol 
Extracellular recordings were made from myenteric neurons in 
tissues which had been incubated 24 h in a Krebs solution containing 
levorphanol (100 nM or l ~M). With the lower concentration, results 
are based on recordings made from 20 units taken from 9 animals. The 
neurons were continuously exposed to levorphanol (100 ru~) throughout 
the period of incubation and the subsequent period of extracellular re-
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Figure 16. The effect on a myenteric neuron of prolonged exposure to 
.morphine. Before beginning the recording (time zero), this 
neuron had been exposed continuously to a solution contain-
:tng morpfine (1 pH) ar..d this solution continued to perfuse 
the tissue throughout the period of recording. During the 
periods indicated by the solid and hatched oars, the per-
fusing solution was switched to one which contained mor-
phine and naloxone respectively. Ordinate: spike frequency 
(bin width-60s). Abscissa: time. Tolerance to the in-
hioitory effect of morphine had developed--that is, increas-
ing the morphine concentration to 30 11H 'tTas without effect 
on the firing rate. Naloxone (100 nlvi) caused an increase 
in spike frequency. When a high concentration of naloxone 
(l 11M) was used the frequency of firing exceeded 10 Hz, 
(period within the dotted lines) and this excitation per-
sisted beyond the period of exposure. As a consequence of 
the naloxone (l 11M) application the longitudinal muscle 
was observed to undergo strong contractions which_led t0 
the dislodgement of the recording electrode from the gan-
glion at time 64 min. 
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cording. The mean firing rate of these neurons was 1.3 + 0.2 Hz (n = 18) 
and this rate was significantly different from that observed in control 
incubations (2.9 ~ 0.4 Hz) (mean~ S.E.M.; p < 0.05, t-test, df = 39) 
and the firing pattern was generally more erratic with distinct bursts 
of firing. Nine out of eleven units tested were not affected by increas-
ing the levorphanol concentration to 300 nM or 1 ~ (Fig. 17). When the 
levorphanol was removed from the perfusing solution during the period 
of extracellular recording, the firing rate of 2 of 2 neurons increased 
(Table 3). Similarly, an excitation was observed in 14 of 16 neurons 
when the perfusing solution was changed to one which contained either 
naloxone (100 nM - 1 ~) or Mr 2266 (100 nM - 1 ~M) in addition to 
levorphanol (100 nM). Naloxone (200 nM) excited 1 of 10 neurons by 
794% ~ 167. The excitation occurred almost immediately when the drug 
reached the tissue, persisted throughout the period of application (3 -
10 min), and rapidly declined when the solution was changed back to one 
containing only levorphanol (100 nM). The excitation was repeatable 
with subsequent applications of naloxone. Mr 2267 (100 nM - 1 ~M) and 
(+) -naloxone were without effect on the firing rate. 
Tissues were also incubated in solutions containing levorphanol 
(l ~M) (4 animals}. The mean firing rate (1.7 ~ 0.3 Hz) (n = 11) and 
pattern of firing were similar to those of neurons incubated in levor-
phanol 100 nM. Seven of 8 n~uxons tested were not inhibited by increas-
ing the levorphanol concentration to 2 - 10 ~. Normorphine (1 - 10 ~M) 
was without effect on the firing rate (n = 5); that is to say, cross-
tolerance had developed. When the levorphanol was removed from the per-
fusing solution during the period of extracellular recording, the firing 
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rate of 3 of 4 neurons increased by 775% (Table 3). When naloxone or 
Mr 2266 was added to the perfusing solution an excitation was observed 
similar to that described above for neurons incubated in levorphanol 
(100 nM) (Table 3). 
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3.5.2.4. Dextrorphan 
These results are based on extracellular recordings from myen-
teric neurons in tissue which had been incubated in dextrorphan (100 nM 
or 1 ~M). The firing rate (2.3 ~ 0.4 Hz) (n = 24), spike waveform and 
firing pattern of these neurons did not differ-markedly from those of 
control incubated tissue (p > 0.05, t-test, df = 45). Neurons treated 
in this manner were still sensitive to the inhibitory action of normor-
phine (30- 300 nM). Normorphine (300 nM) inhibited 12 of 15 cells in-
cubated in dextrorphan (100 nM), and the degree of inhibition was 83% ~ 
3. Normorphine (300 nM) inhibited 8 of 9 cells incubated in dextrorphan 
(1 ~M) by 84% ~ 5. The inhibition was rapid in onset and offset, persisted 
throughout the period of application, and these findings were not distin-
guishable from the effect of normorphine on control incubated tissue. 
In the case of dextrorphan (100 nM), changing to a dextrorphan 
free solution resulted in an excitation in 2 out of 11 cells. The ex-
citation was slight (approximately doubling of firing rate). The effect 
was observed of changing to a solution which contained dextrorphan (100 
nM) and one or other of the isomers of benzomorphan. The (-) isomer, 
(Mr 2266) (100 nM - 1 ~M) caused a small excitation in 2 of 13 cells. 
The (+) isomer (Mr 2267) (100 nM 1 ~M) had no effect on the firing 
rate of 4 cells (Fig. 17). (+)Naloxone (100 ru~- 1 ~M) also had no 
effect on firing when added to the dextrorphan containing solution. 
However, tissues incubated with the higher concentration of dextrorphan 




Figure 17. '::'he eff2ct of the narcotic o.ntagonist Mr 2266 on myenteric 
neurons exposed to levorphanol or dextrorphan for 24 h. 
Before beginning the recording. (time zero), this neuron 
had been exposed continuously either to a solution con-
taining levorphanol (100 ru1) or to one containing dextror-
phan (100,&1) for 24 h; these solutions continued to 
perfuse the tissue throughout the period of ::-ecording. 
During the periods indicated by the solid and hatched bars, 
the perfusing solution was changed to one which contained 
levorphanol and either Mr 2266 or Mr 2267. The n~~bers 
above the bars indicate the concentration (lli\1). Ordinate: 
spike frequency (bin width- 10 s). Abscissa: time. (a) 
A neuron which had been incubated in levorphanol (100 Ih\1). 
The firing rate was not inhibited by the application of a 
high concentration of levorphanol (300 nN). The inactive 
isomer of the benzomorphan antagonist Nr 2267 (100 ru\1), 
(Mr (+)),was without effect on the firing rate whereas Mr 
2266 (100 nM), (Mr (-)), caused an excitation. Even after 
the -.rashout of the antagonist the firing rate rose and fell 
for several min. (b) Mr (+) and Mr (-) were without 
effect on neurons previously incubated in dextrorphan (100 
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fusing solution resulted in an increas.e in the firing rate in 8 of 10 
neurons. Naloxone (100 nM - 1 ~M) and Mr 2266 (100 nM - 1 ~M) excited 
4 of 10 neurons (Table 3) which were incubated with dextrorphan (l ~M). 
The mean excitation produced by naloxone (200 ru~) was '545% (n = 4), and 
this value was not significantly different from the value (692% + 107) 
obtained with levorphanol (1 JlM) incubations (p > 0.05, t-test, df = 11). 
The excitation was rapid in onset and persisted throughout the period of 
application (3- 6 min). An excitation was not observed with either (+) 
-naloxone (100 n.M - 1 ~M) or Mr 2267 (100 nM - 1 ]1M) (n = 5). These 
results suggest that the higher concentration of dextrorphan was producing 
changes analogous to those caused by morphine or levorphanol. 
3.5.2.5. Buprenorphine 
The results are based on extracellular recordiP~s from 22 neur-
ons (6 animals) from tissue which had been incubated for 24 h in Krebs 
solution containing buprenorphine (30 nM). The neurons were contin-
uously·exposed to buprenorphine (30 nM) throughout the subsequent 
period of extracellular recording. The firing rate of these neurons 
(n = 12) was 2.9 ~ 0.5 Hz, and this value did not differ from that 
observed in tissue which had been incubated without buprenorphine (p > 
0.05, t-test, df = 33). Increasing the concentration of buprenorphine 
to 100 nM was without effect on the firing rate. Morphine (2 - 30 ]1M) 
had no effect on firing of 12 of 13 neurons (Fig. 18; Table 3). It is 
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possible that this represents cross-tolerance to morphine. However, 
in the naive tissue (see section 3.2.7.), buprenorphine inhibited the 
firing of only about one-quarter of cells, yet acted as a morphine 
antagonist in every case (n = 5). The blockade of morphine inhibition 
after prolonged presence of buprenorphine may, therefore, be an expres-
sion of buprenorphine's antagonist properties -to which tachyphylaxis 
has not developed. 
When the perfusing solution was changed to one which contained 
both buprenorphine (30 nM) and naloxone (100 nM - 1 ~M) or buprenorphine 
(30 nM) and Mr 2266 (100 nM- 1 ~M), the firing rate was not affected in 
15 of 16 cells (Fig. 18); one neuron was excited (Table 3). 
3.5.2.6. Ketocyclazocine 
The results are based on recordings made from 39 neurons from 
9 animals. Tissue was kept in Krebs solution containing ketocyclazocine 
(300 nM & 1 ~M) for 24 h and perfused with the same solution during the 
period of extracellular recording. The firing rate was 1.9 + 0.2 Hz (mean 
+ S.E.M.) (n = 26) and this value was not different than the value (2.9 ~ 
0.4 Hz) obtained from tissue incubated in a similar solution except that 
it lacked ketocyclazocine (p> 0.05, t-test, df = 47). Increasing the 
concentration of ketocyclazocine to 5 ~M was without effect on the firing 
rate (Fig. 19), whereas in control incubations this concentration inhib-
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ited spike discharge. Morphine (2 ~M) had no effect on the firing rate 
or decreased it by less than 50% (n = 8). Increasing the concentration 
of morphine (or normorphine) up to 6 ~M resulted in an inhibition (77% ~ 
5) of neuronal firing in ll of 20 neurons (Fig. 19): this contrasts with 
the effect of normorphine on tissue incubated with levorphanol or mor-
phine, in which neuronal firing was rarely inhibited by normorphine (5 ~M). 
Neuronal excitations were observed when the perfusing solution was changed 
to one which contained naloxone (n = 16), cyclazocine (n = 2), or Mr 2266 
(n = 8), in addition to ketocyclazocine (Table 3). The excitation by 
naloxone (200 ru~- 2 ~M), or ~rr 2266 (200 nM- 2 ~M) was marked (3- 10 
fold) (Fig. 19) and similar to that caused by naloxone in morphine-incu-
bated tissue. It began immediately upon arrival of the antagonist at 
the tissue, was concentration dependent and often repeatable on the same 
cell. The excitation produced by naloxone (200 nM) was 484% + 166 (n = 5). 
Larger concentrations of naloxone (1 and 2 ~M) gave excitations of 636% + 
162 (n = 7) and 742% + 194 (n = 5), respectively; these excitations were 
comparable to those caused by naloxone in tissues incubated with levor-
phanol (100 1~) (794% + 167) and morphine (1 ~M) (729% + 145) (mean + 
S.E.M.). 
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Figure 18. The effect on a myenteric neuron of prolonged exposure to 
buprenorphine. Before beginning the recording (time zero) 
this neuron had been expo0ed continuously to a solution 
. containing buprenorphine (30 nM) for 24 h and this solu-
tion continued to perfuse the tissue throughout the period 
of recordlng. During the periods indicated by the open, 
solid and hatched bars, the perfusing solution was changed 
to one which contained cyclic-AMP ( 250 f.!M), normorphine ( 3 & 
30 f.!H) and naloxo::1e (200 nM), respectively. Ordinate: 
spike frequency (bin width- 10 s). Abscissa: ..... '"'lme. 
Cyclic-ANP (250 }1M) caused an inhibition in firing rate 
which was maintained throughout the period during which 
the cyclic-l'u\1P. was in the bath. Application of normorphine 
(3 & 30 llM) or naloxone (200 ru~) did not significantly 




























Figure 19. The effect on a myenteric neuron of prolonged exposure to 
ketocyclazocine. ~ne tissue had been exposed to ketocy-
clazocine (1 ~M) for 24 h and was continuously bathed with 
.the same solution throughout the subsequent period of re-
cording except for the time indicated by the open bar. The 
solid, diagonally hatched, vertically hatched, and hori-
zontally hatched bars indicate the periods during which the 
perfusing solution was changed to normorphine (3 - 6 ~M), 
ketocyclazocine (5 ~M), naloxone (200 nM & 1 ~M) and cy-
clazocine (1 & 3 ]lM), respectively. Ordinate: spike fre-
quency (bin width- 10 s). Abscissa: time. (a) Normor-
phine (3 & 6 ~M) produced an inhibition in firing re.te 
which was dose-dependent. However, such concentrations of 
normorphine would completely inhibit cell firing in con-
trol incubated cells (see Fig. 15); that is to say, some 
cross-tolerance tc normorphine had developed. Ketocyclazo-
cine (5 ]lM) was without effect. Naloxone (200 nM- 1 ~M) 
produced a concentration dependent excitation. 






























Figure 19b. Same neuron as in (a). Perfusing the tissue with cyclazo-
cine (1 - 3 ~M) or a ketocyclazocine free Krebs solution 
also produced an excitation, however, the excitations pro-
. duced were not as marked as those caused by naloxone. 
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3.5.3. Prolonged Exposures In Vivo (3 days) 
---
Samples of blood were collected from guinea-pigs subcutaneously 
injected (n = 11) with morphine sulfate or implanted (n = 8) with mor-
phine pellets (see Methods). The average serum concentration of morphine 
from pellet implanted animals (n = 4) was 4.7 ~M while that of the injected 
animals (n = 6) was 12.7 ~M. Samples of blood were collected 2 h after the 
last dose was given to the injected group and on the third day following 
implantation. The average weight loss for the injected and implanted 
animals was 25 and 28 g, respectively. The ileum was removed and pre-
pared for electrophysiological recording. Either morphine or normorphine 
(200 - 500 nM) were present in the Krebs solution throughout the electro-
physiological studies. The firing rate (2.3 ~ 0.3 Hz) (n = 40), spike 
waveform and pattern of discharge of these neurons did not markedly differ 
from those observed in neurons taken from animals not pretreated with mor-
phine (3.0 + 0.2 Hz) (mean+ S.E.M.; p > 0.05, t-test, df = 119). 
- -
Increasing the concentration of morphine or normorphine up to 
10 11M was usually without effect on the firing rate (n = 47), indicating 
the development of tolerance (Fig. 20). At 3 ~M, morphine inhibited 6 of 
21 cells tested, the mean degree of inhibition of these cells being 53% ~ 
11. At 5 ~M, morphine inhibited 3 of 12 cells tested by 56% ~ 16. At 10 
11M morphine was without inhibitory effect on 4 cells to which it was applied. 
Levorphanol (1- 3 ~M) did not inhibit firing (n = 8). When the perfusing 
solution was changed to one which differed only in its lack of morphine, a 
clear increase in firing was observed in 22 of 30 neurons (Table 4). Typi-
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cally, the excitation was moderate (2 - 4 fold increase in firing rate) 
and lasted throughout the period of perfusion with the morphine-free 
solution (6- 60 min). 
Neuronal firing rates increased markedly when the perfusing 
solution was changed to one which contained both naloxone (10 ru~ - 1 ~M) 
and morphine (200 nM) (Fig. 20). Naloxone (200 nM) excited 12 of 17 
neurons by 802% ~ 84, and this value agrees well with that obtained from 
morphine incubated tissue (729% ~ 145). The excitation was rapid in on-
set, often reached frequencies of 10- 20Hz and usually persisted throu&~­
out the duration of the exposure (3- 12 min). Excitations of equal mag-
nitude could usually (65% of experiments) be produced by repeated appli-
cations of the same concentrations of naloxone to a single cell; however, 
in about one-third of cells such excitations became progressively less 
(Fig. 21). With longer periods of exposure, the excitations progressively 
declined during the presence of naloxone. The excitatory effect was 
stereospecific; that is, it was shared by Mr 2266 (100 nM- 300 nM) but 




Table 4. A comparison of the effects of narcotic agonists and. antag- ,,, 
onists on myenteric neurons which have been incubated. (-24 h). 
·in Krebs solutions containing morphine and. those removed. from.'' 
·morphine pretreated. guinea-pigs. An excitation inclicates tha.11 
the firing rate at least cloublecl. An inhibition inclicates 
th~t the firing rate fell to at least 75% of the control rate~ 
I 
Myenteric Neurons 
RESPONSE morphine incubated tissues tissue removed from morphine* 
(24 - 36 h) pretreated animals (1 - 10 h) 
0 0 
Percent of neurons 1 <; J.IM n=55 n=lO 
inhibited by opiates 2-30 ]1M 22 25 
n=27 n=47 
Percent of neurons 
excited by narcotic 
(10 nM - 1 ]1M) an- 79 70 
tagonists n=38 n=46 
Percent of neurons ex-
cited by perfusing with 
an opiate free Krebs 62 73 
solution n=21 I n=30 
*Ileum removed from morphine pretreated animals was placed in a Krebs solution containing 
morphine or norrnorphine (200- 500 nM). 
Figure 20. The effect of normorphine and naloxone on myenteric neurons 
removed from morphine pretreated guinea-pigs. The tissue 
was perfused throughout the period of recording in a Fxebs 
solution-containing morphine or normorphine (200 nM), ex-
cept for the periods indicated by the open bars. During 
the period~ indicated by the solid and hatched bars the 
solution which perfused the tissue contained normorphine 
and naloxone,respectively. Ordinate: spike freq_uency (bin 
width- 10 s). Abscissa: time. (a) The neuronal firing 
rate was slightly decreased by no:rrwrphine (NM) ( 3 J..lM) but 
was markedly increased (indicated by the area within the 
dotted lines) by the (-) isomer of naloxone (100 nM). This 
excitatory effect was not shared by the (+) isomer of 






















Figure 20b. A different cell from that in (a) . The firing rate was in-
creased by removing the morphine from the perfusing solu-
tion; and an excitation was also observed when naloxone 
.(100 nM). was added to the bathing solut1on. The increase 
in firing produced by naloxone vas rapid in onset and 1pass-
ed off' dur~ng the exposure. Ordinate: spike frequency 
(bin width-60s). Abscissa: time. 
tv1orph1ne -dependent gu,nea-pig 

































Figure 21. The effect of naloxone on a myenteric ne~ron removed from 
a morphine pretreated guinea-pig. The tissue was perfused 
throughout the period of extracellular recording in a Krebs 
~o1ution.containing morphine (500 nM). Ordinate: spike 
frequency. Abscissa: time. During the period indicated 
by'the 30li~ bexs the solution which perfused the tissue 
contained ~aloxone (100 nM). The excitatory response to 
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3.6. TIME COURSE 0~ RECOVERY FROM OPIATE TOLERANCE 
A~ID 'DEPENDENCE' 
155 
A study was undertaken to determine the time course of recove~J 
from opiate tolerance and dependence. Tissue from morphine pellet im-
planted guinea-pigs, morphine injected guinea-pigs and from drug naive 
guinea-pigs which had been incubated in Krebs solution containing mor-
phine (1 ~M) for 24 h were studied. In these experiments, morphine was 
withdrawn from the Krebs solution which perfused the neurons, and at 
various known intervals thereafter the degree of tolerance, and naloxone 
induced-excitations (manifestation of dependence; see Methods) was tested. 
A neuron was described as tolerant if 300 nM morphine (or normorphine) did 
not inhibit the neuronal firing rate by at least 50%. 
EXPeriments on tissue incubated in morphine for 24 h. The inhibitor] 
effect of a 2 - 3 min application of normorphine (300 ~~) was tested at 
different time intervals after the first exposure of the tissue to a 
morphine-free solution. A partial return to normal sensitivity (de-
fined as a 50% reduction in firing rate by normorphine 300 ~~) occurred 
rapidly during the first 2 h of morphine withdrawal; 53% of neurons had 
normal sensitivity at 2 h. However, the proportion of neurons Nitb nor-
mal sensitivity rose more slowly thereafter and by 6 - 10 h after mor-
phine removal the percent of cells (70%) which were sensitive was still 
less than in control conditions (85%) (Fig. 22; Table 5). 
~ithdrawal of morphine from the bathing solution resulted in an 
excitation (see section 3.5.2.2.). Following the withdrawal of mor~hine 
Table 5. Time course of the recovery from opiate tolerance in single 
myenteric neurons. .~ inhibition indicates that the firing 
fell to at least 50% of the control rate. 
Abbreviations: MFK- morphine-free Kcebs solution 
-RECOVERY FROM TOLERANCE 
MORPHINE TREATED ANU1A.LS (IN VIVO) 
Number of units which have returned No. of units 
to within normal sensitivity* tested Percent 
2 8 25 
3 10 30 
5 10 50 
5 8 62 
2 3 67 
0 1 0 
II PROLONGED INCUBATIONS IN MORPHINE (IN VITRO) 
Hours in Number of units which have returned No. of units 
MFK to within normal sensitivity* tested Percent 
0-1/2 0 4 0 
1/2-1 1 6 17 
1-2 9 17 53 
2-3 5 9 56 
3-4 2 3 67 
4-6 4 6 67 
6-10 T 10 TO 
*Normal sensitivity was considered to be a 50% inhibition of neuronal 




Figure 22. The effect of morphine (or normorphine) on myenteric neu-
rons undergoing opiate withdrawal. Ordinate: spike fre-
quency (bin width - 10 s). Abscissa: time. During the 
period indicated by the solid bo.rs, morphine (or normor-
phine) was added to the perfusing solution. (a) This neu-
ron had been incubated in morphine (l ~M) for 24 h and 
prior to the start of this recording (time zero) had been 
exposed to a morphine free Krebs (MFK) solution for 8 h. M:r.,. 
phine (0.3- 3 ~M)inhibited the neuronal firing rate in a 
concentration dependent manner, but ~he inhibition of fir-
ing caused was not so large as in non-incubated tissue (see 
Figs .. 3 & 8). That is, tolerance to morphine's effect was 
present even after 8 h in MFK. (b) This neuron had been 
incubated in morphine (1 ~M) for 24 h and at the arrow, the 
perfusing solution was changed to one which was free of 
morphine. Application of normorphine ( 300 n_M) at intervals 
of 15 min resulted in a progressively increasing i~hibition 
of firing during the next l h. However, even after 1 h, 
300 nM normorphine did not cause maximal inhibition of fir- · 
ing. (c) Tissue was removed from a morphine pretreated 
guinea-pig and exposed to a Krebs solution containing mor-
phine (200 ~1). Thirty min prior to the begi~~ing of the 
recording (time zero) the solution was changed to one free 
of morphine. Morphine (400 ru~ - 4 ~M) only weakly i~~ibi-
ted the firing rate, -w-hereas in control tissue a complete 
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sue removed from morphine treated animals or ileum ex-
posed 24 h to morphine (1 ~M). 
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sue removed from morphine treated animals or ileum ex-
posed 24 h to morphine (1 ~M). 
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from the perfusing solution, the neurons rapidly lost their propensity 
to be excited by naloxone. In these experiments naloxone was applied 
only once (3 min duration) to any neuron, the time of this application 
being 15, 30, 45 or 60 min after withdrawal of opiate. At 15 min all 
neurons (n = 2) were excited by naloxone; (+) -naloxone was ineffective. 
The proportion of neurons excited by naloxone fell during the first hour 
in a morphine-free solution (Table 6) until it was not different from 
that in tissue from naive animals never exposed to morphine (23%). 
Experiments on tissue from morphine pretreated guinea-Pigs. Within 2 h 
of changing to a morphine-free Krebs solution, half of the neurons 
tested had returned to normal opiate sensitivity (Table 5). In those 
cells which had recovered their normal sensitivity after withdrawal of 
morphine, the effect of subsequent prolonged exposure (30 - 60 min) to 
normorphine was studied. Normorphine (300 nM- 1 ~M) inhibited the 
neuronal firing by more than 75%, but in 4 of 7 cells tested this inhi-
bition passed off during the presence of the normorphine (Fig. 23). 
In 2 of these 4 cells, a marked increase in neuronal firing (frequencies 
> 20 Hz) was observed upon the washout of the normorphine. Such a de-
cline in the inhibitory effect of normorphine (300 ru~ or 1 ~~),or 
excitations upon r.vashout of normorphine were never observed during ex-
periments on naive tissue. These limited observations suggest that the 
signs of tolerance and excitations on withdrawal of agonist can be read-
ily reinduced in tissue which had previously had prolonged exposure to 
opiates. 
'::'issues '..rere tested vith naloxone (100 - 200 nM) at different 
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periods from the time of morphine withdrawal. A single tissue was ex-
posed to naloxone only once. The degree of excitation caused by naloxone 
(100 - 200 nM) became less as the time from withdrawal of morphine in-
creased (Fig. 24). The excitations themselves were rapid in onset and 
offset but rarely lasted throughout the period of exposure (3- 6 min). 
The excitation was not mimicked by (+) -naloxone (100- 200 nM). The 
proportion of neurons excited by naloxJne also declined progressively 
(Table 6). Sixty-six percent of the neurons were excited by naloxone 
at 15 min whereas only 25% were excited after 45 min of morphine removal. 
This latter value is not different from the proportion excited by nalox-
one in naive tissue and control incubated tissue (see sections 3.2.8. 
and 3.5.2.1.). 
These findings reveal no major differences in the action of 
opiate agonists and antagonists on guinea-pig myenteric neurons exposed 
to opiates in vitro or in vivo (Tables 4, 5 & 6). 
Table 6. The effect of naloxone on myenteric neurons undergoing with-
drawal from morphine. The number of myenteric neurons which 
showed a naloxone induced excitation decreased with increasing 
periods of exposure in morphine free Krebs (~WK) solution. 
An excitation indicates at least a doubling of the firing 
rate. After 45 min in a MFK solution naloxone failed to pro-
duce a significant number of excitations (25%) when compared 
with control tissues (15-23%). 
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TIME COURSE HI THE LOSS OF NALOXONE INDUCED EXCITATIONS 
MORPHINE TREATED Jll1IMALS (IN VIVO) 
I . 
Minutes in Humber of units excited (>2x) No. of units 
MFK by naloxone (100-200 nM) tested Percent 
0-15 2 3 66 
15-30 2 3 66 
30-45 2 4 50 
45-60 1 4 25 
60-75 0 1 0 
PROLONGED INCUBATIONS IN MORPHINE (IN VITRO) 
II 
Minutes in Number of units excited (>2x) No. of units 
MFK by naloxvne (100-200 nM) tested Percent 
0-15 2 2 100 
15-30 3 4 75 
30-45 1 4 25 
45-60 1 4 25 
60-75 0 1 0 
-
75 1 5 20 
Figure 23. The effect of nor~orphine on myenteric neurons removed 
from a morphine pretreated guinea-pig, and subsequently 
perfused in a morphine free Krebs solution. (a) Before 
~he begi~ning of this recording (time zero) the neuron had 
been exposed to a morphine free Krebs (MFK) solution for 
105 min. Ordinate: spike frequency (bin width- 10 s). 
Abscissa: time. The solid bar indicates the period dur-
ing which the bathing solution was changed to one contain-
ing normorphine (NM). Exposure to normorphine (l ~M) re-
sulted in an inhibition of neuronal firing which 'passed 
off' during the presence of the normorphine (contrast this 
with Figs. 8 & 15). Washout of the normorphine produced 
an excitation. Legend continues on the following page. 
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Figure 23b. At time zero, the neuron had been exposed to !<1FK for 70 
min. Normornhine (300 ru\1) inhibited the firing rate, and 
with the prolonged exposure to the narcotic 'tachyphylaxis' 
~o the iphibitory effect was observed. Upon washout of the 
normorphine, no marked increase in neuronal activity was 
observed. ,In tissue taken from drug naive 5~inea-pigs, ex-
posure to normorphine (300 cl~ - 1 ~M) for periods of up to 
60 min ~aused an inhibition of firing which persisted 








Figure 24. T'ne effect of naloxone on the firing rate of a myenteric 
neuron removed from a morphine pretreated guinea-pig. Be-
fore the beginning of the recording the tissue had been 
perfuse~ in a Krebs solution containing morphine (200 nM). 
Ordinate: spike frequency (bin width- 10 s). Abscissa: 
time. The. solid bar indicates the period during which the 
bathing solution was changed to one conte.ining either the 
(+) or (-) isomers of naloxone. At the arrow, the perfus-
ing solution was svitched to a Krebs solution which was · 
free of morphine (l'!FK). The excitatory effect of naloxone 
(-) diminished v:i.th each application vrhile naloxone ( +) 
was without effect. The data from this Figure was not in-
cluded in the resuJ_ts since the tissue was given naloxone 
more than once. 
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3. 7. THE EFFEC~ OF SEVEH.AL AGENTS ON THE DEVELOPHENT OF OPIATE 
TOLERANCE AND 'DEPENDENCE 1 AT THE SI.NGLE NEl.i1\0N LEVEL 
3.7.1. Synaptic Transmission Blockade 
3.7.1.1. Hexamethonium and Hyoscine 
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Incubations in hyoscine and hexamethonium. Tissues were incu-
bated for 24 h in a solution containing hyoscine (1~) and hexamethonium 
(300 ~M). The same solution perfused the tissue during the electro-
physiological experiments. The frequency and pattern of neuronal 
firing was not different from that observed in control incubated tissues. 
Morphine (300 nM) inhibited the firing of all 6 cells to which it was 
applied. Naloxone (100 n..\1 - 1 ~M) had no effect on neuronal firing 
(n = 5). The concentration of hyoscine and hexamethonium used has been 
shown to block completely cholinergic transmission in the myenteric 
plexus-longitudinal muscle preparation (Kosterlitz and Lydon, 1971) and 
to block the fast excitatory postsynaptic potentials recorded from myen-
teric neurons (Nishi and North, 1973a}. 
Incubations in mornhine, hyoscine and hexamethonium. The effects 
of opiate agonists and antagonists on tissue incubated for 24 h in a 
solution containing hexamethonilun (300 ~M), hyoscine (1 ~M) and morphine 
(1 ~M) were studied. The results are based on 20 cells from 7 animals. 
The tissue was continuously exposed to this solution throughout the 
period of extracellular recording. The basal firing rate of these cells 
was 1.5 + 0.3 Hz and this was not different from the firing rate of 
tissues incube.ted in morphine alone (1.5 .:!:._ 0.2 Hz) (mean~ S.E.M.). 
172 
Increasing the morphine concentration to 10 ~M was without ef-
fect on the firing rate, indicating that tolerance to the inhibitory 
effect of morphine had developed (Fig. 25a). Levorphanol (1- 10 ~M) 
had no effect on neuronal firing (n = 3). r~en the perfusing solution 
was changed to one which was free of morphine an increase (411%) in 
neuronal firing was observed in 2 of 3 cells. Similar but more marked 
excitations were observed when the solution was changed to one which 
contained naloxone (in addition to morphine, hyoscine and hexamethonium) 
(n = 16). The excitation produced by naloxone (100 nM) (683% ~ 102) 
occurred in 11 of 13 neurons and was not distinguishable from the ex-
citation by naloxone (636% ~191) in tissue incubated with morphine 
alone. The excitation was mimicked by Mr 2266 (100 nM - 1 ~M) (n = 3) 
but not Mr 2267 (100 nM- 1 ~M) (n = 3) or (+) -naloxone (100 nM- 1 ~M) 
(n = 2) (Fig. 25a; Table 3). 
The results described did not differ from those described for 
tissues incubated in morphine alone (1 pM) (see section 3.5.2.2. ). 
3.7.1.2. Lidocaine 
Incubations with lidocaine alone. Tissues were incubated for 
24 h in a solution containing lidocaine (1 w~). No neuronal activity 
could be recorded from tissue which continued to be perfused with such 
a solution. Within 3 - 10 min of changing to a lidocaine-free Krebs 
solution, neuronal activity could be readily recorded. Extracellular 
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recordings made in these circumstances were not distinguishable from 
those made from control incubated tissue; firing rates were unaffected 
by naloxone (100 nM - 1 ~) (n = 7) and inhibited by morphine (300 nM) 
(Fig. 26). Morphine (300 nM) inhibited 5 of 5 cells and the degree of 
inhibition was 86% + 4) (mean~ S.E.M.). 
Incubations in mornhine and lidocaine. The effects of opiate 
agonists and antagonists on tissue incubated in morphine (1 ~) and 
lidocaine (1 mM) were tested on 19 units from 5 animals. After the 
period of incubation, and during the subsequent period of extracellular 
recording, the Krebs solution contained only morphine (1 ~). 
The results obtained did not differ from those described above 
for tissue incubated in morphine alone (see section 3.5.2.2.). Mor-
phine (5 J.lM) inhibited neuronal firing by 87% + 8 in 3 of 13 cells 
tested; 10 cells were unaffected or excited. Naloxone (200 nM) (n = 11) 
or Mr 2266 (200 nM) (n = 3) produced an immediate and large increase in 
firing rate (829 ~ 116); a less marked excitation (457%) was also observed 
by changing to a morphine-free solution (3 of 4 cells}(Fig. 25b). The 
characteristics of the excitation were closely similar to those observed 
for tissue incubated in morphine alone. Mr 2267 (100 nM - 1 w1) and (+) 
-naloxone (100 nM - 1 ~M) were without effect on the firing rate (Table 
3). 
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Figure 25. Effect on a myenteric neuron of prolonged exposure to mor-
phine in conditions of synaptic transmission blockade. 
·Ordinate: spike frequency (bin width- 10 s). Abscissa: 
·time. During the periods indicated by the solid, diago-
nally hatched, vertically hatched and horizontally hatched 
ba~s, the perfusing solution was switched to one which con-
tained morphine, naloxone, Mr (+) and Mr (-),respectively. 
Note that Mr (-) and I~ (+) refer to the enantiomeric isomers 
of a benzomorphan (see Methods), Mr 2266 and Mr 2267, respect-
ively. (a) Before beginning the recording (time zero), this 
neuron had been exposed continuously to a solution containing 
morphine (1 ~M), hyoscine (1 ~M), and hexamethonium (300 ~M) 
for 24 h. This solution continued to perfuse the tissue 
throughout the period of recording except for the time in-
dicated by the open bar, when it contained only hyoscine 
and hexamethonium. Tolerance to the inhibitory action of 
morphine was evident in that a very high concentration of 
morphine (10 ~M) no longer depressed the neuronal firing 
rate. Naloxone (100 ru~) caused a pronounced increase in 
the firing (in excess of 10 Hz), ;,rr 2266 also caused a marked 
excitation, whereas its (+) isomer, Mr 2267 had no clear 
effect on the firing rate. Removing the morphine from the 
perfusing solution resulted in an increase in firing. Legend 
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Figure 25b. This neuron had been exposed continuously to a solution con-
taining morphine (1 ~M) and lidocaine (l ~~) for 24 h. 
Five min prior to the beginning of this recording (time 
.zero), the perfusing solution was changed to one which dif-
fered only in its lack of lidocaine and this solution con-
tinued to perfuse the tissue throughout the period of re-
cording except for the time indicated by the open bar. Tol-
erance to the inhibitory effect of morphine had developed, 
in that morphine (5 ~M) did not inhibit the firing rate. 
Naloxone (200 nM) and Mr (-) (200 rM) caused a marked in-
crease in firing (in excess of 10 Hz as indicated by the 
area within the broken lines), but Mr (+)was without 
effect. Changing the bathing solution to one which was 
free of morphine (indicated by open bar) also caused an in-
crease in firing. This increase did not persist throughout 
the period of exposure. 
































Figure 26. The effect on a myenteric neuron of a prolonged exposure to 
lidocaine. This neuron had been exposed continuously to a 
solution containing lidocaine (l mM) for 24 h. Ten minutes 
~rior to·the beginning of the recording (time zero), the 
bathing solution was switched to one which was free of lido-
caine (normal Krehs solution). Ordinate: spike frequency 
(bin width- 10 s). Abscissa: time. During the periods 
indicated by the solid, open, and hatched bars, the per-
fusing solution was changed to one which contained normor-
phine, naloxone and lidocaine respectively. Normorphine 
(300 ill~ - l ~M) caused a dose depe~dent inhibition of neu-
ronal firing. Naloxone (200 ruv1) was without effect on the 
firing rate. Lidocaine (l mM) depressed neuronal firing 
in a reversible manner. Compared with control treated tis-
sue, no change in neuronal sensitivity to the agents listed 
above was observed. 
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3.7.2. Protein Synthesis Inhibitors 
Incubations with cycloheximide alone. Tissues were incubated 
for 24 h in a solution containing cycloheximide ( 100 11M). The concen-
tration of cycloheximide used was similar to the concentration neces-
sa~J to block the synthesis of enkenhalin in the myenteric plexus (~c­
Knight et al., 1978). This solution perfused the tissue throughout the 
electrophysiological experiments. The rate of discharge and pat-
tern of neuronal firing were not different from those observed in con-
trol incubated tissue (see section 3.5.2.1.). Naloxone (100 nM- 1 uM) 
had no effect on neuronal firing (n = 6) and morphine (300 nM) inhibited 
(87% + 3) the firing of 7 of 7 cells. 
Incubations with morphine and cycloheximide. The effects of 
opiate agonists and antagonists on tissue incubated in a solution con-
taining morphine (1 uM) and cycloheximide (100 uM) were tested on 20 
cells from 6 animals. The same solution perfused the tissue during the 
electrophysiological recording. Neuronal firing rates ( l. 4 !. 0. 2 Hz) ( n 
= ll) <..rere not different from those observed in tissue incubated in mor-
phine alone (1.5!. 0.2 Hz). In only one of ll cells, was the firing rate 
inhibited by morphine (5 uM) (Table 3). That is, tolerance existed 
which was similar to that caused by incubations with morphine alone. 
Sixty percent of neurons were excited by changing to a solution vhich 
contained naloxone (100 ru~ - 200 nM) i~ addition to morphine and cyclo-
heximide (Table 3). The excitation caused by naloxone ( 200 nM) '.vas 
463% !. 126 ( 5 c:f 8 cells '..rere excited; 3 -..rere not affected) and "':'::lis 
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is not different than that observed with tissue incubated in morphine 
alone (729% ~ 145) (mean+ S.E.M.) (p > 0.05, t-test, df = 11). 
3.7.3. Cyclic Nucleotides 
3.7.3.1. IBMX and Dibutyryl Cyclic-AMP 
Incubations with IBMX and dbc-AMP. Tissues were incubated for 
24 h in a solution containing IBMX ( 500 1JM) and db c-AMP ( 200 lJM); and 
this solution also perfused the tissue during the electrophysiological 
experiments, The frequency of neuronal firing (1.7 ~ 0.5 Hz) was re-
duced when compared with control incubated tissues (2.9 ~ 0.4 Hz). 
Morphine (300 Q~) (or normorphine) inhibited the firing of 7 cells to 
which it was applied (88% ~ 2). Naloxone (200 nM) had no effect on 
neuronal firing (n = 6). 
Incubations with morphine, IBMX and dbc-AMP. The effects were 
studied of opiate agonists and antagonists on tissue incubated for 24 h 
in a solution containing morphine (l 1JM), IBMX (500 uM) and dbc-fu~P 
(200 uM). This same solution perfused the preparation throughout the 
subsequent period of extracellular recording. The following results 
are based on extracellular recordings from 21 neurons from 5 animals. 
~Teuronal firing rates (1.6 ~ 0.3 Hz) were not different from those ob-
served in tissues incubated in morphine alone (1.5 ~ 0.2 Hz) or in 
I3MX and dbc-AJ.'v!P (1.7 ~0.5 Hz) (p > 0.05, t-test). ~~Iorphine (3-
10 uM) failed to inhibit the firing of 9 of 11 neurons tested; two 
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neurons were inhibited. Naloxone (200 nM) produced an immediate increase 
in the firing rate in 9 of 18 neurons (557% ~ 73). The excitation caused 
by naloxone persisted throughout the period of application (3 min). Mr 
2267 (200 nM) (n = 3) and (+) -naloxone (200 nM) (n = 3) were without 
effect on the firing rate (Table 3). 
4. DISCUSSION 
4 .1. ACUTE ACTIONS OF OPIATES ON THE SPONTANEOUS 
ACTIVITY OF' SINGLE fifYENTERIC NEURONS 
Morphine has been shown to inhibit the spontaneous activity of 
single myenteric neurons recorded extracellularly (Sato et al., 1973; 
1974; Dingledine et al., 1974; 1975; 1976; North and Williams, 1977). 
The inhibition was stereospecific,occurred with low concentrations of 
morphine and was antagonized by naloxone. The present investigation 
confirmed these findings with respect to the actions of morphine on 
spontaneously firing myenteric neurons and was extended to include 
the study of the acute actions of ketocyclazocine, cyclazocine and 
buprenorphine. 
The inhibition of firing produced by ketocyclazocine and 
cyclazocine was marked, concentration-dependent, slow in offset and 
poorly antagonized by naloxone. The effective concentration range of 
ketocyclazocine and cyclazocine used in the studies of nerve-mediated 
contractile responses differed from that effective in the extracellular 
studies. The concentration of ketocyclazocine or cyclazocine required 
to inhibit the ner~e mediated contractile response-of the guinea-pig 
ileum by 50% was less than 4 nM (see section 1.4.3.) whereas the con-
centration necessary to inhibit the spontaneous activity of single 
myenteric neurons by So% was at least 8 fold higher. It is possible 
that ketocyclazocine (or cyclazocine) may act on receptors different 
to those affected by morphine (or normorphine) in mediating the inhi-
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bition of the contractile response and the inhibition of neuronal firing. 
Against this possibility is the finding that both actions are blocked 
by naloxone: however, it is not possible to say on the basis of the 
present findings whether the same concentration of naloxone (pA2 ) is 
effective against both these agonist effects. 
Another possibility is that inhibition of the contractile re-
sponse is a more sensitive measure of receptor occupancy and that the 
inhibition of neuronal firing requires a relatively higher occupancy 
before its effects are apparent with the present experimental techniques. 
Against this possibility is the finding that the IC50's for morphine, 
normorphine and enkephalin in inhibiting the contractile response of 
the guinea-pig ileum (Waterfield, Smokcum, Hughes, Kosterlitz and Hender-
son, 1977) agree well with the concentration of these agonists required 
to inhibit cell firing by approximately 50% (present results; also 
North and Williams, 1977; Williams and North, 1979a). 
The effect of buprenorphine on the spontaneous firing rate of 
single myenteric neurons was quite variable (30% of the neurons tested 
were excited, 23% were inhibited and 47% were not affected). The fact 
that buprenorphine was without inhibitory effect on 77% of neurons 
studied was somewhat surprising since all other narcotics tested inhibi-
ted 70-80% of the myenteric neurons to which they were applied. Bupren-
orphine is a highly lipophilic narcotic analgesic with an extremely slow 
rate of onset and offset (several hours) in the isolated guinea-pig 
ileum (KosteYlitz et al., 1975: Schulz and Herz, 1976b). Because of 
the spontaneous changes in firing yate of individual neurons with time 
and because successful recordings from neurons usually lasted only 1-2 n, 
drug effec"Ss ~.vhich are of slow onset would be difficult to detect. In 
addition, c,,~i th the Dresent technique it iS difficult to ascribe any 
185 
action to a drug if it cannot be reversed by washing. On the basis of 
previous studies (Schulz and Herz, 1976b), it would not be expected 
that buprenorphine's effect on spontaneously firing neUTons would rap-
idly washout. The basis of the exci-'catory action of buprenorphine was 
not fully investigated: it differed from the inhibitory effect in being 
reversible on washing. This argues against the possibility that the 
small proportion of neurons inhibited by buprenorphine was the result 
of a concomitant excitation mediated through a different mechanism. 
Analysis of the binding prope.rtie s of buprenorphine in rat 
brain homogenates has revealed the presence of saturable binding sites 
similar to those demonstrated by other workers for a series of o~iates 
(Hambrook and Rance, 1976). In this binding assay, buprenorphine had 
a 'sodium-shift' typical of narcotic antagonists. In the present elec-
trophysiological experiments, myenteric neurons were no longer sensitive 
to the inhibitory effects of normorphine at any time following the admini-
stration of buprenorphine. That is, buprenorphine acted in a manner which 
was similar to naloxone (see section 4.3.2.). This is the first demon-
stration of antagonist properties of buprenorphine at the single neuron 
level (Fig. 7). 
Do multiple forms of the opiate receptor exist on single neurons 
of the myenteric plexus? One purpose of studying the effects of mor-
phine, ketocyclazocine and cyclazocine on spontaneously firing myenteric 
neurons was to test the hypothesis that some neurons would respond to 
only one of these prototypic receptor subtype agonists. The firing rate 
of single myenteric neurons was inhibited by morphine (~ & K agonist), 
cyclazocine (cr & ~.agonist), ketocyclazocine (K-agonist) and enkephalin 
(o-agonist). In many experiments, several of these agonists were were 
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effective on the same neuron. This implies that if these agonists are 
really selective for the proposed receptor subtypes (Hartin et al., 1976) 
then all subtypes exist on each neuron. The restriction of the range of 
concentrations of cyclazocine and ketocyclazocine which were tested in 
the present study imposes some limits on the interpretation of the 
findings with respect to any such receptor subtype selectivity; however, 
the present findings, and previous ones with enkephalin, suggest that 
neurons do not bear only one receptor subtype. 
4. 2. THE INVOLVEHENT OF CYCLIC AMP IN THE ACUTE INHIBITORY 
ACTION OF OPIATES ON NEURONAL FIRING 
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Morphine has two actions in the nyenteric plexus of the guinea-
pig ileum; namely, inhibition of neuronal firing (Sato et al., 1973) and 
inhibition of neurotransmitter release (Paton, 1957). The principal aim 
of the present experiment was to test the hypothesis that inhibition of 
adenylate cyclase (and the resultant fall in cyclic-AMP levels) is an 
intermediate step between occupation of the opiate receptor by the nar-
cotic agonist and the inhibition of neuronal firing which it produces. 
The evidence for this hypothesis has been given in section 1. 3. 
4.2.1. Inhibition of Netrronal Firing 
The fact that both cyclic-ANP and morphine have similar effects 
on myenteric neurons has led to certain difficulties for theories sug-
gesting an inhibition of adenylate cyclase activity as the underlying 
mechanism of opiate action. Furthermore, the finding that the inhibi-
tion of neuronal firing by cyclic-~~ was antagonized by theophylline 
does not support the intracellular site of action for this compound 
which would be expected if cyclic nucleotides were to mediate the acute 
actions of opiates. Similar findings at other sites have led investi-
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gators to conclude that the inhibition caused by the adenine nucleotides 
is mediated through activation of an extracellular receptor (Nathanson, 
1977; Hiyashi et al., 1978). Compatible ~~than extracellular site of 
drl~ action for these compounds was the finding thBt cyclic-fu~ was more 
effective in inhibiting neuronal activity than its dibutyrylderivative, 
which supposedly penetrates through cell m~nbranes more easily (Sawynok 
Jhamandas, 1976). 
If we assume that morphine inhibits cyclic-AMP formation in the 
myenteric plexus of the guinea-pig, and that this is responsible for the 
inhibition of neuronal firing which morphine produces, then attenuation 
of the effect on cell firing might be expected in conditions where lev-
els of cyclic-AMP are elevated. However, no difference in the effective-
ness of morphine was found under such conditions. Prior or concurrent 
administration of dibutyrylcyclic-AMP (or cyclic-AMP) did not reduce the 
sensitivity of the tissue to the opiates (Fig. 11). The adenine nucleo-
tides appear to inhibit cell firing themselves by acting on the outer 
surface of the cell membrane; if a substantial amo~~t enters the cell, 
as is likely in the case of dbcyclic-AMP, then this is ineffective in 
modulating opiate action. 
The results obtained with prostaglandin E2 and IBMX likewise do 
not support the hypothesis that inhibition of adenylate cyclase is an 
intermediate step in the acute action of opiates. The sensitivity of 
the tissue to the opiates was not altered by pretreatment with PGE2 or 
IBMX. Prostaglandin E2 (10 - 30 nM) alone often had a transient ex-
citatory effect on neuronal firing,and higher concentrations led to 
marked excitations of neurons and a direct excitation of the longitudinal 
muscle. The concentration of PGE2 necessary to cause a 2.7 fold increase 
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in cyclic-At\fP levels in rat brain homogenates was 90 pM (Collier and 
Roy, 1974),and the concentration required to stimulate adenylate cyclase 
in cultured neuroblastoma-glioma was 10 ~M (Sharma, Klee and Nirenberg, 
1975). The possibility exists,therefor~that a 1000 fold increase in 
prostaglandin E2 may have revealed an antagonism of the neuronal inhibi-
tory action of morphine. A similar criticism does not apply to the 
experiments with IBMX. In this case a concentration of 50 ~M was used 
which is 10 times the Ic50 for inhibition of cyclic-AMP phosphodiesterase 
in isolated fat cells (Beavo, Rogers, Croffard, Hardman, Sutherland and 
Newman, 1970) and 2 times the IC50 for phosphodiesterase inhibition in 
rat brain homogenate (Francis, Cuthberg, Saeed, Butt and CQlli.er ~ 12.78}. 
The present results are in general agre~~ent with those reported 
1 by Duggan and Griersmith (1979) for cat spinal neurons. These investi-
gators did not observe an effect of electrophoretically applied cyclic-
M4P, its butyrylderivatives or IBMX on the nociceptive responses of 
neurons located within la~ina IV and V of the spinal cord nor did these 
substances alter the ability of electrophoretically applied morphine to 
depress the response to noxious stimulation. 
4.2.2. Inhibition or Acetylcholine Release 
Adenosine and related nucleotides depress the nerve mediated 
contractile response of the longitudinal muscle of the guinea-pig ileum 
by inhibiting the relea.se of acetylcholine (Takagi and Takayanagi, 1972; 
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Gintzler and Mussachio, 1975; Sa~7Uok and Jhamandas, 1976; Hayashi et 
al., 1978). This action is similar to that reported for morphine on 
the guinea-pig isolated ileum (Paton, 1957). However, the mechanism 
of action whereby these compounds are able to depress the release of 
acetylcholine from the cholinergic motoneurons appears to be different 
(see section 1.3.4.). 
Inhibition of the electrically induced contraction of the iso-
lated guinea-pig ileum by morphine is antagonized by prostaglandin E1 
or E2 (Schulz and Cartwright, 1976; Ehrenpreis, Greenberg and Belman, 
1973). It is important to stress that this antagonism is not specific 
for opiate agonists since the inhibito~; action of non-opiates, such 
as, tetrodotoxin and adrenaline were also effectively antagonized by 
PGE1 (Schulz and Cartwright, 1976). This action of PGE does not appear 
to be related to its ability to stimulate adenylate cyclase but rather 
to sensitize the smooth muscle to acetylcholine and in part to increase 
the release of acetylcholine from the myenteric plexus (Schulz and Cart-
wright, 1976). 
4.2.3. Conclusion 
The present results do not support the hypothesis that the inhi-
bition of adenylate cyclase is relevant to the acute inhibitory action 
of morphine on single mammalian neurons. However, it is possible that 
activation of only the a-receptor subtype might be linked to the inhibi-
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tion of adenylate cyclase activity, because the cultured neuroblastoma 
cells posses only a-receptors (Chang et a1 .. , 1979). The studies on 
neuroblastoma-glioma hybrid cells provide by far the strongest evidence 
for an involvement between opiates (or opioid peptides) and cyclic 
nucleotides. However, North and Vitek (1980) were unable to demon-
strate any interaction between either a specific a-receptor agonist or 
~-receptor agonist and the cyclic nucleotides when they studied the 
ability of their agents to depress the excitatory junction potential 
recorded intracellularly from the mouse vas deferens. That is, the 
rc50 's for D-Ala
2
-D-Leu5-enkephalin (DADL) (a-receptor agonist) and 
normorphine (~-receptor agonist) were unchanged in the presence of 
dbcyclic-AMP and IBMX:. 
It has not been demonstrated that opiates inhibit adenylate 
cyclase activity in the myenteric plexus of the guinea-pig. It 
they do, then this is probably not an intermediate step in the acute 
inhibition of neuronal firing which they produce. However, it is pos-
sible that cyclic-P-~ involvement may distinguish the acute from the 
long term actions of opiates in the guinea-pig myenteric plexus (see 
below) (Collier, 1980). 
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4.3. PROLONGED EXPOSURE TO OPIATES IN VIVO OR IN VITRO 
Extracellular recordings were made from myenteric neurons either 
removed from morphine pretreated guinea-pigs, or incubated in opiate 
containing Krebs solution. The effect of opiate agonist and antagonists 
on these neurons were compared with their effect on myenteric neurons 
from drug naive guinea-pigs. The present results have extended previous 
findings on tolerance and 'dependence' demonstrated in whole ileum 
or myenteric plexus longitudinal muscle (~WLM) preparations to the 
level of the single neuron. 
The four major questions addressed by the present study are as 
follows. First, is the reduced inhibitory effect of morphine on neuronal 
firing and the marked excitation of neurons caused by naloxone indic-
ative of opiate tolerance and dependence? Second, does the recovery 
from opiate tolerance and 'dependence' in single neurons parallel the 
time course of recoverJ in MPLM preparations or even whole animals? 
Third, is the tolerance and 'dependence' demonstrated in myenteric 
neurons following in vivo exposure to morphine similar to that pro-
duced by in vitro exposure to morphine? Fourth, can drugs incubated 
concomitantly with morphine modify any development of tolerance and 
'dependence' which is produced? These Doints will be discussed in 
order. 
193 
4.3.1. Tolerance to the Effect of Morphine 
Prolonged exposures to morphine in vivo or in vitro diminished 
the effectiveness of subsequent applications of morphine in inhibiting 
the spontaneous firing rate of myenteric neurons. Three findings indi-
cate the development of tolerance to opiates. First, spontaneous 
firing of neurons could be readily recorded even when the bathing 
solution contained morphine at a concentration which normally inhibi-
ted completely the firing rate of all opiate sensitive neurons. Sec-
ond, increasing the concentration of morphine to 5 or 10 ~M was with-
out any inhibitory effect on approximately 80% of the neurons. Third, 
levorphanol and met-enkephalin had no effect on the firing rate of 
cells pretreated with morphine: on the other hand, cyclic-AMP had the 
same inhibitory effect on morphine pretreated neurons as on untreated 
cells. 
Opiate tolerance induced in single myenteric neurons in vitro 
may not have been complete after 24-36 h of incubation. The mean firing 
rate of neurons incubated with morphine was lower (1.5 + 0.2 Hz) (mean 
~ S.E.M.) than that of control incubated tissue (2.9 + 0.4 Hz); there 
was a significant difference between the mean firing rates of the two 
groups (p < 0.05, t-test, df = 44). With such a large variability of 
firing rates within each group, any difference in frequency would have 
to be large, or a much larger s&~ple would be required, in order for 
it to be detected. The mean basal firing rate of neurons from ileum 
removed from morphine pretreated guinea-pigs (2.4 ~ 0.2 Hz) (mean~ 
S.E.~.) was not different from ~hat of freshly removed tissue (3.0 + 
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0.2 Hz) thus indicating that tolerance to morphine exposure in vivo was 
probably complete (p > 0.05, Student's t-test, df ~ 19). 
4.3.2. Manifestation of 'Dependence' -- Effect of Naloxone 
Addition of naloxone to tissue chronically exposed to morphine 
either in vitro or in vivo resulted in an increase in neuronal activity. 
This excitation almost certainly reflects at the cellular level the 
sustained contracture seen in the twitch studies (Schulz and Herz~. 1976a). 
Naloxone caused an excitation in 79% of the myenteric neurons exposed 
to morphine in vitro and 70% of the neurons exposed to morphine in vivo. 
This neuronal excitation was not simply a reversal of inhibition due to 
the morphine present in the bathing solution for the following reasons. 
First, the frequency of firing produced by naloxone often exceeded 10-
20 Hz, a discharge rarely attained in normal tissue. Second, repeated 
exposures to naloxone resulten in progressively smaller excitations. It 
is possible that with repeated applications of naloxone the tissue has 
become less dependent on morphine and,thus,exhibits weaker excitations 
(signs of dependence) to subsequent naloxone challenges. An excitatory 
effect of naloxone due· to a reversal of the inhibitory action of mor-
phine present in the bathing solution would be expected to be constant 
with each application. Third, prolonged exposures (greater than 60 
minutes) to naloxone resulted in the neuronal excitation 'passing off' 
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during the presence of naloxone. This finding could also be explained 
by a progressively reduced dependence on morphine. The excitation was 
mimicked by the benzomorphan antagonist c~~ 2266) but not its inactive 
(+)-isomer (~rr 2267) or the (+)-isomer of naloxone. This stereospeci-
ficity indicates that the excitation is probably mediated through an 
action on the opiate receptor. A less intense excitation was observed 
by changing the bathing solution from one which contained opiate to one 
which was free of opiate. 
Is it possible that it was the morphine present in the bathing 
solution, (which was added to maintain any changes induced by the pro-
longed in vivo or in vitro exposure to morphine) and not the long term 
exposure to morphine itself which was responsible for the changes in 
sensitivity to opiate agonists and antagonists that were observed? 
Some evidence has been presented already against the possibility that 
it is an ongoing inhibitory action of the morphine which is responsible 
for the~e changes; for example, the finding that repeated applications 
of naloxone do not cause repeated neuronal excitations (see above). 
Furthermore, application of normorphine (1 ~M) to naive tissue for 
periods of 60 min caused an inhibition of firing which persisted through-
out this period, and naloxone did not cause excitations (other than 
simple reversal of morphine depression) when applied after 60 min ex-
posure to normorphine (or morphine). Therefore, the possibility that 
the presence of morphine in t~e bathing solution causes a rapid desensi-
tization of the tissue is unlikely on the basis of these two findings 
and because high concentrations of morphine still produced an inhibi-
tion of firing. 
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Tolerance and 'Dependence' 
Tolerance and 'dependence' was induced by prolonged exposures 
to levorphanol or ketocyclazocine but not by prolonged exposures to 
dextrorphan. Levorphanol incubations induced tolerance to the effects 
of both morphine and levorphanol whereas dextrorphan incubations in-
duced tolerance to neither. Ketocyclazocine incubations induced tol-
erance to the effect of ketocyclazocine but demonstrated poor cross-
tolerance to the effects of morphine or normorphine (Fig. 19). Nalox-
one appeared to be less effective in precipitating a withdrawal reac-
tion (excitation) in tissues incubated with ketocyclazocine as com-
pared to tissues incubated with morphine or levorphanol. 
Morphine failed to inhibit the firing rate of myenteric neurons 
incubated in buprenorphine, but more importantly, naloxone failed to 
excite these same neurons. It is not clear whether failure of morphine 
to inhibit the firing rate of these neurons represents the development 
of cross-tolerance which exists amongst opiates or simply an ongoing 
antagonist action of buprenorphine (see section 4.1.). In support of 
the latter possibility was the finding that buprenorphine antagonized 
the antinociceptive actions of morphine in the mouse and rat tail flick 
tests, precipitated signs of abstinence in morphine dependent mice 
(actions which are analogous to those seen with narcotic antagonists) 
(Cowan et al., 1977) and antagonized the inhibitory effect of morphine 
on the spontaneous activity of single myenteric neurons (present study). 
Even if buprenorphine induces the underlying changes of toler-
ance and dependence, naloxone may be unable to excite these cells be-
cause of the high affinity of the opiate receptor for buprenorphine 
(which exceeds that for naloxone) and/or the high lipid solubility 
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of buprenorphine (Hambrook and Rance, 1976; Rance and Dickens, 1978). 
The present findings on the long term effects of buprenorphine are in 
agreement with those established for the guinea-pig isolated ileum 
(Schulz and Herz, l976b), monkey (Cow~~ et al., 1977) and human (Jasin-
ski et al. , 1978). The conclusion which is reached from these studies 
is that buprenorphine is an opiate agonist with a lov capacity to in-
duce drug dependence. 
These effects of opiate agonists and antagonists on myenteric 
neurons incubated in opiate containing Krebs solution are in many ways 
analogous to the behavioral effects observed in humans or animals sub-
jected to long term administration of morphine, levorphanol, buprenor-
phine or ketocyclazocine (see section 1.1.3.). 
The phenomena of opiate tolerance and dependence have long been 
.considered inseparable. However, the present findings with long term 
dextrorphan incubations support a possible dissociation of these two 
events. Tissues incubated in dextrorphan (l ~M) were still sensitive 
to the inhibitory action of morphine (absence of cross-tolerance) but 
when naloxone was added to the perfusing solution or when dextrorphan 
was removed a marked excitation occurred which was similar·to that ob-
served with morphine incubations (manifestation of 'dependence'). This 
action of naloxone was not observed with incubations at the lower con-
centration of dextrorphan (100 nM). It is possible that dextrorphan acts 
as a weak opiate agonist at the higher concentration (Kosterlitz and 
Waterfield, 1975b) and incubation of tissue with this drug induces as-
pects of opiate dependence without evidence of tolerance. A dissociation 
of tolerance from physical dependence has been previously reported for 
alcohol (Ritzmann and Tabakoff, 1976), LSD (Jaffe, 1975) and caffeine 
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(Ritchie, 1975). An alternative explanation is that the two phenomena 
are inextricably linked but have different time courses in their develop-
ment. That is, the development of opiate tolerance requires a longer 
period of time than the development of opiate dependence. If the con-
ditions of the incubation could be modified so as to maintain viability 
of the preparation for several days in vitro -- then the effects of 
opiate agonists and antagonists on myenteric neurons exposed to dextror-
phan for different lengths of time could be studied. In this way it 
might be possible to determine whether the two events are separable or 
just have different time courses in development. 
4.3.3. Time Course of the Recovery from Opiate Tolerance and 
'Dependence' 
Extracellular recording from single myenteric neurons from 
ileum chronically exposed to morphine in vitro or in vivo were made. 
Within 2 h of switching the bathing solution from one which contained 
morphine to one which was similar but lacked morphine, one-half of the 
neurons tested had returned to normal opiate sensitivity (in vitro 
incubations 53%; in vivo incubations 50%). A second much slower com-
ponent of the recovery process followed (Table 5). The absence of any 
inhibition by morphine (300 nM) or an inhibition which reduced the 
firing rate to not less than 50% of the control rate were the criteria 
used to establish a cell as tolerant. The question which might then 
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be asked is whether a 50% fall in the firing rate produced by morphine 
(300 nM) or normorphine (300 ru1) is really any indication of opiate 
tolerance in these cells? In tissue which has been incubated in nor-
mal Krebs solution, morphine (300 nM) reduced cell firing to less 
than 25% of the control level in 9 of 11 opiate sensitive cells. 
Therefore, failure of morphine to inhibit cell firing by at least 50% 
surely indicates development of tolerance. If the morphine was allowed 
to remain in the perfusing solution for periods exceeding 15 min, the 
inhibition was often seen to 'pass off' during the presence of the mor-
phine. This was never observed with similar concentrations of mor-
phine in control situations (Fig. 8). This finding may indicate that 
although the cells were sensitive to morphine as measured by short 
applications, there was evidence for a persisting underlying change. 
The loss of sensitivity to naloxone during the first h after 
removal of morphine was apparently monotonic (Table 6). Within 60 min 
of switching the bathing solution from one which contained morphine to 
one which was free of drug, application of naloxone had only the same 
effect on the firing rate as on the control cells never exposed to mor-
phine. The time course over which single myenteric neurons recover 
from opiate tolerance and lose the ability to be excited by naloxone 
closely follows the time course of analogous events demonstrated in 
the isolated guinea-pig ileum. Cox (1978b), while studying the nerve 
mediated contractile response, demonstrated two distinct phases in the 
recovery from opiate tolerance in the isolated guinea-pig ileum. One 
phase decayed rapidly after drug withdrawal while the second phase long 
outlasted the removal of the opiate from the bathing solution. Admini-
stration of naloxone in the first or rapidly decaying phase of toler-
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ance induced a sustained contracture of the ileum but was unable to in-
duce a contracture if administered during the second phase of tolerance 
(unless the tissue was again temporarily exposed to an opiate). The 
inference from this study was that within the myenteric plexus of the 
guinea-pig there is a homogenous population of opiate sensitive neurons 
and that each neuron exhibits two distinct phases in the recovery process. 
The present investigation suggests another possible explanation. 
That is, the biphasic pattern in the recovery process observed by Cox 
may be due to the existence of two types of myenteric neurons. One type 
rapidly regained sensitivity (eg. Fig. 23) whilst the second type re-
mained tolerant to morphine for a much longer time (eg. Fig. 22). Cox 
would have been unable to distingtlish such neuronal types in his experi-
ments on the ileum. 
There are similarities in the time course of recovery from 
opiate tolerance in vivo and in isolated tissues. That is, the biphasic 
character of this process in myenteric neurons resembles the biphasic 
pattern characteristic of humans undergoing withdrawal (see section 
1.1.3.). However, the duration of the phases of loss of tolerance in 
humans are measured in days and weeks rather than hours. 
4.3.4. In Vitro and In Vivo Exposures to Morphine --
A Comparison of Effects 
The results from tissues which have been incubated in an opiate 
containing Krebs solution for 24-36 h did not differ noticeably from those 
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of tissues which had been removed from morphine pretreated guinea-pigs 
(and maintained in morphine containing Krebs solution). r1orphine 
(2 - 30 ~M) failed to inhibit the firing rate in 78% of the neurons 
exposed to morphine in vitro and 75% of the neurons exposed to morphine 
in vivo. Naloxone increased the firing rate in 79% of the neurons 
exposed to morphine in vitro and 70% of the neurons exposed to morphine 
in vivo. Thus, both methods of exposure are equivalent. The time 
course of recovery from opiate tolerance and 'dependence' induced by 
the two methods of exposure are also similar. A biphasic recovery 
pattern for opiate tolerance and a monophasic pattern for opiate 
'depen~ence' was found with each method of exposure (Tables 5 and 6). 
~e only apparent difference between the results from the tissues sub-
jected to morphine in vitro or in vivo was the lower mean basal firing 
rate displayed by the tissues incubated in vitro. This finding has 
already been discussed (see section 4.3.1. ). The present results are 
in agreement with those reported by Opmeer and van Ree (1978). These 
authors reported that opiate tolerance and 'dependence' induced in the 
isolated guinea-pig ileum in vitro was similar in many ways to that in-
duced with in vivo exposure. In addition, these authors reported that 
the degree of opiate tolerance induced with in vitro exposure was de-
pendent on the concentration of opiate in the incubation media (0.8 -
So ~M). 
The mean plasma concentration of morphine in guinea-pigs im-
planted with morphine pellets was 4.7 ~Mat the time of death. The 
concentration of morphine in the solution used to bath the myenteric 
plexus from these same animals was 200 - 500 nt\1. It is likely that 
perfusing the tissue with a concentration of morphine 'N"hich is 10% 
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that of plasma levels may have affected the level of toleraLce and the 
time course of recovery, although it has been reported that a dose of 
morphine in human subjects which is 20% that of the normal maintenance 
dose is ·sufficient to prevent any overt signs of opiate withdrawal 
(Martin, 1971). This concentration of morphine (200- 500 nM) was 
used because it has been previously shown to correspond to the concen-
tration of morphine in guinea-pig plasma at the time of tissue removal 
(Schulz and Herz, 1976a; Schulz and Goldstein, 1973). It is possible 
that the high value of the present determination was spurious due to 
inflammation at the site of implantation (of the pellets) which re-
sulted in an increased rate of absorption, in turn yielding a higher 
plasma level. 
Plasma levels of morphine from animals which were injected 3 
times daily with morphine sulfate were considered artificially high 
because these samples of blood were taken only 2 h after the last in-
jection. A more appropriate collection interval would have been 8 h 
post-injection. 
4.3.5. Opiate Tolerance and Dependence in other 
In Vitro Systems 
Neuroblastoma x glioma hybrid cells 
Opiates inhibit adenylate cyclase activity in cultured neuro-
blastoma x glioma hybrid cells (NG108-15) (Sharma et al., 1975). When 
203 
these hybrid cells are cultured for many h in the presence of opiate 
the cells acquire tolerance to the ~~g. That is, cyclic-AMP levels 
which were originally depressed have now returned to normal values. 
Dependence on the opiate is demonstrated by the marked increase in 
cyclic-AMP levels produced by these cells when the opiate is rapidly 
withdrawn or naloxone is administered. The findings from cultured cells 
as well as those from whole animals studies (QMWS) (see section 1.1.4.) 
provide support for the involvement of the cyclic nucleotides in opiate 
tolerance and dependence. However,these studies suffer from certain 
difficulties with respect to their application; those concerning whole 
animal investigation already having been discussed (see section 1 .1. 4) 
Extrapolation of the results obtained from cultured hybrid cells to 
the level of the intact animal poses a certain difficulty; namely, how 
can results obtained from malignant tumor cells in vitro in any way 
apply to the intact,well differentiated and organized central nervous 
system of the adult mammal? This question has not been answered. 
Cultured spinal cord-dorsal root ganglia 
It was recently reported that opiates depressed the dorsal horn 
response in fetal mouse spinal cord-dorsaJ. root ganglia (DRG) explants 
(Crain et al. , 1977) . When such cord-DRG cultures were incubated (at 
35°C) in morphine (2. JlM) for 2-3 days the acute depressant action of 
morphine on sensory evoked dorsal horn responses gradually disappeared 
and increasing the concentration of morphine to 100 JlM was without 
effect. Thus, tolerance to the acute effect of morphine was demon-
strated (as was cross-tolerance to met-enkephalin) (Crain, Crain, 
Finnigan and Simon, 1979). Development of dependence was also·suggested 
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by the enhanced dorsal horn responses in tolerant cultures. The tol-
erance induced with in vitro exposure was long lasting (several days) 
after removal of the morphine but could not be induced with incubations 
at 20°C. 
These findings from eord-DRG explants confirm the present study 
on the myenteric plexus; that is, in vitro development of opiate 
tolerance and dependence in nervous tissue. However, the temperature-
dependence of the opiate tolerance mechanism (which suggests metabolic 
requirements) and the long duration of tolerance seen in the cord-DRG 
explants is in contrast to the opiate tolerance which develops in 
myenteric neurons (present study). Such differences may be due in part 
to differences in the processes involved in the development of opiate 
tolerance in central vs. peripheral neurons as well as differences in 
the stage of maturity of the neurons (differentiated vs. undifferenti-
ated). 
Indeed, one significant advantage the myenteric plexus has over 
the fetal spinal cord-DRG explant or neuroblastoma x glioma hybrid cells 
as a model to study the acute and chronic action of opiates is its full 
differentiation. With respect to this concept, results obtained from 
myenteric neurons may more closely resemble the actual opiate response 
in the adult CNS. 
4.3.6. Alteration of the Development of Opiate Tolerance and 
'Dependence' -- Concomitant Incubations with other Drugs 
·-~05 
Segments of ileum were incubated concomitantly with morphine in 
addition to agents believed to affect either protein synthesis, synaptic 
transmission or cyclic nucleotide metabolism. The purpose of these 
experiments was to determine whether the induction of opiate tolerance 
and 'dependence' in single neurons was somehow dependent on one or more 
of these factors. 
Protein synthesis inhibitors have been previously shown to sup-
press the development of opiate tolerance and dependence in whole ani-
mals and to partially suppress this development in isolated tissues 
(Sharma et al., 1975; Hammond et al., 1976). In the present study it 
was found that incubation of ileum in solutions containing cyclohexi-
mide and morphine did not prevent the development of opiate tolerance. 
That is, there was no difference in opiate sensitivity between tissue 
incubated in solutions containing morphine alone and morphine plus 
cycloheximide. , However, the response to naloxone was affecteq by the 
presence of cycloheximide in the incubation medium. Fewer neurons were 
excited by naloxone and this excitation was of a smaller magnitude when 
tissue was incubated with both morphine and cycloheximide as opposed to 
morphine alone. Two explanations for these findings are offered. First, 
in the isolated guinea-pig ileum, ~rotein synthesis inhibitors (i.e. 
cycloheximide) affect the development of opiate 'dependence' without 
affecting the development of opiate tolerance. Second, protein synthesis 
inhibitors exert their modulatory effect by inhibiting the expression 
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of dependence (neuronal excitation) and not by interfering with the 
underlying mechanism. This action may be secondary due to uncoupling 
of oxidative phosphorylation (Robbins, 1974), fall in intracellular 
pH (Robbins, 1974) or changes in the synthesis of opiate receptors. 
On the other hand, it seems likely that the development of opiate 
tolerance and 'dependence' in single myenteric neurons (as distinct 
from the expression) does not require protein synthesis. Evidence 
for this was the finding that opiate tolerance and 'dependence' could 
be induced in isolated ileum at 4°C (Hammond et al., 1976), a tempera-
ture at which a minimal amount of protein synthesis might be expected 
to be taking place (see section 1.4.5.). 
Agents affecting synaptic transmission were similarly tested 
as to their ability to modify the induction of opiate tolerance and 
'dependence'. Tissues were incubated in solutions containing mor-
phine and lidocaine; or morphine, hexamethonium and hyoscine. Lido-
caine prevented all neuronal activity throughout the 24 h period (see 
section 3.7.1.2.): and hexamethonium and hyoscine block completely 
cholinergic synaptic transmission in the myenteric plexus (see section 
3.7.1.1.). The results obtained from tissues subjected to these con-
ditions did not differ from tissues incubated in morphine alone. The 
present results therefore indicate that long term changes induced by 
morphine in single myenteric neurons are not dependent on ongoing 
neuronal activity or synaptic transmission. 
The present finding does not support those theories suggesting 
changes in synaptic transmission as the underlying mechanism of opiate 
toler&~ce and dependence. Collier (1968) advanced the idea that super-
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sensitivity of the postsynaptic cell to the presynaptic transmitter 
could be induced by morphine if it acted by suppressing synaptic trans-
mission. This drug-induced supersensitivity could account both for 
aspects of opiate tolerance and abstinence. Release of neurotrans-
mitter would remain depressed throughout the exposure to the morphine 
but changes in the postsynaptic cell would compensate for this effect 
much like the changes observed with denervation supersensitivity (Thes-
leff, 1960); as a result, tolerance to morphine deYelops, because, even 
in the presence of morphine, a normal response is observed. If, on with-
drawing the morphine, normal release of transmitter is restored, then a 
response which opposes that seen when opiates are giYen acutely should 
be observed (abstinence). However, in the isolated myenteric plexus 
there is an absence of any ongoing synaptic actiYity (Nishi and North, 
1973a), and it is well established that the action of opiates is directly 
on the cell under investigation (Dingledine et al., 1976). The present 
study indicates that opiate tolerance and dependence can be induced at 
the cellular leYel without ongoing neuronal actiYity or synaptic trans-
mission, and therefore, argues against the theo~J of Collier (1968). 
When tissues Nere incubated in solutions containing morphine, 
dbc-&~ and IBMX the results obtained were inconclusiYe. There was no 
iifference between sensitiYity of neurons in such tissue to opiates ani 
that of neurons incubated in morphine alone; howeYer, less than 50% of 
the neurons tested with r.aloxone responded with an excitation and the 
degree of excitation was small. This contrasts with the ~arked exci-
-::ations produced by naloxone in tissue incubated in solutions lacking 
a?;ents ·w-hich ~ay affect cyclic nucleotide levels. At least tl.;o possible 
explanations :f'or this finding exist. First, it is possible that in-
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creasing intracellular levels of cyclic nucleotides (cyclic-AMP) sup~ 
presses the development of opiate 'dependence' without affecting the 
development of opiate tolerance. Second, altering cyclic nucleotide 
levels may affect the development of neither. The acute action of dbc-
AMP + IBMX on myenteri·c neurons was inhibition of cell firing. Indeed, 
the mean basal firing rate of neurons incubated in dbc-"~ + IBMX was 
lower than that of control incubated tissue (see section 3.7.3.1. ). 
Perhaps the manifestation of 'dependence' (naloxone induced excitation) 
was attenuated because of an ongoing depression of neuronal activity 
caused by these compounds. In other words, IBMX and dbc-AMP have no 
effect on the underlying mechanism of opiate dependence but exert their 
modulatory effects through a physiological antagonism: IBMX and dbc-
AMP to inhibit these cells and naloxone to excite them. 
In any event, further investigation on the effects of the cyclic 
nucleotides in the mechanism underlying opiate tolerance and dependence 
should be performed prior to the assessment of a role. Such an investi-
gation should look at the time course of events leading to and the re-
covery from this state. 
4.3.7. Cellular Mechanism of Opiate 'Dependence" 
Speculation -- Enhanced Neuronal Excitability 
It has been suggested that the morphine withdrawal s~1drome re-
flects a state of rebound hyperexcitability of the CNS (Jaffe and Sharp-
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less, 1968). This withdrawal syndrome should not be considered a uni-
tary phenomenon but as an ensemble of signs which probably reflect the 
intense activation of a number of brain sites. The neurotransmitter 
systems which have been implicated in opiate withdrawal are the choliner-
gic (Frederickson, 1975), dopaminergic (Lal and Numan, 1976) and norda-
renergic (Herz et al., 1974) systems. Atropine, haloperidol and pro-
panolol have all been shown to alter the severity of the withdrawal 
syndrome. Consistent with this idea of neuronal hyperexcitability is 
an increase in activity of myenteric neurons (which have been chronic-
ally exposed to morphine) by simply withdrawing the morphine from the 
bmidng solution or by administering naloxone. The underlying mechanism 
for this increase in firing is most likely a depolarization of the cell 
membrane (Johnson and North, 1980). 
The therapeutic implications of this knowledge of hyperexcitabil-
ity for the management of opiate withdrawal are far ~eaching especially 
if the directly affected neurons can be identified. Drugs acting to 
stabilize the neuronal membrane or to produce CNS depression would most 
likely be effective agents in alleviating discomforting signs of ab-
stinence. Indeed, clonidine, a central noradrenergic agonist with 
potent_ inhibitory action in the brain (Svensson, Bunney and Aghajanian, 
1975) and guinea-pig ileum (Werner, Starke and Schuman, 1972) have been 
used to successfully withdraw subjects from a state of chronic opiate 
addiction (Gold, Redmond and Kleber, 1978). Clonidine has also been 
shown to suppress signs of morphine withdrawal in single neurons of 
the rat locus coeruleus (Aghajanian, 1978). Agents which act by stabil-
izing the cell membrane, for example the tricyclic antidepressants, are 
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also very effective in suppressing signs of morphine withdrawal in mice 
(Contreras, Tamayo and Quijada, 1977). 
Clinical manifestations of the withdrawal reaction are in a 
direction which opposes that seen when morphine is given acutely to 
drug naive individuals. This finding suggests that Himmelsbach's homeo-
static counteradaptive theory is still operative. Whatever the under-
lying mechanism,the ultimate withdrawal reaction seems to be the result 
of an increased excitability of structure and ?athways mediating specific 
physiological effects. 
4.3.8. General Conclusions 
Tolerance and 'dependence' can be induced in single mammalian 
neurons exposed to morphine in vitro. This action was mediated through 
the opiate receptor since levorphanol but not dextrorphan induced the 
response. The time course of recovery from opiate tolerance and 'depend-
ence was studied,and their pattern of recove~J was shown to be multi-
phasic - similar to the pattern observed in human addicts. ~vo types of 
myenteric neurons were observed with respect to recoverJ from opiate 
tolerance. The present findings support the 7alidi ty of the :.'IPLH prep-
aration as a u.seful C!'.Od.el to study the ur.derl:ying changes associated 
with opiate tolerance and dependence. The inability of protein syn-
thesis inhibitors or agents affecting synaptic transmission to modify 
the development of opiate tolerance and dependence argues ag<1.inst their 
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involvement in the underlying mechanism. The results with agents affect-
ing cyclic nucleotide metabolism were less clear. The results obtained 
with in vivo exposure to morphine were not different from the results 
obtained with in vitro incubations. 
The present experiments have helped in understanding the basic 
change in the properties of neurons in the tolerant/dependent state. 
The fact that naloxone so greatly excited these cells (whereas it norm-
ally is without effect) implies that the primarJ change underlying the 
withdrawal state is rebound neuronal excitability. There is recent 
evidence suggesting that the mechanism underlying this enhanced excitabil-
ity is a depolarization of the cell membrane. It is likely that drugs 
affecting membrane properties (e& membrane stabilizing drugs) or drugs 
which selectively depress the activity of opiate sensitive cells (eg. 
clonidine) will provide a pharmacological means to detoxi~J and stabil-
ize drug addicts without themselves producing dependence. The thera-
peutic implications of such drugs are far reaching in light of the fact 
that over 500,000 Americans are currently dependent on narcotics. 
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4.4. EXTRACELLULAR RECORDINGS OF MYENTERIC NEURONS -- LIMITATIONS 
Extracellular recordings afford one the oprortunity to measure 
directly the activity of single neurons and the action of drugs which 
may affect this activity (see section 1.). When applied to the myen-
teric plexus longitudinal muscle preparation this technique suffers from 
3 major criticisms. One, the firing rate of neurons was often variable 
and sporadic; this does not allow for easy interpretation of drug 
effects which may be slight. That is, it was difficult to ascribe a 
small effect to a drug because of the variability of neuronal firing. 
Two, successful recordings of single myenteric neurons usually lasted 
only 1-2 h so drug effects which were slow in onset and offset were 
not easily measured; for example, the action of buprenorphine on single 
myenteric neurons (see above). Three, extracellular recording techniques 
do not easily lend themselves to quantification of drug effects. This 
point should be stressed since it is an important one. The large vari-
ability in opiate sensitivity and neuronal firing rate amongst the 
myenteric neurons makes statistical comparisons of limited value unless 
very large samples are used; on the other hand, effects of drugs on a 
given neuron are clear, dose-dependent and readily reproducible when re-
cording conditions permit. 
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4.5. PROPOSALS FOR FUTURE RESEARCH 
The present experiments represent a preliminary approach in the 
use of this technique to study the long term effects of opiates. Three 
proposals for future studies are offered. First, a careful study of 
those drugs which may modify the development or expression of opiate 
dependence in the whole animal should be performed at the level of 
the single mammalian neuron. In this way it will be possible to deter-
mine whether these drugs are effective directly at the cellular level 
or by some indirect mechanism. Particular attention should be given to 
those drugs which are thought to stabilize the cell membrane. Second, 
an in vivo study is required of the long term effects of opiates on 
several brain sites. The action of opiate agonists and antagonists at 
these sites should be studied to determine whether these sites demon-
strate characteristics of both opiate tolerance and 'dependence'; or, 
as suggested by the lesion studies, aspects of only tolerance or of 
only dependence. Third, intracellular recordings of neurons should 
be performed so as to help elucidate the mechanisms underlying the 
changes bro,~ht on by such long term exposures to opiates. 
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